
<html lang="en"     class="pb-page"  data-request-id="46af67db-b86a-45a2-b8f9-f030ac5daac0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-6;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01858;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2" /></meta><meta name="dc.Creator" content="Kazuki  Fujimoto" /></meta><meta name="dc.Creator" content="Shuhei  Yoshida" /></meta><meta name="dc.Creator" content="Genta  Tadano" /></meta><meta name="dc.Creator" content="Naoya  Asada" /></meta><meta name="dc.Creator" content="Kouki  Fuchino" /></meta><meta name="dc.Creator" content="Shinji  Suzuki" /></meta><meta name="dc.Creator" content="Eriko  Matsuoka" /></meta><meta name="dc.Creator" content="Takahiko  Yamamoto" /></meta><meta name="dc.Creator" content="Shiho  Yamamoto" /></meta><meta name="dc.Creator" content="Shigeru  Ando" /></meta><meta name="dc.Creator" content="Naoki  Kanegawa" /></meta><meta name="dc.Creator" content="Yutaka  Tonomura" /></meta><meta name="dc.Creator" content="Hisanori  Ito" /></meta><meta name="dc.Creator" content="Diederik  Moechars" /></meta><meta name="dc.Creator" content="Frederik J. R.  Rombouts" /></meta><meta name="dc.Creator" content="Harrie J. M.  Gijsen" /></meta><meta name="dc.Creator" content="Ken-ichi  Kusakabe" /></meta><meta name="dc.Description" content="BACE1 is an attractive target for disease-modifying treatment of Alzheimer’s disease. BACE2, having high homology around the catalytic site, poses a critical challenge to identifying selective BACE..." /></meta><meta name="Description" content="BACE1 is an attractive target for disease-modifying treatment of Alzheimer’s disease. BACE2, having high homology around the catalytic site, poses a critical challenge to identifying selective BACE..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01858" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01858" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01858" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01858" /></link>
        
    
    

<title>Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01858" /></meta><meta property="og:title" content="Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0010.jpeg" /></meta><meta property="og:description" content="BACE1 is an attractive target for disease-modifying treatment of Alzheimer’s disease. BACE2, having high homology around the catalytic site, poses a critical challenge to identifying selective BACE1 inhibitors. Recent evidence indicated that BACE2 has various roles in peripheral tissues and the brain, and therefore, the chronic use of nonselective inhibitors may cause side effects derived from BACE2 inhibition. Crystallographic analysis of the nonselective inhibitor verubecestat identified explicit water molecules with different levels of free energy in the S2′ pocket. Structure-based design targeting them enabled the identification of propynyl oxazine 3 with improved selectivity. Further optimization efforts led to the discovery of compound 6 with high selectivity. The cocrystal structures of 7, a close analogue of 6, bound to BACE1 and BACE2 confirmed that one of the explicit water molecules is displaced by the propynyl group, suggesting that the difference in the relative water displacement cost may contribute to the improved selectivity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01858"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01858">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01858&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01858&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01858&amp;href=/doi/10.1021/acs.jmedchem.0c01858" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 3075-3085</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01836" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01878" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kazuki Fujimoto</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuki Fujimoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#5b303a212e3032753d2e313236342f341b2833323435343c3275383475312b"><span class="__cf_email__" data-cfemail="254e445f504e4c0b43504f4c484a514a65564d4c4a4b4a424c0b464a0b4f55">[email protected]</span></a>. Tel.: +81-6-6331-8029. Fax: +81-6-6332-6385.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuki++Fujimoto">Kazuki Fujimoto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8013-4209" title="Orcid link">http://orcid.org/0000-0001-8013-4209</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuhei Yoshida</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuhei Yoshida</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuhei++Yoshida">Shuhei Yoshida</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Genta Tadano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Genta Tadano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Genta++Tadano">Genta Tadano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoya Asada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoya Asada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Asada">Naoya Asada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kouki Fuchino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kouki Fuchino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kouki++Fuchino">Kouki Fuchino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shinji Suzuki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shinji Suzuki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shinji++Suzuki">Shinji Suzuki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eriko Matsuoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eriko Matsuoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eriko++Matsuoka">Eriko Matsuoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takahiko Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takahiko Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takahiko++Yamamoto">Takahiko Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shiho Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shiho Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shiho++Yamamoto">Shiho Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shigeru Ando</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shigeru Ando</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Drug Discovery & Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shigeru++Ando">Shigeru Ando</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoki Kanegawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoki Kanegawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Drug Discovery & Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoki++Kanegawa">Naoki Kanegawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yutaka Tonomura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yutaka Tonomura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Drug Discovery & Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yutaka++Tonomura">Yutaka Tonomura</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hisanori Ito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hisanori Ito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Drug Discovery & Disease Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hisanori++Ito">Hisanori Ito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diederik Moechars</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diederik Moechars</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diederik++Moechars">Diederik Moechars</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frederik J. R. Rombouts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederik J. R. Rombouts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederik+J.+R.++Rombouts">Frederik J. R. Rombouts</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1986-0476" title="Orcid link">http://orcid.org/0000-0003-1986-0476</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harrie J. M. Gijsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harrie J. M. Gijsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harrie+J.+M.++Gijsen">Harrie J. M. Gijsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ken-ichi Kusakabe</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ken-ichi Kusakabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#5b303e35763238333275302e283a303a393e1b2833323435343c3275383475312b"><span class="__cf_email__" data-cfemail="38535d5615515b505116534d4b5953595a5d784b50515756575f51165b57165248">[email protected]</span></a>. Tel.: +81-6-6331-6190. Fax: +81-6-6332-6385.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ken-ichi++Kusakabe">Ken-ichi Kusakabe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01858&amp;href=/doi/10.1021%2Facs.jmedchem.0c01858" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 3075–3085</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 October 2020</li><li><span class="item_label"><b>Published</b> online</span>15 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01858</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3075%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKazuki%2BFujimoto%252C%2BShuhei%2BYoshida%252C%2BGenta%2BTadano%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D6%26contentID%3Dacs.jmedchem.0c01858%26title%3DStructure-Based%2BApproaches%2Bto%2BImproving%2BSelectivity%2Bthrough%2BUtilizing%2BExplicit%2BWater%2BMolecules%253A%2BDiscovery%2Bof%2BSelective%2B%25CE%25B2-Secretase%2B%2528BACE1%2529%2BInhibitors%2Bover%2BBACE2%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3085%26publicationDate%3DMarch%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01858"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1275</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01858" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kazuki&quot;,&quot;last_name&quot;:&quot;Fujimoto&quot;},{&quot;first_name&quot;:&quot;Shuhei&quot;,&quot;last_name&quot;:&quot;Yoshida&quot;},{&quot;first_name&quot;:&quot;Genta&quot;,&quot;last_name&quot;:&quot;Tadano&quot;},{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Asada&quot;},{&quot;first_name&quot;:&quot;Kouki&quot;,&quot;last_name&quot;:&quot;Fuchino&quot;},{&quot;first_name&quot;:&quot;Shinji&quot;,&quot;last_name&quot;:&quot;Suzuki&quot;},{&quot;first_name&quot;:&quot;Eriko&quot;,&quot;last_name&quot;:&quot;Matsuoka&quot;},{&quot;first_name&quot;:&quot;Takahiko&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Shiho&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Shigeru&quot;,&quot;last_name&quot;:&quot;Ando&quot;},{&quot;first_name&quot;:&quot;Naoki&quot;,&quot;last_name&quot;:&quot;Kanegawa&quot;},{&quot;first_name&quot;:&quot;Yutaka&quot;,&quot;last_name&quot;:&quot;Tonomura&quot;},{&quot;first_name&quot;:&quot;Hisanori&quot;,&quot;last_name&quot;:&quot;Ito&quot;},{&quot;first_name&quot;:&quot;Diederik&quot;,&quot;last_name&quot;:&quot;Moechars&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;J. R. Rombouts&quot;},{&quot;first_name&quot;:&quot;Harrie&quot;,&quot;last_name&quot;:&quot;J. M. Gijsen&quot;},{&quot;first_name&quot;:&quot;Ken-ichi&quot;,&quot;last_name&quot;:&quot;Kusakabe&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;3075-3085&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01858&quot;},&quot;abstract&quot;:&quot;BACE1 is an attractive target for disease-modifying treatment of Alzheimer’s disease. BACE2, having high homology around the catalytic site, poses a critical challenge to identifying selective BACE1 inhibitors. Recent evidence indicated that BACE2 has various roles in peripheral tissues and the brain, and therefore, the chronic use of nonselective inhibitors may cause side effects derived from BACE2 inhibition. Crystallographic analysis of the nonselective inhibitor verubecestat identified explicit water molecules with different levels of free energy in the S2′ pocket. Structure-based design targeting them enabled the identification of propynyl oxazine 3 with improved selectivity. Further optimization efforts led to the discovery of compound 6 with high selectivity. The cocrystal structures of 7, a close analogue of 6, bound to BACE1 and BACE2 confirmed that one of the explicit water molecules is displaced by the propynyl group, suggesting that the difference in the relative water displacement cost may contri&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01858&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01858" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01858&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01858" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01858&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01858" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01858&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01858&amp;href=/doi/10.1021/acs.jmedchem.0c01858" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01858" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01858" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01858%26sid%3Dliteratum%253Aachs%26pmid%3D33719429%26genre%3Darticle%26aulast%3DFujimoto%26date%3D2021%26atitle%3DStructure-Based%2BApproaches%2Bto%2BImproving%2BSelectivity%2Bthrough%2BUtilizing%2BExplicit%2BWater%2BMolecules%253A%2BDiscovery%2Bof%2BSelective%2B%25CE%25B2-Secretase%2B%2528BACE1%2529%2BInhibitors%2Bover%2BBACE2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D6%26spage%3D3075%26epage%3D3085%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/jmcmar.2021.64.issue-6/20210325/jmcmar.2021.64.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">BACE1 is an attractive target for disease-modifying treatment of Alzheimer’s disease. BACE2, having high homology around the catalytic site, poses a critical challenge to identifying selective BACE1 inhibitors. Recent evidence indicated that BACE2 has various roles in peripheral tissues and the brain, and therefore, the chronic use of nonselective inhibitors may cause side effects derived from BACE2 inhibition. Crystallographic analysis of the nonselective inhibitor verubecestat identified explicit water molecules with different levels of free energy in the S2′ pocket. Structure-based design targeting them enabled the identification of propynyl oxazine <b>3</b> with improved selectivity. Further optimization efforts led to the discovery of compound <b>6</b> with high selectivity. The cocrystal structures of <b>7</b>, a close analogue of <b>6</b>, bound to BACE1 and BACE2 confirmed that one of the explicit water molecules is displaced by the propynyl group, suggesting that the difference in the relative water displacement cost may contribute to the improved selectivity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a neurodegenerative disease that accounts for most cases of dementia. In 2019, 50 million people were living with dementia, and that number is expected to reach more than 152 million by 2050<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> with the total cost for the disease estimated to be US$ 305 billion in the United States alone.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> To date, the only available treatment options for AD are acetylcholinesterase inhibitors and an <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonist, which only provide temporary symptomatic effects. Thus, there is a clear need to develop disease-modifying therapies for the underlying disease pathogenesis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">A prevalent pathological hallmark of AD is the presence of extracellular amyloid plaques composed of amyloid β (Aβ) peptides, which are generated from the amyloid precursor protein (APP) through processing by β-site amyloid precursor protein cleaving enzyme 1 (BACE1, also known as β-secretase) followed by γ-secretase. Genetic evidence from humans indicates that accumulation of Aβ is clearly involved in the pathogenesis of AD. Autosomal dominant mutations in APP and presenilin, the catalytic site of γ-secretase, increase Aβ production and thereby cause familial AD (FAD).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In contrast, the Ala673Thr mutation in APP is found to be protective against AD, where the mutation inhibits BACE1 resulting in a decrease in Aβ production by approximately 40%.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, inhibition of BACE1 is one of the most promising approaches for the development of disease-modifying therapeutics for AD.</div><div class="NLM_p">Since the discovery of BACE1, substantial efforts have been made to discover potent and brain penetrant BACE1 inhibitors,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> which culminated in several clinical compounds that have advanced into phase 3 trials, such as verubecestat (<b>1</b>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> atabecestat,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> elenbecestat,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and umibecestat<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). In spite of the advancement of multiple BACE1 inhibitors in late state clinical trials, they have failed to provide significant clinical outcomes for patients with symptoms of cognitive impairments.<a onclick="showRef(event, 'cit7e cit8c cit8d cit10b'); return false;" href="javascript:void(0);" class="ref cit7e cit8c cit8d cit10b">(7(e),8c,d,10(b))</a> The Dominantly Inherited Alzheimer Network (DIAN) study shows that accumulation of Aβ in the brain in individuals with known mutations for autosomal dominant AD begins more than 20 years before the onset of clinical symptoms, indicating the validity of the secondary prevention trials with people showing abnormal CSF Aβ levels but diagnosed as clinically asymptomatic (preclinical AD).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although the question remains as to how early therapeutic intervention is needed, such clinical trials necessitate long-term treatment, suggesting the need for safer and tolerable BACE1 inhibitors.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Profiles of Verubecestat <b>1</b> and Dihydro-1,3-oxazine <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">BACE2 is a close homologue of BACE1, and the sequence identity and similarity between these enzymes are 55 and 71%, respectively, where similarity within 6 Å around the ligand increases up to 78 and 88%, which poses a critical challenge to identify selective BACE1 inhibitors over BACE2.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In fact, of the clinical compounds in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>, compound <b>1</b> and atabecestat have low selectivity over BACE2, whereas elenbecestat and umibecestat show moderate selectivity.<a onclick="showRef(event, 'cit13c'); return false;" href="javascript:void(0);" class="ref cit13c">(13c)</a> Unlike BACE1, which is mainly expressed in the brain, the expression levels of BACE2 are high in peripheral tissues, in which transmembrane protein 27 (TMEM27), islet amyloid polypeptide (IAPP), and pigment cell-specific melanocyte protein (PMEL) are well-known substrates for BACE2. TMEM27, proproliferative plasma membrane protein, is involved in β cell production in the pancreas, while IAPP is stored in pancreatic β cells and cosecreted with insulin to maintain glucose homeostasis. Fur hypopigmentation is a major phenotype observed in BACE2 knockout mice as well as rabbits and mice chronically dosed with nonselective BACE1 inhibitors.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Recent investigations showed that BACE2 was expressed in the mouse brain, in particular the hippocampus and fiber tracts. In the same report, multiple BACE2 substrates in the brain, such as vascular cell adhesion molecule 1 (VCAM1), were identified using cultured glia cells in mice, where BACE2 processing of VCAM1 was upregulated under inflammatory conditions.<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> Further support for pursuing selectivity over BACE2 can be found in a recent report from Nižetić and colleagues, in which they indicated that BACE2 confers protection against AD. Approximately 70% of individuals with Down’s syndrome, who have an extra copy of chromosome 21, develop AD or dementia during their lifetime, whereas 100% of non-Down’s syndrome individuals inheriting triplication of the APP gene develop AD-like symptoms by the age of 60. Based on the evidence that both APP and BACE2 are expressed on chromosome 21 and BACE2 works as θ-secretase, preventing Aβ formation, and Aβ-degrading protease, the authors excellently demonstrated why about 30% of those with Down’s syndrome show delayed onset of AD.<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a> Taken together, these findings indicate that BACE2 has various roles in the peripheral tissues and the brain, and the chronic use of nonselective BACE1 inhibitors may cause side effects due to BACE2 inhibition.</div><div class="NLM_p last">Selective BACE1 inhibitors have been pursued by several organizations, leading to PF-06751979 and AM-6494, which utilized the two loop regions, the flap and 10s loops, to improve selectivity.<a onclick="showRef(event, 'cit13c ref16'); return false;" href="javascript:void(0);" class="ref cit13c ref16">(13c,16)</a> Both loops form “open” and “closed” conformations, with “open” providing a wider pocket around the region. The flap and 10s loops contain nonconserved residues between the enzymes, which cause conformational differences. Interestingly, in both loops, BACE2 prefers the “closed” conformation, whereas BACE1 can adopt both conformations, thereby accommodating larger substituents around the regions.<a onclick="showRef(event, 'cit6e ref17'); return false;" href="javascript:void(0);" class="ref cit6e ref17">(6e,17)</a> Therefore, targeting the two loops is the most commonly used method for exploring selective BACE1 inhibitors. Recently, a number of rational approaches to improve selectivity over off-targets have been reported. Most of the approaches utilize the differences in amino acid residues between the target and the off-targets, utilizing shape, electrostatics, and conformational flexibility differences. Even when the amino acid residues around the binding sites are similar, there can still be a difference in the location and thermodynamic profiles of water molecules.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Thus, targeting such water molecules could provide opportunities to gain selectivity over off-targets without depending on the difference in amino acid residues. Herein, we describe the discovery of BACE1 selective inhibitor <b>6</b>, starting from dihydro-1,3-oxazine <b>2</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> by utilizing two explicit water molecules in the S2′ pocket. Comparison of the cocrystal structures of <b>1</b> bound to BACE1 and BACE2 identified two explicit water molecules with distinct thermodynamic profiles. Following a design targeting the water molecules led to propynyl dihydro-1,3-oxazine <b>3</b> with improved selectivity. Further optimization culminated in the highly selective compound <b>6</b>. The cocrystal structures of <b>7</b>, a close analogue of <b>6</b>, bound to BACE1 and BACE2 revealed that <b>7</b> displaced one of the two water molecules in both enzymes, which provided an explanation for the selectivity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Inhibitor Design</h3><div class="NLM_p">Of the known amidine-based BACE1 inhibitors at hand, verubecestat <b>1</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> was very potent in a BACE1 fluorescence resonance energy transfer (FRET) assay<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and was also found to be equally potent to BACE2 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), whereas a close analogue of dihydro-1,3-oxazine <b>2</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> was relatively less potent for BACE2 and hence carried some selectivity over BACE2. By comparing the structures of <b>1</b> and <b>2</b>, a major difference was seen at the sulfonyl moiety in <b>1</b>, with compound <b>2</b> having a methylene at this position, and thus, we postulated that the region around the polar sulfonyl group could contribute to increase potency for BACE2. This suggested that in-depth analysis of this region might provide a clue as to how to gain BACE1 selectivity over BACE2. To this end, we solved the X-ray structures of <b>1</b> bound to both BACE1 and BACE2,<a onclick="showRef(event, 'cit13c'); return false;" href="javascript:void(0);" class="ref cit13c">(13c)</a><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> at 2.1 and 1.3 Å resolutions, respectively. Interestingly, for both BACE1 and BACE2, the cocrystal structures confirmed two explicit water molecules around the region, the S2′ pocket, although somewhat surprisingly, no clear interactions between the water molecules and the sulfonyl group are seen, as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The two conserved water molecules are also observed in crystal structures of other amidine-based inhibitors bound to BACE1 and BACE2 and form hydrogen bonds with Ser35 and Tyr71 in BACE1 and Ser51 and Tyr87 in BACE2.<a onclick="showRef(event, 'cit7a ref13 cit16g ref17 cit20b'); return false;" href="javascript:void(0);" class="ref cit7a ref13 cit16g ref17 cit20b">(7a,13,16g,17,20b)</a> Importantly, comparative analysis of the water molecules confirmed the difference in the thermodynamic stability between BACE1 and BACE2, in which the BACE1 structure had high-energy water molecules relative to those in BACE2 and thus indicated that the water molecules in BACE1 are relatively unstable. This led to our hypothesis that targeting them could cause potency loss in BACE2 and thus lead to gaining selectivity over BACE2.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structures of verubecestat <b>1</b> bound to BACE1 (A) and BACE2 (B). The key water molecules are shown as a space-filling model and colored in red. The flap and 10s loops are highlighted in yellow and purple, respectively. Compound <b>1</b> and key residues are depicted as stick models. Numerical values beside water molecules represent their binding free energy, which were calculated using the solvent analysis module in MOE2016.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Identification of Propynyl Oxazine <b>3</b></h3><div class="NLM_p">Based on this hypothesis, we started our efforts by designing substituted head groups (dihydro-1,3-oxazine moiety) that can provide vectors toward the water molecules using the cocrystal structure of <b>2</b> bound to BACE1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Consistent with the structure of <b>1</b> bound to BACE1, the two conserved water molecules were observed in <b>2</b> bound to the BACE1 structure.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Of the designed head groups with substituents at the 4-, 5-, or 6-positions, we found that those with a linear substitution of a propynyl group at the 4-position could reach the water molecules (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), which prompted us to synthesize 4-propynyl oxazine <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). As expected, BACE2 potency in <b>3</b> was significantly decreased, along with a slightly decreased potency in BACE1, leading to improved selectivity over BACE2 (25-fold). The cocrystal structure of <b>3</b> bound to BACE1 revealed that the propynyl group in <b>3</b> successfully displaces one of the two conserved water molecules (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) and has no interactions with the amino acid residues in BACE1. The significant potency loss in BACE2 relative to that in BACE1 could account for the difference in thermodynamic stabilities of the water molecules; thus, there are tightly bound water molecules in BACE2, while BACE1 has loosely bound ones. This led to a relative difference in the water displacement cost when <b>3</b> displaced them and resulted in the gain in selectivity over BACE2.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of compound <b>2</b> (A) (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J0P">4J0P</a>) and <b>3</b> (B) bound to BACE1. The color schemes of water, residues, and loops are the same as for <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Profiles of Propynyl Oxazines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Biochemical FRET assay using APP-derived peptides. Values represent the mean values of at least two independent experiments.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization Leading to Compound <b>6</b></h3><div class="NLM_p">Incorporation of the propynyl group also led to a lowering of the p<i>K</i><sub>a</sub> value of the amidine basic center by 1.5 units, which resulted in a reduced P-gp efflux of 5.7 in an MDR1-LLC-PK cell line. However, the P-gp efflux and hERG inhibitory activity were still high (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Our previous study demonstrated that the use of a fluoromethoxypyrazine in the amide substituent impaired P-gp efflux and hERG inhibition.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Indeed, compound <b>4</b> with the fluoromethoxypyrazine mitigated these liabilities and further improved selectivity (>69-fold), although the improvements came at the price of reduced BACE1 potency. Stabilizing the bioactive conformation was an approach adopted by scientists at Merck<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and our laboratory<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> to improve BACE1 activity in an amidine series of BACE1 inhibitors, where incorporation of a fused ring system at the 4- and 5-postions or a fluorine substituent at the 5-position contributed to better potency. Modeling studies of possible head groups suggested that introduction of spirocycles could stabilize the bioactive conformation. As for the fluorine substituent at the 5-position, consistent with the previous report, the compound with the (5<i>R</i>)-configuration alone showed the stabilizing effect (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf" class="ext-link">Figure S1</a>, see the Supporting Information). Of these head group variations, we postulated that incorporation of a difluorocyclobutyl and a fluorine substituent could not only improve potency in BACE but also reduce hERG inhibition and P-gp efflux via its p<i>K</i><sub>a</sub> lowering effect. As expected, these stabilizing effects on the bioactive conformation translated into increased BACE1 potency for both the 5-fluoro and difluorocyclobutyl compounds <b>5</b> and <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), although <b>5</b> showed relatively reduced cellular potency due to its low p<i>K</i><sub>a</sub> values.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> Compound <b>6</b> was found to be highly BACE1 selective in the biochemical assay (107-fold) with a balanced profile, considering cellular potency, hERG inhibition, and P-gp efflux. In APP-transfected SNKBE2 cells, <b>6</b> inhibited Aβ42 secretion with an IC<sub>50</sub> of 6.9 nM, while in TMEM27-transfected Min6 cells, <b>6</b> inhibited TMEM27 N-terminal domain secretion with an IC<sub>50</sub> of 1290 nM, indicating a BACE1/BACE2 cell potency selectivity of 187-fold. Finally, to correctly determine its BACE1 selectivity over BACE2, we employed a competitive binding assay using a previously reported tritiated nonselective BACE1/BACE2 inhibitor (JNJ-962),<a onclick="showRef(event, 'cit13c'); return false;" href="javascript:void(0);" class="ref cit13c">(13c)</a> where compound <b>6</b> showed <i>K</i><sub>i</sub> values of 3.5 and 1091 nM, respectively, for BACE1 and BACE2, corresponding to an affinity selectivity of 312-fold.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. hERG Inhibitory Activity, P-gp Efflux Ratio, and p<i>K</i><sub>a</sub> Values for Compounds <b>2</b>–<b>4</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center" char=".">hERG inhib at 3 μM (%)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">P-gp ER<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Percent inhibition at 3 μM measured in CHO cells transfected with hERG channels using an automated patch clamp system.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Efflux ratio measured in LLC-PK cells transfected with human MDR1.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">p<i>K</i><sub>a</sub> determined by capillary electrophoresis.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Substituents at the 5-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0009.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">FRET IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center" char=".">BACE1</th><th class="colsep0 rowsep0" align="center">BACE2</th><th class="colsep0 rowsep0" align="center" char=".">cellular Aβ IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">hERG inhib at 3 μM (%)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">P-gp ER<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">145</td><td class="colsep0 rowsep0" align="left">>10,000</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">631</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left">2570</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Biochemical FRET assay using APP-derived peptides. Values represent the mean values of at least two independent experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> determined by measuring the levels of Aβ42 in human neuroblastoma SKNBE2 cells expressing the wild-type amyloid precursor protein.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Percent inhibition at 3 μM measured in CHO cells transfected with hERG channels using an automated patch clamp system.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Efflux ratio measured in LLC-PK cells transfected with human MDR1.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">p<i>K</i><sub>a</sub> determined by capillary electrophoresis.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structural Analysis of Compound <b>7</b> Bound to BACE1 and BACE2</h3><div class="NLM_p">To confirm the hypothesis that the improved selectivity was related to displacement of the water molecules, the cocrystal structures of <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf" class="ext-link">Chart S1</a>), a close analogue of <b>6</b>, bound to BACE1 and BACE2 were solved (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Consistent with the propynyl oxazine <b>3</b> bound to BACE1, one of the two conserved water molecules in BACE1 is also displaced (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Also, displacement of the water molecule is observed in the BACE2–compound <b>7</b> complex, which disrupts the hydrogen-bond network of the water molecules in BACE2 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). This confirms the hypothesis that displacing the tightly bound water molecules in BACE2, relative to those in BACE1, could increase BACE1 selectivity over BACE2 due to the relative difference in water displacement costs. Our previous report demonstrated that incorporation of spirocycles with six-membered rings, as in compound <b>8a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf" class="ext-link">Chart S1</a>), improved selectivity over BACE2 via the interaction with the flap, whereas improvement in selectivity by use of the corresponding difluorocyclobutyl group (<b>8b</b>) was minimal relative to the nonsubstituted <b>8c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf" class="ext-link">Chart S1</a>). Indeed, no significant movement of the flap in the structure of <b>7</b> bound to BACE2 was seen when compared with the apo-BACE2 structure (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf" class="ext-link">Figure S2</a>). Thus, the gain in selectivity observed with compound <b>6</b> would be attributable to the displacement of the water molecules in BACE1 and BACE2 and not to the interaction with the flap.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of <b>7</b> bound to BACE1 (A) and BACE2 (B). The color schemes of water, residues, and loops are the same as for <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of the propynyl oxazines <b>3</b> and <b>4</b> started with aldehyde <b>9</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Addition of propynylmagnesium bromide to <b>9</b> yielded alcohol <b>10</b>. Oxidation of <b>10</b> and subsequent reaction with (<i>R</i>)-<i>tert</i>-butylsulfinamide<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> provided ketimine <b>11</b>. The titanium enolate prepared from the lithium enolate of <i>tert</i>-butyl acetate was reacted with <b>11</b> to give the ester <b>12</b>. The ester group in <b>12</b> was reduced to the corresponding alcohol, after which the sulfinyl group was removed and the resulting amine condensed into benzoylthiourea <b>13</b>. Subsequent oxazine ring formation using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) yielded <b>14</b>. After removal of the benzoyl group, the deprotected compound was nitrated to give <b>15</b>. Finally, reduction of the nitro group and subsequent amide formation provided the target compounds <b>3</b> and <b>4</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Propynyl Oxazines <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-propynylmagnesium bromide, THF, 0 °C, and quant; (b) (i) 2-iodoxybenzoic acid, EtOAc, and reflux and (ii) (<i>R</i>)-<i>tert</i>-butylsulfinamide, Ti(OEt)<sub>4</sub>, toluene, 80 °C, and 66% over two steps; (c) <i>n</i>-BuLi, diisopropylamine, <i>tert</i>-butyl acetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, and 80%; (d) (i) LiBH<sub>4</sub>, MeOH, THF, and rt, (ii) 4 M HCl in 1,4-dioxane, MeOH, and rt, and (iii) BzNCS, DCM, 0 °C to rt, and 86% over three steps; (e) EDC·HCl, THF, MeCN, 0 °C to rt, and 55%; (f) (i) DBU, MeOH, and 60 °C, (ii) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C, and 88% over two steps; (g) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, and 64%; and (h) RCOOH, EDC·HCl, aq HCl, MeOH, rt, and 87 and 75% for <b>3</b> and <b>4</b>, respectively.</p></p></figure><div class="NLM_p">Compounds <b>6</b> and <b>7</b> were synthesized according to a modified procedure for compounds <b>3</b> and <b>4</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Addition of the titanium enolate of benzyl 3,3-difluorocyclobutane-1-carboxylate to ketimine <b>11</b> provided compound <b>18</b>, which was then reduced to the corresponding alcohol <b>19</b> followed by deprotection of the sulfinyl group and with subsequent urea formation yielding <b>20</b>. Ring closure using the Burgess reagent formed an oxazine ring to afford <b>21</b>,<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> which was followed by deprotection of the benzoyl group to give <b>22</b>. Finally, the intermediate <b>22</b> was converted to propynyl oxazines <b>6</b> and <b>7</b>, following the procedures shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Propynyl Oxazines <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, benzyl 3,3-difluorocyclobutane-1-carboxylate, diisopropylamine, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, and 59%; (b) LiBH<sub>4</sub>, MeOH, THF, rt, and 60%; (c) (i) 4 M HCl in 1,4-dioxane, MeOH, and rt, (ii) BzNCO, DCM, 0 °C, and 80% over two steps; (d) Burgess reagent, toluene, reflux, and 50%; (e) DBU, MeOH, 60 °C, and 68%; and (f) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, and −30 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, and 80 °C, and (iii) RCOOH, EDC·HCl, aq HCl, MeOH, 0 °C, and 62 and 81% over three steps for <b>6</b> and <b>7</b>, respectively.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A structure-based design targeting explicit water molecules in BACE1 and BACE2 enabled discovery of a highly selective BACE1 inhibitor <b>6</b>. Our medicinal chemistry efforts began with comparative analysis of the cocrystal structures of the nonselective BACE1 inhibitor verubecestat <b>1</b> and the moderate selective oxazine <b>2</b>, where we identified two explicit water molecules in the S2′ pocket having distinct free energy levels. Incorporation of a propynyl group at the 4-position of the oxazine ring in <b>2</b> (<b>3</b>) successfully reached the water molecules and displaced one of the two water molecules in BACE1, leading to improved selectivity over BACE2. Further optimization of the amide substituent followed by conformational analysis culminated in the propynyl oxazine <b>6</b> with a well-balanced profile of selectivity, cellular potency, hERG inhibition, and P-gp efflux. Compound <b>6</b> exhibited a high 107-fold biochemical selectivity, 187-fold cellular selectivity, and 312-fold affinity selectivity. Consistent with the structure of <b>3</b> bound to BACE1, the cocrystal structures of <b>7</b>, a close analogue of <b>6</b>, bound to BACE1 and BACE2 confirmed that the propynyl group displaced one of the explicit water molecules in both enzymes. Given the distinct free energy levels of the two water molecules between the enzymes and no interactions of the propynyl group with amino acid residues, we believe that the improved selectivity observed in <b>6</b> was achieved through the relative difference in the water displacement cost. Although the difference in conformation in the flap and 10s loops is often employed to modulate BACE1/2 selectivity, leveraging the explicit water molecules as presented here offers a novel approach for the rational design of BACE1 selective inhibitors over BACE2.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Chemistry</h3><div class="NLM_p">All commercial reagents and solvents were used as received without further purification. Flash column chromatography was carried out on an automated purification system using Yamazen or Fuji Silysia prepacked silica gel columns. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 400 and 100 MHz, respectively. Spectral data are reported as follows: chemical shift (as ppm referenced to tetramethylsilane), integration value, multiplicity (s = singlet, d = doublet, dd = double doublets, ddd = double double doublet, dt = double triplet, t = triplet, q = quartet, m = multiplet, and br = broad peak), and coupling constant. Analytical LC/MS was performed on a Shimadzu Shim-pack XR-ODS (C18, 2.2 μm, 3.0 × 50 mm, a linear gradient from 10 to 100% B over 3 min and then 100% B for 0.5 min (A = water + 0.1% formic acid; B = MeCN + 0.1% formic acid), and a flow rate of 1.6 mL/min) using a Shimadzu UFLC system equipped with an LCMS-2020 mass spectrometer, LC-20AD binary gradient module, SPD-M20A photodiode array detector (detection at 254 nm), and SIL-20AC sample manager. The purity of all compounds used in the bioassays was determined by this method to be >95%. High-resolution mass spectra were recorded on a Thermo Fisher Scientific LTQ Orbitrap using electrospray positive ionization.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-(2-Fluorophenyl)but-2-yn-1-ol (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>9</b> (5.64 g, 45.4 mmol) in THF (23 mL) at 0 °C was added a solution of 1-propynylmagnesium bromide (0.5 M in THF; 100 mL, 50.0 mmol). After stirring for 0.5 h, the mixture was diluted with aqueous NH<sub>4</sub>Cl solution. The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography using 5–20% EtOAc in hexane gradient to provide compound <b>10</b> (7.59 g, 46.2 mmol, 102%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.66 (1H, td, <i>J</i> = 7.6, 1.8 Hz), 7.34–7.28 (1H, m), 7.17 (1H, td, <i>J</i> = 7.6, 0.9 Hz), 7.06 (1H, ddd, <i>J</i> = 10.3, 8.3, 0.9 Hz), 5.73–5.70 (1H, m), 2.26 (1H, dd, <i>J</i> = 5.8, 0.8 Hz), 1.91 (3H, d, <i>J</i> = 2.3 Hz).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>R</i>,<i>E</i>)-<i>N</i>-(1-(2-Fluorophenyl)but-2-yn-1-ylidene)-2-methylpropane-2-sulfinamide (<b>11</b>)</h4><div class="NLM_p last">A mixture of <b>10</b> (7.59 g, 45.4 mmol) and 2-iodoxybenzoic acid (19.1 g, 68.1 mmol) was heated to reflux for 6.5 h. The mixture was allowed to cool to room temperature, filtered, and then evaporated to afford the crude compound (7.22 g). To a solution of this compound in toluene (36 mL) were added (<i>R</i>)-2-methylpropane-2-sulfinamide (9.71 g, 80.2 mmol) and Ti(OEt)<sub>4</sub> (23.3 mL, 111 mmol). After stirring at 80 °C for 19 h, the mixture was diluted with MeCN and H<sub>2</sub>O. After stirring at room temperature for 15 min, the mixture was filtered through Celite, and the filtrate was evaporated. The crude compound was purified by silica gel column chromatography using 10–40% EtOAc in hexane gradient to provide compound <b>11</b> (7.92 g, 66% in two steps) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.89 (1H, td, <i>J</i> = 7.5, 1.4 Hz), 7.49–7.43 (1H, m), 7.20 (1H, td, <i>J</i> = 7.5, 0.9 Hz), 7.12 (1H, ddd, <i>J</i> = 11.0, 8.3, 0.9 Hz), 2.20 (3H, s), 1.32 (9H, s). MS-ESI (<i>m</i>/<i>z</i>): 266 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl (<i>R</i>)-3-(((<i>R</i>)-<i>tert</i>-Butylsulfinyl)amino)-3-(2-fluorophenyl)hex-4-ynoate (<b>12</b>)</h4><div class="NLM_p last">To a solution of diisopropylamine (11.8 mL, 84.0 mmol) in THF (45 mL) at −78 °C was added dropwise <i>n</i>-BuLi (1.55 M in hexane; 54.1 mL, 84.0 mmol). The mixture was allowed to warm to 0 °C and stirred at the same temperature for 20 min. The mixture was again cooled to −78 °C, and a solution of <i>tert</i>-butyl acetate (9.74 g, 84.0 mmol) in THF (30 mL) was added dropwise to the mixture. After stirring at the same temperature for 15 min, a solution of ClTi(O<i>i-</i>Pr)<sub>3</sub> (26.7 mL, 112 mmol) in THF (30 mL) was added dropwise at −78 °C. The mixture was stirred at the same temperature for 15 min, and then <b>11</b> (7.42 g, 28.0 mmol) in THF (30 mL) was added dropwise. After being stirred for 40 min, the mixture was quenched with aqueous NH<sub>4</sub>Cl solution. The resulting mixture was filtered through Celite and evaporated. The residue was purified by flash column chromatography using 10–40% EtOAc in hexane gradient to give <b>12</b> (8.51 g, 80%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (1H, t, <i>J</i> = 7.9 Hz), 7.33–7.27 (1H, m), 7.14 (1H, t, <i>J</i> = 7.5 Hz), 7.01 (1H, dd, <i>J</i> = 12.3, 8.2 Hz), 5.39 (1H, s), 3.43 (1H, d, <i>J</i> = 14.8 Hz), 2.95 (1H, d, <i>J</i> = 14.8 Hz), 1.97 (3H, s), 1.39 (9H, s), 1.20 (9H, s). MS-ESI (<i>m</i>/<i>z</i>): 382 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-<i>N</i>-((3-(2-Fluorophenyl)-1-hydroxyhex-4-yn-3-yl)carbamothioyl)benzamide (<b>13</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (8.50 g, 22.3 mmol) and MeOH (2.71 mL, 66.8 mmol) in THF (85 mL) was added LiBH<sub>4</sub> (3.0 M in THF; 22.3 mL, 66.8 mmol) at 0 °C. After being stirred for 1 day at room temperature, the mixture was cooled to 0 °C and then quenched with AcOH and H<sub>2</sub>O. The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (6.20 g) as a white solid. A mixture of this crude compound (1.57 g) and HCl (4 M in 1,4-dioxane; 1.89 mL, 7.56 mmol) in MeOH (4.7 mL) was stirred at room temperature for 15 min. The mixture was diluted with isopropyl ether, and the organic layer was back extracted with H<sub>2</sub>O. The aqueous layer was basified with NaHCO<sub>3</sub>, and then the aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (1.04 g) as a pale yellow oil. To a solution of this crude compound (430 mg) in dichloromethane (DCM) (4.3 mL) at 0 °C was added benzoyl isothiocyanate (BzNCS) (372 mg, 2.28 mmol) in DCM (2.2 mL). After being stirred at room temperature for 30 min, the reaction mixture was diluted with H<sub>2</sub>O. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography using 10–50% EtOAc in hexane gradient to provide compound <b>13</b> (740 mg, 86% over three steps) as a yellow amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.64 (1H, s), 8.84 (1H, s), 7.89–7.82 (3H, m), 7.63–7.59 (1H, m), 7.52–7.48 (2H, m), 7.31–7.26 (1H, m), 7.17 (1H, td, <i>J</i> = 7.6, 1.0 Hz), 7.00 (1H, ddd, <i>J</i> = 12.2, 8.2, 1.1 Hz), 4.10–4.05 (1H, m), 3.90–3.86 (1H, m), 2.75 (1H, ddd, <i>J</i> = 13.8, 7.5, 5.4 Hz), 2.37 (1H, dt, <i>J</i> = 13.9, 5.4 Hz), 2.03 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 371 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-<i>N</i>-(4-(2-Fluorophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-yl)benzamide (<b>14</b>)</h4><div class="NLM_p last">To a solution of <b>13</b> (740 mg, 2.00 mmol) in THF (7.4 mL) and MeCN (15 mL) was added EDC·HCl (766 mg, 4.00 mmol) at 0 °C. After being stirred at room temperature overnight, the mixture was diluted with H<sub>2</sub>O. The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography using 10–50% EtOAc in hexane gradient followed by amino silica gel column chromatography using 10–40% EtOAc in hexane gradient to provide compound <b>14</b> (370 mg, 55%) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.79 (1H, br s), 8.24–8.22 (2H, m), 7.64 (1H, td, <i>J</i> = 8.0, 1.6 Hz), 7.51–7.46 (1H, m), 7.43–7.35 (3H, m), 7.20 (1H, td, <i>J</i> = 7.8, 1.1 Hz), 7.13 (1H, ddd, <i>J</i> = 11.9, 8.2, 1.1 Hz), 4.69 (1H, ddd, <i>J</i> = 11.4, 9.2, 3.0 Hz), 4.36 (1H, ddd, <i>J</i> = 11.5, 5.8, 3.6 Hz), 2.68 (1H, ddd, <i>J</i> = 14.0, 9.3, 3.6 Hz), 2.52 (1H, ddd, <i>J</i> = 14.0, 5.9, 3.0 Hz), 1.92 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 337 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-4-(2-Fluoro-5-nitrophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-amine (<b>15</b>)</h4><div class="NLM_p last">A mixture of <b>14</b> (290 mg, 0.862 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (130 μL, 0.862 mmol) in MeOH (8.7 mL) was stirred at 60 °C overnight. The reaction mixture was cooled to room temperature and treated with HCl solution (2 M in water). The mixture was diluted with Et<sub>2</sub>O, and the organic layers were back extracted with H<sub>2</sub>O. The aqueous layer was basified with aqueous K<sub>2</sub>CO<sub>3</sub> solution and extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (180 mg) as a white solid. To a solution of this crude compound in TFA (1.2 mL) at −20 °C was added sulfuric acid (310 μL, 5.81 mmol). After being stirred at the same temperature for 10 min, to the mixture was added dropwise HNO<sub>3</sub> (52.0 μL, 1.16 mmol). The reaction mixture was stirred at −20 °C for 20 min and then poured into aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography using 0–1% MeOH in CHCl<sub>3</sub> gradient to provide compound <b>15</b> (210 mg, 88% over two steps) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.76 (1H, dd, <i>J</i> = 6.8, 3.0 Hz), 8.18–8.16 (1H, m), 7.18 (1H, dd, <i>J</i> = 10.2, 8.9 Hz), 4.57 (1H, td, <i>J</i> = 11.1, 2.8 Hz), 4.21 (1H, dt, <i>J</i> = 11.0, 3.8 Hz), 4.15 (2H, br s), 2.56–2.50 (1H, m), 2.00 (1H, ddd, <i>J</i> = 13.7, 11.4, 4.1 Hz), 1.86 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 278 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>R</i>)-4-(5-Amino-2-fluorophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-amine (<b>16</b>)</h4><div class="NLM_p last">A suspension of <b>15</b> (210 mg, 0.757 mmol), Fe (338 mg, 6.06 mmol), and NH<sub>4</sub>Cl (486 mg, 9.09 mmol) in toluene/H<sub>2</sub>O (2.1 mL/2.1 mL) was stirred at 80 °C for 2 h. The mixture was cooled to room temperature, quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution, and filtered through Celite. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by amino silica gel column chromatography using 0–2% MeOH in CHCl<sub>3</sub> gradient to provide compound <b>16</b> (120 mg, 64%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.06 (1H, dd, <i>J</i> = 6.8, 3.0 Hz), 6.82 (1H, dd, <i>J</i> = 11.3, 8.5 Hz), 6.54–6.50 (1H, m), 4.45 (1H, ddd, <i>J</i> = 10.8, 9.8, 3.0 Hz), 4.09 (1H, ddd, <i>J</i> = 10.8, 5.2, 3.9 Hz), 4.04 (2H, br s), 3.55 (2H, br s), 2.47–2.41 (1H, m), 2.14 (1H, ddd, <i>J</i> = 13.7, 9.8, 3.9 Hz), 1.86 (3H, t, <i>J</i> = 7.0 Hz). MS-ESI (<i>m</i>/<i>z</i>): 248 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-<i>N</i>-(3-(2-Amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide (<b>3</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (27.5 mg, 0.111 mmol), 5-cyanopicolinic acid (16.5 mg, 0.111 mmol), and HCl (2 M in water; 55.6 μL, 0.111 mmol) in MeOH (2.0 mL) was added EDC·HCl (23.5 mg, 0.122 mmol) at 0 °C. The mixture was stirred at room temperature for 30 min and quenched with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub><span class="strike">4</span></sub>, filtered, and concentrated. The crude product was triturated with hexane/EtOAc (10/1) to give <b>3</b> (36.3 mg, 87%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.86 (1H, br s), 8.91 (1H, br s), 8.43 (1H, d, <i>J</i> = 8.1 Hz), 8.20 (1H, dd, <i>J</i> = 8.1, 1.9 Hz), 8.05–8.01 (1H, m), 7.81 (1H, dd, <i>J</i> = 6.9, 2.8 Hz), 7.09 (1H, dd, <i>J</i> = 10.9, 8.9 Hz), 4.54 (1H, td, <i>J</i> = 10.7, 2.7 Hz), 4.19–4.13 (1H, m), 4.09 (3H, br s), 2.57–2.51 (1H, m), 2.13–2.05 (1H, m), 1.87 (3H, s). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 159.95, 157.22 (d, <i>J</i> = 247.2 Hz), 152.81, 152.39, 150.70, 141.26, 133.70 (d, <i>J</i> = 12.5 Hz), 132.85 (d, <i>J</i> = 2.9 Hz), 122.34, 120.22 (d, <i>J</i> = 8.1 Hz), 120.14 (d, <i>J</i> = 3.7 Hz), 116.80 (d, <i>J</i> = 24.2 Hz), 115.95, 112.40, 81.33, 78.99 (d, <i>J</i> = 2.9 Hz), 63.35, 50.83 (d, <i>J</i> = 1.5 Hz), 33.71 (d, <i>J</i> = 3.7 Hz), 3.84. MS-ESI (<i>m</i>/<i>z</i>): 378 [M + H]<sup>+</sup>. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>O<sub>3</sub>N<sub>5</sub>F<sub>2</sub>, 402.1372; found, 402.1365.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>R</i>)-<i>N</i>-(3-(2-Amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>4</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (50.0 mg, 0.202 mmol), 5-(fluoromethoxy)pyrazine-2-carboxylic acid (36.5 mg, 0.212 mmol), and HCl (2 M in water; 101 μL, 0.202 mmol) in MeOH (1.0 mL) was added EDC·HCl (42.6 mg, 0.222 mmol) at 0 °C. The mixture was stirred at room temperature for 2 h and quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub><span class="strike">4</span></sub>, filtered, and concentrated. The crude product was triturated with MeOH and water to give <b>6</b> (60.9 mg, 75%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.50 (1H, br s), 9.08 (1H, d, <i>J</i> = 1.3 Hz), 8.30 (1H, d, <i>J</i> = 1.3 Hz), 8.00 (1H, ddd, <i>J</i> = 8.8, 4.0, 2.8 Hz), 7.77 (1H, dd, <i>J</i> = 6.9, 2.8 Hz), 7.08 (1H, dd, <i>J</i> = 11.0, 8.8 Hz), 6.15 (2H, ddd, <i>J</i> = 51.0, 4.4, 1.9 Hz), 4.52 (1H, td, <i>J</i> = 10.6, 2.9 Hz), 4.16 (1H, dt, <i>J</i> = 10.6, 4.2 Hz), 4.12 (2H, br s), 2.56–2.50 (1H, m), 2.10 (1H, ddd, <i>J</i> = 14.1, 10.6, 4.2 Hz), 1.87 (3H, s). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.38, 159.33 (d, <i>J</i> = 2.9 Hz), 157.03 (d, <i>J</i> = 247.2 Hz), 152.86, 141.79, 139.89, 133.55 (d, <i>J</i> = 11.7 Hz), 133.18, 133.11 (d, <i>J</i> = 2.9 Hz), 120.24 (d, <i>J</i> = 8.1 Hz), 120.03 (d, <i>J</i> = 2.9 Hz), 116.73 (d, <i>J</i> = 23.5 Hz), 95.85 (d, <i>J</i> = 224.0 Hz), 81.39, 78.91 (d, <i>J</i> = 2.2 Hz), 63.35, 50.87, 33.74 (d, <i>J</i> = 3.7 Hz), 3.83. MS-ESI (<i>m</i>/<i>z</i>): 402 [M + H]<sup>+</sup>. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>17</sub>O<sub>2</sub>N<sub>5</sub>F, 378.1361; found, 378.1354.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Benzyl 1-((<i>S</i>)-1-(((<i>R</i>)-<i>tert</i>-Butylsulfinyl)amino)-1-(2-fluorophenyl)but-2-yn-1-yl)-3,3-difluorocyclobutane-1-carboxylate (<b>18</b>)</h4><div class="NLM_p last">To a solution of diisopropylamine (4.45 mL, 31.7 mmol) in THF (30 mL) was added dropwise <i>n</i>-BuLi (1.60 M in hexane; 18.8 mL, 30.1 mmol) at −78 °C. The mixture was allowed to warm to 0 °C and stirred at the same temperature for 20 min. The mixture was again cooled to −78 °C, and a solution of benzyl 3,3-difluorocyclobutane-1-carboxylate (5.12 g, 22.6 mmol) in THF (15 mL) was added dropwise to the mixture. After stirring at the same temperature for 45 min, a solution of ClTi(O<i>i-</i>Pr)<sub>3</sub> (7.57 mL, 31.7 mmol) in THF (15 mL) was added dropwise at −78 °C. The mixture was stirred at the same temperature for 10 min, and then <b>11</b> (2.00 g, 7.54 mmol) in THF (16 mL) was added dropwise. After being stirred for 2 h, the mixture was quenched with aqueous NH<sub>4</sub>Cl solution. The resulting mixture was filtered through Celite and evaporated. The residue was purified by silica gel column chromatography using 30% EtOAc in hexane to provide compound <b>18</b> (2.18 g, 59%) as a brown oil. <sup>1</sup>H NMR (400 mHz, CDCl<sub>3</sub>): δ 7.50 (1H, td, <i>J</i> = 8.1, 1.6 Hz), 7.37 (2H, d, <i>J</i> = 4.4 Hz), 7.33–7.31 (3H, m), 7.17–7.14 (1H, m), 7.06 (1H, td, <i>J</i> = 7.7, 1.1 Hz), 6.96 (1H, ddd, <i>J</i> = 12.5, 8.0, 1.1 Hz), 5.46 (1H, s), 5.01 (1H, d, <i>J</i> = 12.2 Hz), 4.92 (1H, d, <i>J</i> = 12.2 Hz), 3.66–3.55 (1H, m), 3.31–3.20 (1H, m), 3.06 (1H, tt, <i>J</i> = 14.1, 4.9 Hz), 2.90 (1H, tt, <i>J</i> = 14.9, 4.9 Hz), 2.05 (3H, s), 1.20 (9H, d, <i>J</i> = 14.2 Hz). MS-ESI (<i>m</i>/<i>z</i>): 492 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>R</i>)-<i>N</i>-((<i>S</i>)-1-(3,3-Difluoro-1-(hydroxymethyl)cyclobutyl)-1-(2-fluorophenyl)but-2-yn-1-yl)-2-methylpropane-2-sulfinamide (<b>19</b>)</h4><div class="NLM_p last">To a solution of <b>18</b> (2.08 g, 4.23 mmol) and MeOH (515 μL, 12.7 mmol) in THF (21 mL) was added LiBH<sub>4</sub> (3.0 M in THF; 4.23 mL, 12.7 mmol) at 0 °C. After being stirred for 1.5 h at room temperature, the mixture was cooled to 0 °C and then quenched with H<sub>2</sub>O and AcOH. The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography using 50–80% EtOAc in hexane gradient to provide compound <b>19</b> (978 mg, 60%) as a white solid. <sup>1</sup>H NMR (400 mHz, CDCl<sub>3</sub>): δ 7.76 (1H, td, <i>J</i> = 8.2, 1.7 Hz), 7.37–7.31 (1H, m), 7.18 (1H, td, <i>J</i> = 7.5, 1.1 Hz), 7.08 (1H, ddd, <i>J</i> = 12.9, 8.3, 1.0 Hz), 5.45 (1H, d, <i>J</i> = 2.9 Hz), 4.05 (1H, dd, <i>J</i> = 12.2, 4.4 Hz), 3.62 (1H, dd, <i>J</i> = 12.3, 7.0 Hz), 3.45 (1H, dd, <i>J</i> = 7.1, 4.5 Hz), 2.98 (1H, q, <i>J</i> = 14.5 Hz), 2.80 (1H, q, <i>J</i> = 14.5 Hz), 2.49 (1H, tt, <i>J</i> = 14.7, 5.3 Hz), 2.25 (1H, tt, <i>J</i> = 14.5, 5.1 Hz), 2.07 (3H, s), 1.22 (9H, s). MS-ESI (<i>m</i>/<i>z</i>): 388 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-<i>N</i>-((1-(3,3-Difluoro-1-(hydroxymethyl)cyclobutyl)-1-(2-fluorophenyl)but-2-yn-1-yl)carbamothioyl)benzamide (<b>20</b>)</h4><div class="NLM_p last">A mixture of <b>19</b> (978 mg, 2.52 mmol) and HCl (4 M in 1,4-dioxane; 947 μL, 3.79 mmol) in MeOH (20 mL) was stirred at room temperature for 2 h. The mixture was diluted with Et<sub>2</sub>O and H<sub>2</sub>O, and the organic layer was back extracted with H<sub>2</sub>O. The aqueous layers were basified with NaHCO<sub>3</sub> and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (795 mg) as a yellow oil. To a solution of this crude compound (398 mg) in DCM (4.0 mL) was added BzNCO (198 μL, 1.41 mmol) at 0 °C. After being stirred for 40 min at the same temperature, the reaction mixture was concentrated. The residue was purified by silica gel column chromatography using 10–50% EtOAc in hexane gradient to provide compound <b>20</b> (434 mg, 80% over two steps) as a white amorphous substance. <sup>1</sup>H NMR (400 mHz, CDCl<sub>3</sub>): δ 9.87 (1H, s), 8.18 (1H, br s), 7.87–7.85 (2H, m), 7.69 (1H, td, <i>J</i> = 8.1, 1.6 Hz), 7.62–7.58 (1H, m), 7.49 (2H, t, <i>J</i> = 7.9 Hz), 7.33–7.28 (1H, m), 7.19–7.15 (1H, m), 7.04 (1H, dd, <i>J</i> = 12.7, 8.3 Hz), 3.80 (1H, ddd, <i>J</i> = 12.3, 5.8, 1.4 Hz), 3.72–3.67 (1H, m), 3.29–3.14 (2H, m), 2.92–2.82 (1H, m), 2.15–2.06 (1H, m), 1.97 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 431 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-<i>N</i>-(4-(2-Fluorophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-yl)benzamide (<b>21</b>)</h4><div class="NLM_p last">A mixture of <b>20</b> (377 mg, 0.877 mmol) and Burgess reagent (418 mg, 1.75 mmol) in toluene (7.5 mL) was heated to reflux for 2 h. The mixture was cooled to room temperature and diluted with H<sub>2</sub>O. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography using 10–50% EtOAc in hexane gradient to provide compound <b>21</b> (182 mg, 50%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.75 (1H, s), 8.23 (2H, d, <i>J</i> = 7.2 Hz), 7.56 (1H, td, <i>J</i> = 8.1, 1.6 Hz), 7.52–7.48 (1H, m), 7.45–7.40 (3H, m), 7.23 (1H, td, <i>J</i> = 7.7, 1.1 Hz), 7.14 (1H, ddd, <i>J</i> = 12.3, 8.3, 1.1 Hz), 4.58 (1H, d, <i>J</i> = 11.7 Hz), 4.33 (1H, d, <i>J</i> = 11.7 Hz), 3.13–3.03 (1H, m), 2.89–2.77 (1H, m), 2.64–2.54 (1H, m), 2.39–2.30 (1H, m), 1.99 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 413 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>R</i>)-4-(2-Fluorophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-amine (<b>22</b>)</h4><div class="NLM_p last">A mixture of <b>21</b> (182 mg, 0.442 mmol) and DBU (66.6 μL, 0.442 mmol) in MeOH (5.5 mL) was stirred at 60 °C overnight. The reaction mixture was cooled to room temperature and then treated with HCl solution (2 M in water). The mixture was diluted with Et<sub>2</sub>O, and the organic layers were back extracted with H<sub>2</sub>O. The aqueous layer was basified with K<sub>2</sub>CO<sub>3</sub> and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by amino silica gel column chromatography using 30–80% EtOAc in hexane gradient to provide compound <b>22</b> (93.0 mg, 68%) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.52 (1H, td, <i>J</i> = 8.1, 1.8 Hz), 7.32–7.27 (1H, m), 7.15 (1H, td, <i>J</i> = 7.5, 1.3 Hz), 7.05 (1H, ddd, <i>J</i> = 12.2, 8.2, 1.3 Hz), 4.32 (1H, d, <i>J</i> = 11.0 Hz), 4.12 (2H, br s), 3.98 (1H, d, <i>J</i> = 11.0 Hz), 3.15–3.03 (1H, m), 2.83–2.71 (1H, m), 2.46–2.36 (1H, m), 2.20–2.10 (1H, m), 1.92 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 309 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-<i>N</i>-(3-(7-Amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>6</b>)</h4><div class="NLM_p last">To a solution of <b>22</b> (117.8 mg, 0.382 mmol) in TFA (618 μL) at −30 °C was added sulfuric acid (153 μL, 2.87 mmol). After being stirred at the same temperature for 10 min, the mixture was added dropwise HNO<sub>3</sub> (25.6 μL, 0.573 mmol). The reaction mixture was stirred at −30 °C for 50 min and then poured into aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (154 mg) as a yellow oil. A suspension of this crude compound, Fe (171 mg, 3.06 mmol), and NH<sub>4</sub>Cl (245 mg, 4.58 mmol) in toluene/H<sub>2</sub>O (2.6 mL/2.6 mL) was stirred at 80 °C for 6 h. The mixture was cooled to 0 °C, quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution, and filtered through Celite. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a crude product of (<i>R</i>)-4-(5-amino-2-fluorophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-amine (133 mg) as a yellow amorphous substance. To a solution of this crude compound (39.0 mg), 5-(fluoromethoxy)pyrazine-2-carboxylic acid (19.3 mg, 0.112 mmol), and HCl (2 M in water; 56.0 μL, 0.112 mmol) in MeOH (1.0 mL) was added EDC·HCl (23.7 mg, 0.123 mmol) at 0 °C. The mixture was stirred at room temperature for 30 min and quenched with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub><span class="strike">4</span></sub>, filtered, and evaporated. The crude product was triturated with hexane to give <b>6</b> (32.9 mg, 62% over three steps) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.50 (1H, s), 9.09 (1H, d, <i>J</i> = 1.1 Hz), 8.30 (1H, d, <i>J</i> = 1.1 Hz), 7.87–7.83 (1H, m), 7.75 (1H, dd, <i>J</i> = 7.0, 2.6 Hz), 7.10 (1H, dd, <i>J</i> = 11.4, 8.8 Hz), 6.16 (2H, d, <i>J</i> = 51.1 Hz), 4.40 (1H, d, <i>J</i> = 10.7 Hz), 4.21 (2H, br s), 4.05 (1H, d, <i>J</i> = 10.7 Hz), 3.19–3.07 (1H, m), 2.83–2.72 (1H, m), 2.45–2.37 (1H, m), 2.25–2.15 (1H, m), 1.93 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 478 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-(3-(7-Amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl)-4-fluorophenyl)-5-cyanopicolinamide (<b>7</b>)</h4><div class="NLM_p last">To a solution of the crude product of (<i>R</i>)-4-(5-amino-2-fluorophenyl)-4-(prop-1-yn-1-yl)-5,6-dihydro-4<i>H</i>-1,3-oxazin-2-amine obtained above (39.4 mg), 5-cyanopicolinic acid monohydrate (18.8 mg, 0.113 mmol), and HCl (2 M in water; 57.0 μL, 0.113 mmol) in MeOH (2.0 mL) was added EDC·HCl (23.9 mg, 0.125 mmol) at 0 °C. The mixture was stirred at room temperature for 30 min and quenched with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub><span class="strike">4</span></sub>, filtered, and evaporated. The crude product was triturated with hexane/EtOAc (10/1) to give <b>6</b> (41.3 mg, 81% over three steps) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.86 (1H, s), 8.91 (1H, dd, <i>J</i> = 2.0, 0.7 Hz), 8.44 (1H, dd, <i>J</i> = 8.2, 0.8 Hz), 8.21 (1H, dd, <i>J</i> = 8.2, 2.0 Hz), 7.88 (1H, ddd, <i>J</i> = 8.8, 3.5, 3.0 Hz), 7.79 (1H, dd, <i>J</i> = 6.9, 2.8 Hz), 7.12 (1H, dd, <i>J</i> = 11.4, 8.8 Hz), 4.41 (1H, d, <i>J</i> = 11.0 Hz), 4.21 (2H, br s), 4.05 (1H, d, <i>J</i> = 11.4 Hz), 3.18–3.07 (1H, m), 2.81–2.69 (1H, m), 2.47–2.37 (1H, m), 2.26–2.17 (1H, m), 1.94 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 454 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Biochemical BACE1 and BACE2 FRET Assay</h3><div class="NLM_p last">The biochemical BACE1 and BACE IC<sub>50</sub> values were determined by a FRET assay using an APP-derived peptide as described previously.<a onclick="showRef(event, 'cit13c ref19'); return false;" href="javascript:void(0);" class="ref cit13c ref19">(13c,19)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Cellular BACE1 and BACE2 Assays</h3><div class="NLM_p last">The BACE1 cellular Aβ IC<sub>50</sub> values were determined by measuring Aβ42 using a sandwich AlphaLISA assay in SKNBE2 cells expressing the wild-type APP as described previously.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The BACE2 cellular TMEM27 values were determined in Min6 cells expressing the wild-type TMEM27 by measuring the TMEM27 N-terminal part using MSD electrochemiluminescence detection technology based on electrochemiluminescence labels, called SULFO-TAG.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Biochemical Radioligand Binding Assay for BACE1 and BACE2</h3><div class="NLM_p last">The binding affinity (<i>K</i><sub>i</sub>) for BACE1 and BACE2 was determined using a competitive radioligand, [<sup>3</sup>H]-JNJ-962, as described previously.<a onclick="showRef(event, 'cit13c'); return false;" href="javascript:void(0);" class="ref cit13c">(13c)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> P-gp Assay</h3><div class="NLM_p last">The P-gp efflux ratios were measured in LLC-PK1 cells stably transfected with the human MDR1 gene as described previously.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> hERG Assay</h3><div class="NLM_p last">hERG inhibition at 3 μM was measured in CHO cells transfected with the hERG gene as described previously.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01858" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01858?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01858</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings, BACE1 IC<sub>50</sub>, BACE2 IC<sub>50</sub>, and cellular Aβ42 IC<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental procedures and characterization data for compound <b>5</b>; HPLC spectra for final compounds; Figure S1, conformational analysis of 5-substituted oxazines; Figure S2, superposition of the flap in the <b>7</b>-bound BACE2 and apo-BACE2; Figure S3, NOESY analysis for compound <b>26</b>; Chart S1, biochemical profiles of compounds <b>7</b> and <b>8a</b>–<b>8c</b>; experimental procedures for BACE2 biochemical and BACE1 and BACE2 binding assays; and crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_001.csv">jm0c01858_si_001.csv (0.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf">jm0c01858_si_007.pdf (937.15 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><b>1</b> bound to BACE1: 7D2V; <b>1</b> bound to BACE2: 7D5B; <b>3</b> bound to BACE1: 7D2X; <b>7</b> bound to BACE1: 7D5A; and <b>7</b> bound to BACE2: 7D5U.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01858" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuki Fujimoto</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8013-4209" title="Orcid link">http://orcid.org/0000-0001-8013-4209</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9df6fce7e8f6f4b3fbe8f7f4f0f2e9f2ddeef5f4f2f3f2faf4b3fef2b3f7ed"><span class="__cf_email__" data-cfemail="0368627976686a2d6576696a6e6c776c43706b6a6c6d6c646a2d606c2d6973">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken-ichi Kusakabe</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#375c52591a5e545f5e195c4244565c56555277445f5e585958505e195458195d47"><span class="__cf_email__" data-cfemail="056e606b286c666d6c2b6e7076646e64676045766d6c6a6b6a626c2b666a2b6f75">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuhei Yoshida</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Genta Tadano</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Asada</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kouki Fuchino</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinji Suzuki</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eriko Matsuoka</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takahiko Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span>Present Address:
                        API Process Development Department (Biotechnology), Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-1, Ukima 5-chome, Kita-ku, Tokyo 115-8543, Japan (T.Y.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiho Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Medicinal Chemistry Research, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shigeru Ando</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Drug Discovery & Development, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoki Kanegawa</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Drug Discovery & Development, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yutaka Tonomura</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Drug Discovery & Development, Shionogi
Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span>Present Address:
                        Pharmacokinetics and Safety Assessment Department, Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan (Y.T.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hisanori Ito</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Drug Discovery & Disease Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diederik Moechars</span> - <span class="hlFld-Affiliation affiliation">Neuroscience, Janssen Research
& Development, Turnhoutseweg
30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik J. R. Rombouts</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1986-0476" title="Orcid link">http://orcid.org/0000-0003-1986-0476</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harrie J. M. Gijsen</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Stefan Steinbacher (Proteros) for the BACE2 X-ray crystallography, Maki Hattori, Masanori Nakae, and Maito Douma for the biological assays, Atsushi Morimoto for the HRMS analysis, and Yukiko Kan for the NMR analysis. We gratefully thank the members of the Janssen-Shionogi research collaboration for the support of this program. We are grateful to Judy Noguchi for proofreading the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site amyloid precursor protein cleaving enzyme 1</p></td></tr><tr><td class="NLM_term">BzNCS</td><td class="NLM_def"><p class="first last">benzoyl isothiocyanate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DIAN</td><td class="NLM_def"><p class="first last">Dominantly Inherited Alzheimer Network</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">familial AD</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PMEL</td><td class="NLM_def"><p class="first last">pigment cell-specific melanocyte protein</p></td></tr><tr><td class="NLM_term">TMEM27</td><td class="NLM_def"><p class="first last">transmembrane protein 27</p></td></tr><tr><td class="NLM_term">VCAM1</td><td class="NLM_def"><p class="first last">vascular cell adhesion molecule 1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span> <i>World Alzheimer Report
2019</i>;  (accessed April 30, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Disease%0AInternational+World+Alzheimer+Report%0A2019%3B+%28accessed+April+30%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Alzheimer%2520Report%250A2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Alzheimer’s Association</span> <i>2020
Alzheimer’s Disease Facts and
Figures</i>;  (accessed April 30, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association+2020%0AAlzheimer%E2%80%99s+Disease+Facts+and%0AFigures%3B+%28accessed+April+30%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3D2020%250AAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%250AFigures" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chancellor, D.</span>; <span class="NLM_string-name">Dube, S.</span>; <span class="NLM_string-name">Huntley, C.</span></span> <i>Alzheimer’s disease</i>; Ref Code: DMKC4740.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chancellor%2C+D.%3B+Dube%2C+S.%3B+Huntley%2C+C.+Alzheimer%E2%80%99s+disease%3B+Ref+Code%3A+DMKC4740."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChancellor%26aufirst%3DD.%26jtitle%3DAlzheimer%25E2%2580%2599s%2520disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0ljDEEDJprz7jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljX9_2MUXdHuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0ljX9_2MUXdHuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>; <span class="NLM_edition">3</span><sup>rd</sup> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>; <span class="NLM_string-name">Rotella, D. P.</span>; <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; vol.  <span class="NLM_volume">7</span>, pp.  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-Secretase%2520%2528BACE%2529%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761-777&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0liaGXdX3Rclog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26epage%3D777%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0liaGXdX3Rclog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of β-site APP cleaving enzyme 1 (BACE) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0liaGXdX3Rclog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1080/13543776.2021.1832463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1080%2F13543776.2021.1832463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=33006491" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=25-52&author=F.+Romboutsauthor=K.-I.+Kusakabeauthor=C.-C.+Hsiaoauthor=H.+J.+M.+Gijsen&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282011+to+2020%29&doi=10.1080%2F13543776.2021.1832463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1080%2F13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282011%2520to%25202020%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D31%26spage%3D25%26epage%3D52%26doi%3D10.1080%2F13543776.2021.1832463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)–A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29%E2%80%93A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0ljhxZYzo-wM1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%25E2%2580%2593A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=E.+M.+Parkerauthor=J.+N.+Cummingauthor=W.+Liauthor=J.+D.+Scottauthor=K.+Coxauthor=M.+F.+Dockendorfauthor=H.+J.+Kleijnauthor=H.+Meiauthor=J.+A.+Stoneauthor=M.+Eganauthor=L.+Ereshefskyauthor=S.+Jheeauthor=B.+A.+Mattsonauthor=J.+Palczaauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span>; <span class="NLM_string-name">Scott, J. D.</span>; <span class="NLM_string-name">Strickland, C. O.</span></span> <span> </span><span class="NLM_article-title">Verubecestat</span>. In  <i>Comprehensive Medicinal Chemistry III</i>; <span class="NLM_edition">3</span><sup>rd</sup> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>; <span class="NLM_string-name">Rotella, D. P.</span>; <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; vol.  <span class="NLM_volume">8</span>, pp.  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">251</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=204-251&author=J.+N.+Cumming&author=J.+D.+Scott&author=C.+O.+Stricklandauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26atitle%3DVerubecestat%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D8%26spage%3D204%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1706441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1056%2FNEJMoa1706441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=29719179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2018&pages=1691-1703&author=M.+F.+Eganauthor=J.+Kostauthor=P.+N.+Tariotauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=B.+Vellasauthor=C.+Surauthor=Y.+Mukaiauthor=T.+Vossauthor=C.+Furtekauthor=E.+Mahoneyauthor=L.+H.+Mozleyauthor=R.+Vandenbergheauthor=Y.+Moauthor=D.+Michelson&title=Randomized+trial+of+verubecestat+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1706441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the deposition of amyloid-beta (Aβ) plaques in the brain.  Aβ is produced from the sequential cleavage of amyloid precursor protein by β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by γ-secretase.  Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer's disease.  Methods: We conducted a randomized, double-blind, placebo-controlled, 78-wk trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clin. diagnosis of mild-to-moderate Alzheimer's disease.  The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function).  Results: A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo.  The trial was terminated early for futility 50 mo after onset, which was within 5 mo before its scheduled completion, and after enrollment of the planned 1958 patients was complete.  The estd. mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group).  The estd. mean change from baseline to week 78 in the ADCS-ADL score was -8.4 in the 12-mg group, -8.2 in the 40-mg group, and -8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group).  Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, wt. loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. conclusions Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was assocd. with treatment-related adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroW5Tf-VIj2LVg90H21EOLACvtfcHk0lhND62mNd_lwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D&md5=e6ecfbd2981616b343468ae8bed1db2d</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1706441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1706441%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMahoney%26aufirst%3DE.%26aulast%3DMozley%26aufirst%3DL.%2BH.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520trial%2520of%2520verubecestat%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D378%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1706441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span> <i>Merck & Co., Inc.</i>;  (accessed January 7, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Merck+%26+Co.%2C+Inc.%3B+%28accessed+January+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DMerck%2520%2526%2520Co.%252C%2520Inc." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimers Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=202-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span></div><div class="casAuthors">Timmers Maarten; Van Broeck Bianca; De Waepenaert Katja; Russu Alberto; Stieltjes Hans; Moechars Dieder; Mercken Marc; Kemp John; Van Nueten Luc; Tritsmans Luc; Streffer Johannes Rolf; Timmers Maarten; Engelborghs Sebastiaan; Streffer Johannes Rolf; Ramael Steven; Slemmon John; Liu Enchi; Bogert Jennifer; Shaw Leslie M; Engelborghs Sebastiaan; Sinha Vikash</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">OBJECTIVES:  Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, JNJ-54861911, were assessed after single and multiple dosing in healthy participants.  METHODS:  Two randomized, placebo-controlled, double-blind studies were performed using single and multiple ascending JNJ-54861911 doses (up to 14 days) in young and elderly healthy participants.  Regular blood samples and frequent CSF samples, up to 36 hours after last dose, were collected to assess the pharmacokinetic and pharmacodynamic (Aβ, sAPPα,β,total levels) profiles of JNJ-54861911.  RESULTS:  JNJ-54861911 was well-tolerated, adverse events were uncommon and unrelated to JNJ-54861911.  JNJ-54861911 showed dose-proportional CSF and plasma pharmacokinetic profiles.  Plasma- and CSF-Aβ and CSF-sAPPβ were reduced in a dose-dependent manner.  Aβ reductions (up to 95%) outlasted exposure to JNJ-54861911.  APOE ε4 carrier status and baseline Aβ levels did not influence Aβ/sAPPβ reductions.  CONCLUSION:  JNJ-54861911, a potent brain-penetrant BACE1 inhibitor, achieved high and stable Aβ reductions after single and multiple dosing in healthy participants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQDdblLE_E9PWfW6udTcc2eZHuZCMfRaT9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D&md5=46e0c106c2560f0b2c9aeba095fc20de</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimers%2520Dementia%26date%3D2016%26volume%3D2%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatikola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smekens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson-Hanson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matias-Guiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baquero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesseur, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">85</span>, <span class="refDoi"> DOI: 10.1186/s13195-018-0415-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1186%2Fs13195-018-0415-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFSisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=85&author=M.+Timmersauthor=J.+R.+Strefferauthor=A.+Russuauthor=Y.+Tominagaauthor=H.+Shimizuauthor=A.+Shiraishiauthor=K.+Tatikolaauthor=P.+Smekensauthor=A.+B%C3%B6rjesson-Hansonauthor=N.+Andreasenauthor=J.+Matias-Guiuauthor=M.+Baqueroauthor=M.+Boadaauthor=I.+Tesseurauthor=L.+Tritsmansauthor=L.+Van+Nuetenauthor=S.+Engelborghs&title=Pharmacodynamics+of+atabecestat+%28JNJ-54861911%29%2C+an+oral+BACE1+inhibitor+in+patients+with+early+Alzheimer%E2%80%99s+disease%3A+randomized%2C+double-blind%2C+placebo-controlled+study&doi=10.1186%2Fs13195-018-0415-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study</span></div><div class="casAuthors">Timmers, Maarten; Streffer, Johannes Rolf; Russu, Alberto; Tominaga, Yushin; Shimizu, Hiroko; Shiraishi, Ayako; Tatikola, Kanaka; Smekens, Pascale; Borjesson-Hanson, Anne; Andreasen, Niels; Matias-Guiu, Jorge; Baquero, Miquel; Boada, Merce; Tesseur, Ina; Tritsmans, Luc; Van Nueten, Luc; Engelborghs, Sebastiaan</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85/1-85/18</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: β-Secretase enzyme (BACE) inhibition has been proposed as a priority treatment mechanism for Alzheimer's disease (AD), but treatment initiation may need to be very early.  We present proof of mechanism of atabecestat (also known as JNJ-54861911), an oral BACE inhibitor for the treatment of AD, in Caucasian and Japanese populations with early AD who do not show signs of dementia.  Methods: In two similarly designed phase I studies, a sample of amyloid-pos. elderly patients comprising 45 Caucasian patients with early AD diagnosed as preclin. AD (n = 15, Clin. Dementia Rating [CDR] = 0) or with mild cognitive impairment due to AD (n = 30, CDR = 0.5) and 18 Japanese patients diagnosed as preclin. AD (CDR-J = 0) were randomized 1:1:1 to atabecestat 10 or 50 mg or placebo (n = 6-8/treatment) daily for 4 wk.  Safety, pharmacokinetics (PK), and pharmacodynamics (PD) (i.e., redn. of cerebrospinal fluid [CSF] amyloid beta 1-40 [Aβ1-40] levels [primary endpoint] and effect on other AD biomarkers) of atabecestat were evaluated.  Results: In both populations, atabecestat was well tolerated and characterized by linear PK and high central nervous system penetrance of unbound drug.  Atabecestat significantly reduced CSF Aβ1-40 levels from baseline at day 28 in both the 10-mg (67-68%) and 50-mg (87-90%) dose groups compared with placebo.  For Caucasians with early AD, the least squares mean differences (95% CI) were - 69.37 (- 72.25; - 61.50) and - 92.74 (- 100.08; - 85.39), and for Japanese with preclin. AD, they were - 62.48 (- 78.32; - 46.64) and - 80.81 (- 96.13; - 65.49), resp.  PK/PD model simulations confirmed that once-daily 10 mg and 50 mg atabecestat can attain 60-70% and 90% Aβ1-40 redns., resp.  The trend of the redn. was similar across the Aβ1-37, Aβ1-38, and Aβ1-42 fragments in both atabecestat dose groups, consistent with Aβ1-40.  CSF amyloid precursor protein fragment (sAPPβ) levels declined from baseline, regardless of patient population, whereas CSF sAPPα levels increased compared with placebo.  There were no relevant changes in either CSF total tau or phosphorylated tau 181P over a 4-wk treatment period.  Conclusions: JNJ-54861911 at 10 and 50 mg daily doses after 4 wk resulted in mean CSF Aβ1-40 redns. of 67% and up to 90% in both Caucasian and Japanese patients with early stage AD, confirming results in healthy elderly adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs-nRFnefSK7Vg90H21EOLACvtfcHk0lgHCRS_-aXTjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFSisL8%253D&md5=5368ac1a51165aa7be020c9ec1512424</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1186%2Fs13195-018-0415-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-018-0415-6%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DTominaga%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DShiraishi%26aufirst%3DA.%26aulast%3DTatikola%26aufirst%3DK.%26aulast%3DSmekens%26aufirst%3DP.%26aulast%3DB%25C3%25B6rjesson-Hanson%26aufirst%3DA.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DMatias-Guiu%26aufirst%3DJ.%26aulast%3DBaquero%26aufirst%3DM.%26aulast%3DBoada%26aufirst%3DM.%26aulast%3DTesseur%26aufirst%3DI.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DEngelborghs%26aufirst%3DS.%26atitle%3DPharmacodynamics%2520of%2520atabecestat%2520%2528JNJ-54861911%2529%252C%2520an%2520oral%2520BACE1%2520inhibitor%2520in%2520patients%2520with%2520early%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2018%26volume%3D10%26spage%3D85%26doi%3D10.1186%2Fs13195-018-0415-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, G.</span></span> <span> </span><span class="NLM_article-title">Preliminary results of a trial of atabecestat in preclinical Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1485</span>, <span class="refDoi"> DOI: 10.1056/NEJMc1813435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1056%2FNEJMc1813435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30970197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FjvFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=1483-1485&author=D.+Henleyauthor=N.+Raghavanauthor=R.+Sperlingauthor=P.+Aisenauthor=R.+Ramanauthor=G.+Romano&title=Preliminary+results+of+a+trial+of+atabecestat+in+preclinical+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMc1813435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease</span></div><div class="casAuthors">Henley David; Raghavan Nandini; Sperling Reisa; Aisen Paul; Raman Rema; Romano Gary</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1483-1485</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfD9bI0ZsheHELvajU9pjPfW6udTcc2eZSSWIDk6urVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FjvFGqtg%253D%253D&md5=42b37561fb1b3bd8102b7ba3ba64d588</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1056%2FNEJMc1813435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMc1813435%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DD.%26aulast%3DRaghavan%26aufirst%3DN.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DAisen%26aufirst%3DP.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DRomano%26aufirst%3DG.%26atitle%3DPreliminary%2520results%2520of%2520a%2520trial%2520of%2520atabecestat%2520in%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26spage%3D1483%26epage%3D1485%26doi%3D10.1056%2FNEJMc1813435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koriyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonezawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einaru, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of atabecestat (JNJ-54861911): a thiazine-based β-amyloid precursor protein cleaving enzyme 1 inhibitor advanced to the phase 2b/3 EARLY clinical trial</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1873</span>– <span class="NLM_lpage">1888</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BB3MXjvFeguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2021&pages=1873-1888&author=Y.+Koriyamaauthor=A.+Horiauthor=H.+Itoauthor=S.+Yonezawaauthor=Y.+Babaauthor=N.+Tanimotoauthor=T.+Uenoauthor=Y.+Yamamotoauthor=T.+Yamamotoauthor=N.+Asadaauthor=K.+Morimotoauthor=E.+Einaruauthor=K.+Sakaiauthor=T.+Kanazuauthor=A.+Matsudaauthor=Y.+Yamaguchiauthor=T.+Ogumaauthor=M.+Timmersauthor=L.+Tritsmansauthor=K.-i.+Kusakabeauthor=A.+Katoauthor=G.+Sakaguchi&title=Discovery+of+atabecestat+%28JNJ-54861911%29%3A+a+thiazine-based+%CE%B2-amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+advanced+to+the+phase+2b%2F3+EARLY+clinical+trial&doi=10.1021%2Facs.jmedchem.0c01917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial</span></div><div class="casAuthors">Koriyama, Yuji; Hori, Akihiro; Ito, Hisanori; Yonezawa, Shuji; Baba, Yoshiyasu; Tanimoto, Norihiko; Ueno, Tatsuhiko; Yamamoto, Shiho; Yamamoto, Takahiko; Asada, Naoya; Morimoto, Kenji; Einaru, Shunsuke; Sakai, Katsunori; Kanazu, Takushi; Matsuda, Akihiro; Yamaguchi, Yoshitaka; Oguma, Takuya; Timmers, Maarten; Tritsmans, Luc; Kusakabe, Ken-ichi; Kato, Akira; Sakaguchi, Gaku</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1873-1888</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of amyloid β peptides (Aβ) is thought to be one of the causal factors of Alzheimer's disease (AD).  The aspartyl protease β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting protease for Aβ prodn., and therefore, BACE1 inhibition is a promising therapeutic approach for the treatment of AD.  Starting with a dihydro-1,3-thiazine-based lead, Compd. J, we discovered atabecestat 1 (JNJ-54861911) as a centrally efficacious BACE1 inhibitor that was advanced into the EARLY Phase 2b/3 clin. trial for the treatment of preclin. AD patients.  Compd. 1 demonstrated robust and dose-dependent Aβ redn. and showed sufficient safety margins in preclin. models.  The potential of reactive metabolite formation was evaluated in a covalent binding study to assess its irreversible binding to human hepatocytes.  Unfortunately, the EARLY trial was discontinued due to significant elevation of liver enzymes, and subsequent anal. of the clin. outcomes showed dose-related cognitive worsening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq20LJrxpaavLVg90H21EOLACvtfcHk0lgJVHzF5yu3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXjvFeguro%253D&md5=ad7220218f10e5f110db63153bbaa98b</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01917%26sid%3Dliteratum%253Aachs%26aulast%3DKoriyama%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DYonezawa%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DEinaru%26aufirst%3DE.%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DKanazu%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DSakaguchi%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520atabecestat%2520%2528JNJ-54861911%2529%253A%2520a%2520thiazine-based%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520advanced%2520to%2520the%2520phase%25202b%252F3%2520EARLY%2520clinical%2520trial%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2021%26volume%3D64%26spage%3D1873%26epage%3D1888%26doi%3D10.1021%2Facs.jmedchem.0c01917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <i>Alzforum</i>;  (accessed July 24, 2017)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Alzforum%3B+%28accessed+July+24%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzforum" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Kita, Y.</span>; <span class="NLM_string-name">Yamamoto, N.</span>; <span class="NLM_string-name">Khan, A.</span>; <span class="NLM_string-name">Dimopoulos, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of condensed aminodihydrothiazine derivatives as inhibitors of β-site APP-cleaving enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO2,009,091,016A1</span>, July 23, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+condensed+aminodihydrothiazine+derivatives+as+inhibitors+of+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520condensed%2520aminodihydrothiazine%2520derivatives%2520as%2520inhibitors%2520of%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüönd, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.-L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+L%C3%BC%C3%B6ndauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.-M.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.-L.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DL%25C3%25BC%25C3%25B6nd%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <i>Novartis AG</i>;  (accessed September 1, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Novartis+AG%3B+%28accessed+September+1%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DNovartis%2520AG" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santacruz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckles, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDade, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayeux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossor, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group">Dominantly inherited Alzheimer network</span> <span> </span><span class="NLM_article-title">Clinical and biomarker changes in dominantly inherited Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1202753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1056%2FNEJMoa1202753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=22784036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=795-804&author=R.+J.+Batemanauthor=C.+Xiongauthor=T.+L.+S.+Benzingerauthor=A.+M.+Faganauthor=A.+Goateauthor=N.+C.+Foxauthor=D.+S.+Marcusauthor=N.+J.+Cairnsauthor=X.+Xieauthor=T.+M.+Blazeyauthor=D.+M.+Holtzmanauthor=A.+Santacruzauthor=V.+Bucklesauthor=A.+Oliverauthor=K.+Moulderauthor=P.+S.+Aisenauthor=B.+Ghettiauthor=W.+E.+Klunkauthor=E.+McDadeauthor=R.+N.+Martinsauthor=C.+L.+Mastersauthor=R.+Mayeuxauthor=J.+M.+Ringmanauthor=M.+N.+Rossorauthor=P.+R.+Schofieldauthor=R.+A.+Sperlingauthor=S.+Sallowayauthor=J.+C.+Morrisauthor=Dominantly+inherited+Alzheimer+network&title=Clinical+and+biomarker+changes+in+dominantly+inherited+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1202753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and biomarker changes in dominantly inherited Alzheimer's disease</span></div><div class="casAuthors">Bateman, Randall J.; Xiong, Chengjie; Benzinger, Tammie L. S.; Fagan, Anne M.; Goate, Alison; Fox, Nick C.; Marcus, Daniel S.; Cairns, Nigel J.; Xie, Xianyun; Blazey, Tyler M.; Holtzman, David M.; Santacruz, Anna; Buckles, Virginia; Oliver, Angela; Moulder, Krista; Aisen, Paul S.; Ghetti, Bernardino; Klunk, William E.; McDade, Eric; Martins, Ralph N.; Masters, Colin L.; Mayeux, Richard; Ringman, John M.; Rossor, Martin N.; Schofield, Peter R.; Sperling, Reisa A.; Salloway, Stephen; Morris, John C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">795-804</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The order and magnitude of pathol. processes in Alzheimer's disease are not well understood, partly because the disease develops over many years.  Autosomal dominant Alzheimer's disease has a predictable age at onset and provides an opportunity to det. the sequence and magnitude of pathol. changes that culminate in symptomatic disease.  METHODS: In this prospective, longitudinal study, we analyzed data from 128 participants who underwent baseline clin. and cognitive assessments, brain imaging, and cerebrospinal fluid (CSF) and blood tests.  We used the participant's age at baseline assessment and the parent's age at the onset of symptoms of Alzheimer's disease to calc. the estd. years from expected symptom onset (age of the participant minus parent's age at symptom onset).  We conducted cross-sectional analyses of baseline data in relation to estd. years from expected symptom onset in order to det. the relative order and magnitude of pathophysiol. changes.  RESULTS: Concns. of amyloid-beta (Aβ)42 in the CSF appeared to decline 25 years before expected symptom onset.  Aβ deposition, as measured by positron-emission tomog. with the use of Pittsburgh compd. B, was detected 15 years before expected symptom onset.  Increased concns. of tau protein in the CSF and an increase in brain atrophy were detected 15 years before expected symptom onset.  Cerebral hypometabolism and impaired episodic memory were obsd. 10 years before expected symptom onset.  Global cognitive impairment, as measured by the Mini-Mental State Examn. and the Clin. Dementia Rating scale, was detected 5 years before expected symptom onset, and patients met diagnostic criteria for dementia at an av. of 3 years after expected symptom onset.  CONCLUSIONS: We found that autosomal dominant Alzheimer's disease was assocd. with a series of pathophysiol. changes over decades in CSF biochem. markers of Alzheimer's disease, brain amyloid deposition, and brain metab. as well as progressive cognitive impairment.  Our results require confirmation with the use of longitudinal data and may not apply to patients with sporadic Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptJNV9eDXBCLVg90H21EOLACvtfcHk0liO-LrYsog65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J&md5=c4f999ea3401af9651a2770724757bed</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1202753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1202753%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DMarcus%26aufirst%3DD.%2BS.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DBlazey%26aufirst%3DT.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DSantacruz%26aufirst%3DA.%26aulast%3DBuckles%26aufirst%3DV.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DMoulder%26aufirst%3DK.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMcDade%26aufirst%3DE.%26aulast%3DMartins%26aufirst%3DR.%2BN.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DRingman%26aufirst%3DJ.%2BM.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3D%26atitle%3DClinical%2520and%2520biomarker%2520changes%2520in%2520dominantly%2520inherited%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D795%26epage%3D804%26doi%3D10.1056%2FNEJMoa1202753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzler, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilieva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span> <span> </span><span class="NLM_article-title">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">9712</span>– <span class="NLM_lpage">9717</span>, <span class="refDoi"> DOI: 10.1073/pnas.160115697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1073%2Fpnas.160115697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10931940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9712-9717&author=M.+Farzanauthor=C.+E.+Schnitzlerauthor=N.+Vasilievaauthor=D.+Leungauthor=H.+Choe&title=BACE2%2C+a+%CE%B2-secretase+homolog%2C+cleaves+at+the+%CE%B2+site+and+within+the+amyloid-%CE%B2+region+of+the+amyloid-%CE%B2+precursor+protein&doi=10.1073%2Fpnas.160115697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span></div><div class="casAuthors">Farzan, Michael; Schnitzler, Christine E.; Vasilieva, Natalya; Leung, Doris; Choe, Hyeryun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9712-9717</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prodn. of amyloid-β protein (Aβ) is initiated by a β-secretase that cleaves the Aβ precursor protein (APP) at the N terminus of Aβ (the β site).  A recently identified aspartyl protease, BACE, cleaves the β site and at residue 11 within the Aβ region of APP.  Here we show that BACE2, a BACE homolog, cleaves at the β site and more efficiently at a different site within Aβ.  The Flemish missense mutation of APP, implicated in a form of familial Alzheimer's disease, is adjacent to this latter site and markedly increases Aβ prodn. by BACE2 but not by BACE.  BACE and BACE2 respond identically to conservative β-site mutations, and alteration of a common active site Arg inhibits β-site cleavage but not cleavage within Aβ by both enzymes.  These data suggest that BACE2 contributes to Aβ prodn. in individuals bearing the Flemish mutation, and that selective inhibition of these highly similar proteases may be feasible and therapeutically advantageous.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKuCTBTrzorVg90H21EOLACvtfcHk0liO-LrYsog65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D&md5=4cafdc5cf3c57bb981323281cc55cbae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.160115697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.160115697%26sid%3Dliteratum%253Aachs%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DSchnitzler%26aufirst%3DC.%2BE.%26aulast%3DVasilieva%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DChoe%26aufirst%3DH.%26atitle%3DBACE2%252C%2520a%2520%25CE%25B2-secretase%2520homolog%252C%2520cleaves%2520at%2520the%2520%25CE%25B2%2520site%2520and%2520within%2520the%2520amyloid-%25CE%25B2%2520region%2520of%2520the%2520amyloid-%25CE%25B2%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D9712%26epage%3D9717%26doi%3D10.1073%2Fpnas.160115697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyabu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel 1,3-oxazine based β-secretase (BACE1) inhibitors: Incorporation of a double bond to reduce P-gp efflux leading to robust Aβ reduction in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5122</span>– <span class="NLM_lpage">5137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5122-5137&author=K.+Fuchinoauthor=Y.+Mitsuokaauthor=M.+Masuiauthor=N.+Kuroseauthor=S.+Yoshidaauthor=K.+Komanoauthor=T.+Yamamotoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=H.+Miyajimaauthor=S.+Hiroyamaauthor=K.+Koyabuauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-i.+Kusakabe&title=Rational+design+of+novel+1%2C3-oxazine+based+%CE%B2-secretase+%28BACE1%29+inhibitors%3A+Incorporation+of+a+double+bond+to+reduce+P-gp+efflux+leading+to+robust+A%CE%B2+reduction+in+the+brain&doi=10.1021%2Facs.jmedchem.8b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></div><div class="casAuthors">Fuchino, Kouki; Mitsuoka, Yasunori; Masui, Moriyasu; Kurose, Noriyuki; Yoshida, Shuhei; Komano, Kazuo; Yamamoto, Takahiko; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Miyajima, Hirofumi; Hiroyama, Shuichi; Koyabu, Kiyotaka; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5122-5137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of Aβ peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD.  β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD.  Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration.  Starting from a 1,3-dihydrooxazine lead I identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of II that produced significant Aβ redn. with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models.  This compd. II improved the brain-to-plasma ratio relative to I by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPZsGRa22ZLVg90H21EOLACvtfcHk0lias1DlLjlycA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D&md5=ac366bddfe3492a0a47ce02918b5ea41</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DM.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DH.%26aulast%3DHiroyama%26aufirst%3DS.%26aulast%3DKoyabu%26aufirst%3DK.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DRational%2520design%2520of%2520novel%25201%252C3-oxazine%2520based%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%253A%2520Incorporation%2520of%2520a%2520double%2520bond%2520to%2520reduce%2520P-gp%2520efflux%2520leading%2520to%2520robust%2520A%25CE%25B2%2520reduction%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5122%26epage%3D5137%26doi%3D10.1021%2Facs.jmedchem.8b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and centrally active 6-substituted 5-fluoro-1,3-dihydro-oxazine β-secretase (BACE1) inhibitors via active conformation stabilization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5525</span>– <span class="NLM_lpage">5546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5525-5546&author=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Komanoauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Hasegawaauthor=T.+Yamamotoauthor=Y.+Sakoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.+Kusakabe&title=Discovery+of+potent+and+centrally+active+6-substituted+5-fluoro-1%2C3-dihydro-oxazine+%CE%B2-secretase+%28BACE1%29+inhibitors+via+active+conformation+stabilization&doi=10.1021%2Facs.jmedchem.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization</span></div><div class="casAuthors">Nakahara, Kenji; Fuchino, Kouki; Komano, Kazuo; Asada, Naoya; Tadano, Genta; Hasegawa, Tsuyoshi; Yamamoto, Takahiko; Sako, Yusuke; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) has an essential role in the prodn. of amyloid β peptides that accumulate in patients with Alzheimer's disease (AD).  Thus, inhibition of BACE1 is considered to be a disease-modifying approach for the treatment of AD.  The authors' hit-to-lead efforts led to a cellular potent 1,3-dihydro-oxazine I, which however inhibited hERG and showed high P-gp efflux.  The close analog of 5-fluoro-oxazine II reduced P-gp efflux; further introduction of electron withdrawing groups at the 6-position improved potency and also mitigated P-gp efflux and hERG inhibition.  Changing to a pyrazine followed by optimization of substituents on both the oxazine and the pyrazine culminated in III with robust Aβ redn. in vivo at low doses as well as reduced CYP2D6 inhibition.  On the basis of the X-ray anal. and the QM calcn. of given dihydro-oxazines, it was reasoned that the substituents at the 6-position as well as the 5-fluorine on the oxazine would stabilize a bioactive conformation to increase potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBTrC8rX3RE7Vg90H21EOLACvtfcHk0lias1DlLjlycA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D&md5=e622beaca28e64ea0da30c87d0828086</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSako%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520centrally%2520active%25206-substituted%25205-fluoro-1%252C3-dihydro-oxazine%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520via%2520active%2520conformation%2520stabilization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5525%26epage%3D5546%26doi%3D10.1021%2Facs.jmedchem.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of selective β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: targeting the flap to gain selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5080</span>– <span class="NLM_lpage">5095</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5080-5095&author=K.+Fujimotoauthor=E.+Matsuokaauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Yamamotoauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=H.+Itoauthor=N.+Kanegawaauthor=D.+Moecharsauthor=H.+J.+M.+Gijsenauthor=K.+Kusakabe&title=Structure-based+design+of+selective+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+targeting+the+flap+to+gain+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b00309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2</span></div><div class="casAuthors">Fujimoto, Kazuki; Matsuoka, Eriko; Asada, Naoya; Tadano, Genta; Yamamoto, Takahiko; Nakahara, Kenji; Fuchino, Kouki; Ito, Hisanori; Kanegawa, Naoki; Moechars, Diederik; Gijsen, Harrie J. M.; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5080-5095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer's disease.  BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments.  This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2.  Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design.  We targeted the flap region, where the shape and flexibility differ between these enzymes.  Anal. of the cocrystal structures of an initial lead 8 prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compds. 21 and 22.  The structures of 22 bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the 22-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity.  These findings and insights should contribute to responding to the challenges in exploring selective BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGdAN0ejWNyrVg90H21EOLACvtfcHk0ljaN86U-5Uwfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D&md5=9ceba959612bdac96dfdda689ad6f0e8</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DKusakabe%26aufirst%3DK.%26atitle%3DStructure-based%2520design%2520of%2520selective%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520targeting%2520the%2520flap%2520to%2520gain%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5080%26epage%3D5095%26doi%3D10.1021%2Facs.jmedchem.9b00309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a 6-CF<sub>3</sub>-substituted 2-amino-dihydro-1,3-thiazine β-secretase inhibitor by <i>N,N</i>-diethylsulfur trifluoride-mediated chemoselective cyclization</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">4893</span>– <span class="NLM_lpage">4897</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.8b02179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.8b02179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSrsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2019&pages=4893-4897&author=T.+Ogumaauthor=K.+Ananauthor=S.+Suzukiauthor=S.+Hisakawaauthor=A.+Takadaauthor=M.+Ogawaauthor=K.-i.+Kusakabe&title=Synthesis+of+a+6-CF3-substituted+2-amino-dihydro-1%2C3-thiazine+%CE%B2-secretase+inhibitor+by+N%2CN-diethylsulfur+trifluoride-mediated+chemoselective+cyclization&doi=10.1021%2Facs.joc.8b02179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a 6-CF3-Substituted 2-Amino-dihydro-1,3-thiazine β-Secretase Inhibitor by N,N-Diethylaminosulfur Trifluoride-Mediated Chemoselective Cyclization</span></div><div class="casAuthors">Oguma, Takuya; Anan, Kosuke; Suzuki, Shinji; Hisakawa, Shinya; Takada, Akihiro; Ogawa, Masayoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4893-4897</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a 6-CF3-substituted 2-amino-dihydro-1,3-thiazine via N,N-diethylaminosulfur trifluoride (DAST)-mediated cyclization of N-hydroxypropyl thiourea I is described.  This reaction gave 6-CF3-1,3-thiazine II with high chem. yield and chemoselectivity, suppressing the common byproduct of oxazine.  This new protocol enabled access to 6-CF3-substituted 1,3-thiazine β-secretase inhibitor III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB5R8g_SarTbVg90H21EOLACvtfcHk0ljaN86U-5Uwfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSrsbbO&md5=a84b7f683474108cbbccabc9c7fa7078</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.8b02179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.8b02179%26sid%3Dliteratum%253Aachs%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DAnan%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DSynthesis%2520of%2520a%25206-CF3-substituted%25202-amino-dihydro-1%252C3-thiazine%2520%25CE%25B2-secretase%2520inhibitor%2520by%2520N%252CN-diethylsulfur%2520trifluoride-mediated%2520chemoselective%2520cyclization%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2019%26volume%3D84%26spage%3D4893%26epage%3D4897%26doi%3D10.1021%2Facs.joc.8b02179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urmaliya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bergh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verboven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Trifluoromethyl dihydrothiazine-based β-Secretase (BACE1) inhibitors with robust central β-amyloid reduction and minimal covalent binding burden</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1894</span>– <span class="NLM_lpage">1910</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1002%2Fcmdc.201900478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=31657130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFarur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1894-1910&author=K.+Ananauthor=Y.+Isoauthor=T.+Ogumaauthor=K.+Nakaharaauthor=S.+Suzukiauthor=T.+Yamamotoauthor=E.+Matsuokaauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=K.+Morimotoauthor=N.+Kanegawaauthor=Y.+Kidoauthor=T.+Kawachiauthor=T.+Fukushimaauthor=A.+Teismanauthor=V.+Urmaliyaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=N.+Austinauthor=A.+Van+Den+Berghauthor=P.+Verbovenauthor=F.+Bischoffauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=K.-i.+Kusakabe&title=Trifluoromethyl+dihydrothiazine-based+%CE%B2-Secretase+%28BACE1%29+inhibitors+with+robust+central+%CE%B2-amyloid+reduction+and+minimal+covalent+binding+burden&doi=10.1002%2Fcmdc.201900478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoromethyl Dihydrothiazine-Based β-Secretase (BACE1) Inhibitors with Robust Central β-Amyloid Reduction and Minimal Covalent Binding Burden</span></div><div class="casAuthors">Anan, Kosuke; Iso, Yasuyoshi; Oguma, Takuya; Nakahara, Kenji; Suzuki, Shinji; Yamamoto, Takahiko; Matsuoka, Eriko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Morimoto, Kenji; Kanegawa, Naoki; Kido, Yasuto; Kawachi, Tomoyuki; Fukushima, Tamio; Teisman, Ard; Urmaliya, Vijay; Dhuyvetter, Deborah; Borghys, Herman; Austin, Nigel; Van Den Bergh, An; Verboven, Peter; Bischoff, Francois; Gijsen, Harrie J. M.; Yamano, Yoshinori; Kusakabe, Kenichi</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1894-1910</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The β-site amyloid precursor protein cleaving enzyme 1 (BACE1, also known as β-secretase) is a promising target for the treatment of Alzheimer's disease.  A pKa lowering approach over the initial leads was adopted to mitigate hERG inhibition and P-gp efflux, leading to the design of 6-CF3 dihydrothiazine 8 (N-(3-((4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide).  Optimization of 8 led to the discovery of 15 (N-(3-((4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide) with an excellent balance of potency, hERG inhibition, P-gp efflux, and metabolic stability.  Oral administration of 8 elicited robust Aβ redn. in dog even at 0.16 mg/kg.  Reflecting the reduced hERG inhibitory activity, no QTc prolongation was obsd. at high doses.  The potential for reactive metabolite formation of 15 was realized in a nucleophile trapping assay using [14C]-KCN in human liver microsomes.  Utilizing covalent binding (CVB) in human hepatocytes and the max. projected human dosage, the daily CVB burden of 15 was calcd. to be at an acceptable value of below 1 mg/day.  However, hepatotoxicity was obsd. when 15 was subjected to a two-week tolerance study in dog, which prevented further evaluation of this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppg1JHQpg4S7Vg90H21EOLACvtfcHk0ljaN86U-5Uwfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFarur%252FM&md5=1fbb54003cfb52eceb1ab778705314d9</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900478%26sid%3Dliteratum%253Aachs%26aulast%3DAnan%26aufirst%3DK.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DKawachi%26aufirst%3DT.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DTeisman%26aufirst%3DA.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DVan%2BDen%2BBergh%26aufirst%3DA.%26aulast%3DVerboven%26aufirst%3DP.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DTrifluoromethyl%2520dihydrothiazine-based%2520%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520robust%2520central%2520%25CE%25B2-amyloid%2520reduction%2520and%2520minimal%2520covalent%2520binding%2520burden%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1894%26epage%3D1910%26doi%3D10.1002%2Fcmdc.201900478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urmaliya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bergh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Discovery of an extremely potent thiazine-based β-secretase inhibitor with reduced cardiovascular and liver toxicity at a low projected human dose</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9337</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9331-9337&author=G.+Tadanoauthor=K.+Komanoauthor=S.+Yoshidaauthor=S.+Suzukiauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Fujimotoauthor=E.+Matsuokaauthor=T.+Yamamotoauthor=N.+Asadaauthor=H.+Itoauthor=G.+Sakaguchiauthor=N.+Kanegawaauthor=Y.+Kidoauthor=S.+Andoauthor=T.+Fukushimaauthor=A.+Teismanauthor=V.+Urmaliyaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=A.+Van+Den+Berghauthor=N.+Austinauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-i.+Kusakabe&title=Discovery+of+an+extremely+potent+thiazine-based+%CE%B2-secretase+inhibitor+with+reduced+cardiovascular+and+liver+toxicity+at+a+low+projected+human+dose&doi=10.1021%2Facs.jmedchem.9b01140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13fR"><div class="casContent"><span class="casTitleNuber">13f</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose</span></div><div class="casAuthors">Tadano, Genta; Komano, Kazuo; Yoshida, Shuhei; Suzuki, Shinji; Nakahara, Kenji; Fuchino, Kouki; Fujimoto, Kazuki; Matsuoka, Eriko; Yamamoto, Takahiko; Asada, Naoya; Ito, Hisanori; Sakaguchi, Gaku; Kanegawa, Naoki; Kido, Yasuto; Ando, Shigeru; Fukushima, Tamio; Teisman, Ard; Urmaliya, Vijay; Dhuyvetter, Deborah; Borghys, Herman; Van Den Bergh, An; Austin, Nigel; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9331-9337</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer's disease.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ redn. in vivo at low concns., leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ redn. of 80% at trough level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCgZp0A9J8rbVg90H21EOLACvtfcHk0li7PgXdGwWM_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO&md5=8f6c618bad3fc4bcf7bfb97b48972fa3</span></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DTeisman%26aufirst%3DA.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BDen%2BBergh%26aufirst%3DA.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DDiscovery%2520of%2520an%2520extremely%2520potent%2520thiazine-based%2520%25CE%25B2-secretase%2520inhibitor%2520with%2520reduced%2520cardiovascular%2520and%2520liver%2520toxicity%2520at%2520a%2520low%2520projected%2520human%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9331%26epage%3D9337%26doi%3D10.1021%2Facs.jmedchem.9b01140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Esterházy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döbeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+St%C3%BCtzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+D%C3%B6beliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+is+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lgVU0TgoJtk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DSt%25C3%25BCtzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520is%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0lgVU0TgoJtk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lhGnquoW_dWNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rulifson, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samayoa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baribault, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltzius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Identification of human islet amyloid polypeptide as a BACE2 substrate</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0147254</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0147254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1371%2Fjournal.pone.0147254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=26840340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=I.+C.+Rulifsonauthor=P.+Caoauthor=L.+Miaoauthor=D.+Kopeckyauthor=L.+Huangauthor=R.+D.+Whiteauthor=K.+Samayoaauthor=J.+Gardnerauthor=X.+Wuauthor=K.+Chenauthor=T.+Tsurudaauthor=O.+Homannauthor=H.+Baribaultauthor=H.+Yamaneauthor=T.+Carlsonauthor=J.+Wiltziusauthor=Y.+Li&title=Identification+of+human+islet+amyloid+polypeptide+as+a+BACE2+substrate&doi=10.1371%2Fjournal.pone.0147254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human islet amyloid polypeptide as a BACE2 substrate</span></div><div class="casAuthors">Rulifson, Ingrid C.; Cao, Ping; Miao, Li; Kopecky, David; Huang, Linda; White, Ryan D.; Samayoa, Kim; Gardner, Jonitha; Wu, Xiaosu; Chen, Kui; Tsuruda, Trace; Homann, Oliver; Baribault, Helene; Yamane, Harvey; Carlson, Tim; Wiltzius, Jed; Li, Yang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0147254/1-e0147254/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Pancreatic amyloid formation by islet amyloid polypeptide (IAPP) is a hallmark pathol. feature of type 2 diabetes.  IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis.  IAPP is innocuous under homeostatic conditions but imbalances in prodn. or processing of IAPP may result in homodimer formation leading to the rapid prodn. of cytotoxic oligomers and amyloid fibrils.  The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets.  Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly assocd. with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease.  Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity.  The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degrdn.  These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-assocd. hyperamylinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxpM4hmm1pLVg90H21EOLACvtfcHk0lhGnquoW_dWNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D&md5=ab081153a95c7462bd208bac8779bd1d</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0147254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0147254%26sid%3Dliteratum%253Aachs%26aulast%3DRulifson%26aufirst%3DI.%2BC.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DKopecky%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DSamayoa%26aufirst%3DK.%26aulast%3DGardner%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DT.%26aulast%3DHomann%26aufirst%3DO.%26aulast%3DBaribault%26aufirst%3DH.%26aulast%3DYamane%26aufirst%3DH.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DWiltzius%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520human%2520islet%2520amyloid%2520polypeptide%2520as%2520a%2520BACE2%2520substrate%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0147254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Voytyuk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snellinx, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">BACE2 distribution in major brain cell types and identification of novel substrates</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e201800026</span> <span class="refDoi"> DOI: 10.26508/lsa.201800026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.26508%2Flsa.201800026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30456346" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&author=I.+Voytyukauthor=S.+A.+Muellerauthor=J.+Herberauthor=A.+Snellinxauthor=D.+Moecharsauthor=G.+van+Looauthor=S.+F.+Lichtenthalerauthor=B.+De+Strooper&title=BACE2+distribution+in+major+brain+cell+types+and+identification+of+novel+substrates&doi=10.26508%2Flsa.201800026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800026%26sid%3Dliteratum%253Aachs%26aulast%3DVoytyuk%26aufirst%3DI.%26aulast%3DMueller%26aufirst%3DS.%2BA.%26aulast%3DHerber%26aufirst%3DJ.%26aulast%3DSnellinx%26aufirst%3DA.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DBACE2%2520distribution%2520in%2520major%2520brain%2520cell%2520types%2520and%2520identification%2520of%2520novel%2520substrates%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2018%26volume%3D1%26doi%3D10.26508%2Flsa.201800026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alić, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portelius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gkanatsiou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschut, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunmeir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havlicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvartsberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmalm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hithersay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Startin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamburg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervushin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turmaine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovelet-Lecrux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krsnik, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šimić, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostović, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitrečić, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consortium, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strydom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nižetić, D.</span></span> <span> </span><span class="NLM_article-title">Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene-dose-sensitive AD-suppressor in human brain</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1038/s41380-020-0806-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1038%2Fs41380-020-0806-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1&author=I.+Ali%C4%87author=P.+A.+Gohauthor=A.+Murrayauthor=E.+Porteliusauthor=E.+Gkanatsiouauthor=G.+Goughauthor=K.+Y.+Mokauthor=D.+Koschutauthor=R.+Brunmeirauthor=Y.+J.+Yeapauthor=N.+L.+O%E2%80%99Brienauthor=J.+Groetauthor=X.+Shaoauthor=S.+Havlicekauthor=N.+R.+Dunnauthor=H.+Kvartsbergauthor=G.+Brinkmalmauthor=R.+Hithersayauthor=C.+Startinauthor=S.+Hamburgauthor=M.+Phillipsauthor=K.+Pervushinauthor=M.+Turmaineauthor=D.+Wallonauthor=A.+Rovelet-Lecruxauthor=H.+Soininenauthor=E.+Volpiauthor=J.+E.+Martinauthor=J.+N.+Fooauthor=D.+L.+Beckerauthor=A.+Rostagnoauthor=J.+Ghisoauthor=%C5%BD.+Krsnikauthor=G.+%C5%A0imi%C4%87author=I.+Kostovi%C4%87author=D.+Mitre%C4%8Di%C4%87author=L.+Consortiumauthor=P.+T.+Francisauthor=K.+Blennowauthor=A.+Strydomauthor=J.+Hardyauthor=H.+Zetterbergauthor=D.+Ni%C5%BEeti%C4%87&title=Patient-specific+Alzheimer-like+pathology+in+trisomy+21+cerebral+organoids+reveals+BACE2+as+a+gene-dose-sensitive+AD-suppressor+in+human+brain&doi=10.1038%2Fs41380-020-0806-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1038%2Fs41380-020-0806-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41380-020-0806-5%26sid%3Dliteratum%253Aachs%26aulast%3DAli%25C4%2587%26aufirst%3DI.%26aulast%3DGoh%26aufirst%3DP.%2BA.%26aulast%3DMurray%26aufirst%3DA.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DGkanatsiou%26aufirst%3DE.%26aulast%3DGough%26aufirst%3DG.%26aulast%3DMok%26aufirst%3DK.%2BY.%26aulast%3DKoschut%26aufirst%3DD.%26aulast%3DBrunmeir%26aufirst%3DR.%26aulast%3DYeap%26aufirst%3DY.%2BJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DN.%2BL.%26aulast%3DGroet%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DHavlicek%26aufirst%3DS.%26aulast%3DDunn%26aufirst%3DN.%2BR.%26aulast%3DKvartsberg%26aufirst%3DH.%26aulast%3DBrinkmalm%26aufirst%3DG.%26aulast%3DHithersay%26aufirst%3DR.%26aulast%3DStartin%26aufirst%3DC.%26aulast%3DHamburg%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPervushin%26aufirst%3DK.%26aulast%3DTurmaine%26aufirst%3DM.%26aulast%3DWallon%26aufirst%3DD.%26aulast%3DRovelet-Lecrux%26aufirst%3DA.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DVolpi%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DJ.%2BE.%26aulast%3DFoo%26aufirst%3DJ.%2BN.%26aulast%3DBecker%26aufirst%3DD.%2BL.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DKrsnik%26aufirst%3D%25C5%25BD.%26aulast%3D%25C5%25A0imi%25C4%2587%26aufirst%3DG.%26aulast%3DKostovi%25C4%2587%26aufirst%3DI.%26aulast%3DMitre%25C4%258Di%25C4%2587%26aufirst%3DD.%26aulast%3DConsortium%26aufirst%3DL.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DStrydom%26aufirst%3DA.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DNi%25C5%25BEeti%25C4%2587%26aufirst%3DD.%26atitle%3DPatient-specific%2520Alzheimer-like%2520pathology%2520in%2520trisomy%252021%2520cerebral%2520organoids%2520reveals%2520BACE2%2520as%2520a%2520gene-dose-sensitive%2520AD-suppressor%2520in%2520human%2520brain%26jtitle%3DMol.%2520Psychiatry%26date%3D2020%26spage%3D1%26doi%3D10.1038%2Fs41380-020-0806-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.bmc.2009.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=20045648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=630-639&author=M.+S.+Malamasauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=P.+Zhouauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=M.+Pangalosauthor=P.+Reinhartauthor=A.+J.+Robichaud&title=Di-substituted+pyridinyl+aminohydantoins+as+potent+and+highly+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1016%2Fj.bmc.2009.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Barnes, Keith; Johnson, Matthew; Hui, Yu; Zhou, Ping; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Pangalos, Menelas; Reinhart, Peter; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">630-639</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of highly selective small mol. di-substituted pyridinyl aminohydantoins as β-secretase inhibitors is reported.  The more potent and selective analogs demonstrate low nanomolar potency for the BACE1 enzyme as measured in a FRET assay, and exhibit comparable activity in a cell-based (ELISA) assay.  In addn., these pyridine-aminohydantoins are highly selectivity (>500×) against the other structurally related aspartyl proteases BACE2, cathepsin D, pepsin and renin.  Our design strategy followed a traditional SAR approach and was supported by mol. modeling studies based on the previously reported aminohydantoin I.  We have taken advantage of the amino acid difference between the BACE1 and BACE2 at the S2' pocket (BACE1 Pro70 changed to BACE2 Lys86) to build ligands with >500-fold selectivity against BACE2.  The addn. of large substituents on the targeted ligand at the vicinity of this aberration has generated a steric conflict between the ligand and these two proteins, thus impacting the ligand's affinity and selectivity.  These ligands have also shown an exceptional selectivity against cathepsin D (>5000-fold) as well as the other aspartyl proteases mentioned.  One of the more potent compds. (S)-II displayed an IC50 value for BACE1 of 10 nM, and exhibited cellular activity with an EC50 value of 130 nM in the ELISA assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPjXCZYzfhLVg90H21EOLACvtfcHk0lgpSDrsMM_CUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D&md5=7b509e226d91b162059777507e7f8463</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDi-substituted%2520pyridinyl%2520aminohydantoins%2520as%2520potent%2520and%2520highly%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D630%26epage%3D639%26doi%3D10.1016%2Fj.bmc.2009.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">O’Neill, B. T.</span>; <span class="NLM_string-name">Barreiro, G.</span>; <span class="NLM_string-name">Lachapelle, E. A.</span>; <span class="NLM_string-name">Rogers, B. N.</span></span> <span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>h</i>)-yl-1,3-thiazol-4-yl) Amides as Inhibitors of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO2,015,155,626A1</span>, Oct 15, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=E.+M.+Beck&author=C.+R.+Butler&author=L.+Zhang&author=B.+T.+O%E2%80%99Neill&author=G.+Barreiro&author=E.+A.+Lachapelle&author=B.+N.+Rogers&title=Preparation+of+N-%282-Amino-6-methyl-4%2C4a%2C5%2C6-tetrahydropyrano%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-8a%288h%29-yl-1%2C3-thiazol-4-yl%29+Amides+as+Inhibitors+of+Beta-site+Amyloid+Precursor+Protein+Cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520N-%25282-Amino-6-methyl-4%252C4a%252C5%252C6-tetrahydropyrano%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-8a%25288h%2529-yl-1%252C3-thiazol-4-yl%2529%2520Amides%2520as%2520Inhibitors%2520of%2520Beta-site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Hembre, E. J.</span>; <span class="NLM_string-name">Lopez, J. E.</span>; <span class="NLM_string-name">Winneroski, L. L.,  Jr.</span>; <span class="NLM_string-name">Woods, T. A.</span>; <span class="NLM_string-name">Mcmahon, J. A.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Amino-5-(1,1-difluoroalkyl)-4,4<i>a</i>,5,7-tetrahydrofuro[3,4-<i>d</i>][1,3]thiazin-7<i>a</i>-yl-4-fluorophenyl-5-(1,2,4-triazol-1-yl)pyrazine-2-carboxamides as Selective BACE1 Inhibitors</span>. <span class="NLM_patent">US20,160,244,465A1</span>, Aug 25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+J.+Richards&author=E.+J.+Hembre&author=J.+E.+Lopez&author=L.+L.+Winneroski&author=T.+A.+Woods&author=J.+A.+Mcmahon&title=Preparation+of+2-Amino-5-%281%2C1-difluoroalkyl%29-4%2C4a%2C5%2C7-tetrahydrofuro%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-7a-yl-4-fluorophenyl-5-%281%2C2%2C4-triazol-1-yl%29pyrazine-2-carboxamides+as+Selective+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DS.%2BJ.%26atitle%3DPreparation%2520of%25202-Amino-5-%25281%252C1-difluoroalkyl%2529-4%252C4a%252C5%252C7-tetrahydrofuro%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-7a-yl-4-fluorophenyl-5-%25281%252C2%252C4-triazol-1-yl%2529pyrazine-2-carboxamides%2520as%2520Selective%2520BACE1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span>; <span class="NLM_string-name">Amegadzie, A.</span>; <span class="NLM_string-name">Bourbeau, M. P.</span>; <span class="NLM_string-name">Brown, J. A.</span>; <span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Frohn, M. J.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Pettus, L. H.</span>; <span class="NLM_string-name">Qian, W.</span>; <span class="NLM_string-name">Reeves, C. M.</span>; <span class="NLM_string-name">Siegmund, A. C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Vinyl Fluoride Cyclopropyl Fused Thiazin-2-amine Compounds as Beta-secretase Inhibitors and Methods of Use</span>. <span class="NLM_patent">WO2,017,024,180A1</span>, Feb 9, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+R.+Allen&author=A.+Amegadzie&author=M.+P.+Bourbeau&author=J.+A.+Brown&author=N.+Chen&author=M.+J.+Frohn&author=L.+Liu&author=Q.+Liu&author=L.+H.+Pettus&author=W.+Qian&author=C.+M.+Reeves&author=A.+C.+Siegmund&title=Preparation+of+Vinyl+Fluoride+Cyclopropyl+Fused+Thiazin-2-amine+Compounds+as+Beta-secretase+Inhibitors+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DPreparation%2520of%2520Vinyl%2520Fluoride%2520Cyclopropyl%2520Fused%2520Thiazin-2-amine%2520Compounds%2520as%2520Beta-secretase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Chapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of clinical candidate PF-06751979: A potent, brain penetrant, β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor lacking hypopigmentation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4476</span>– <span class="NLM_lpage">4504</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00246</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00246" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4476-4504&author=B.+T.+O%E2%80%99Neillauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=C.+E.+Nolanauthor=C.+Gonzalesauthor=L.+Zhangauthor=S.+D.+Doranauthor=K.+Laphamauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=G.+Barreiroauthor=X.+Houauthor=L.+A.+Martinez-Alsinaauthor=B.+N.+Rogersauthor=A.+Villalobosauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=E.+A.+La+Chapelleauthor=C.+Changauthor=L.+F.+Lanyonauthor=C.+M.+Steppanauthor=A.+Robshawauthor=K.+Halesauthor=G.+G.+Boucherauthor=K.+Pandherauthor=C.+Houleauthor=C.+W.+Ambroiseauthor=D.+Karanianauthor=D.+Riddellauthor=K.+R.+Balesauthor=M.+A.+Brodney&title=Design+and+synthesis+of+clinical+candidate+PF-06751979%3A+A+potent%2C+brain+penetrant%2C+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+lacking+hypopigmentation&doi=10.1021%2Facs.jmedchem.8b00246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16eR"><div class="casContent"><span class="casTitleNuber">16e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation</span></div><div class="casAuthors">O'Neill, Brian T.; Beck, Elizabeth M.; Butler, Christopher R.; Nolan, Charles E.; Gonzales, Cathleen; Zhang, Lei; Doran, Shawn D.; Lapham, Kimberly; Buzon, Leanne M.; Dutra, Jason K.; Barreiro, Gabriela; Hou, Xinjun; Martinez-Alsina, Luis A.; Rogers, Bruce N.; Villalobos, Anabella; Murray, John C.; Ogilvie, Kevin; La Chapelle, Erik A.; Chang, Cheng; Lanyon, Lorraine F.; Steppan, Claire M.; Robshaw, Ashley; Hales, Katherine; Boucher, Germaine G.; Pandher, Karamjeet; Houle, Christopher; Ambroise, Claude W.; Karanian, David; Riddell, David; Bales, Kelly R.; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4476-4504</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2.  The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphol. resulting in a depigmentation phenotype.  Herein, the authors describe the identification of clin. candidate PF-06751979 (I), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2.  Chronic dosing of I for up to 9 mo in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1F61vo0jBbVg90H21EOLACvtfcHk0lic7grDtzWMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D&md5=3d8cae0bb20298e66f6da1c26cf8d5bc</span></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DLapham%26aufirst%3DK.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DLa%2BChapelle%26aufirst%3DE.%2BA.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DLanyon%26aufirst%3DL.%2BF.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DHales%26aufirst%3DK.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DPandher%26aufirst%3DK.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DAmbroise%26aufirst%3DC.%2BW.%26aulast%3DKaranian%26aufirst%3DD.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520clinical%2520candidate%2520PF-06751979%253A%2520A%2520potent%252C%2520brain%2520penetrant%252C%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520lacking%2520hypopigmentation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4476%26epage%3D4504%26doi%3D10.1021%2Facs.jmedchem.8b00246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bäck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span> <span> </span><span class="NLM_article-title">Toward β-secretase-1 inhibitors with improved isoform selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3491</span>– <span class="NLM_lpage">3502</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3491-3502&author=P.+Johanssonauthor=K.+Kasperssonauthor=I.+K.+Gurrellauthor=E.+B%C3%A4ckauthor=S.+Eketj%C3%A4llauthor=C.+W.+Scottauthor=G.+Cebersauthor=P.+Thorneauthor=M.+J.+McKenzieauthor=H.+Beatonauthor=P.+Daveyauthor=K.+Kolmodinauthor=J.+Holenzauthor=M.+E.+Dugganauthor=S.+B.+Haeberleinauthor=R.+W.+B%C3%BCrli&title=Toward+%CE%B2-secretase-1+inhibitors+with+improved+isoform+selectivity&doi=10.1021%2Facs.jmedchem.7b01716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16fR"><div class="casContent"><span class="casTitleNuber">16f</span><div class="casTitle"><span class="NLM_cas:atitle">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span></div><div class="casAuthors">Johansson, Patrik; Kaspersson, Karin; Gurrell, Ian K.; Baeck, Elisabeth; Eketjaell, Susanna; Scott, Clay W.; Cebers, Gvido; Thorne, Philip; McKenzie, Michael J.; Beaton, Haydn; Davey, Paul; Kolmodin, Karin; Holenz, Joerg; Duggan, Mark E.; Budd Haeberlein, Samantha; Burli, Roland W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3491-3502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ prodn., and has been indicated to play a key role in the pathogenesis of Alzheimer's disease.  The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein.  To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors.  Cocrystal structures of 47 compds. were analyzed and clustered according to their selectivity profiles.  Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket.  Several new mols. were designed and tested to make use of this observation.  The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead mol. 28, which exhibited ∼50-fold selectivity.  Compared to a nonselective BACE1/2 inhibitor, 28 showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functional selectivity of this inhibitor class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCCtmcFz6HrVg90H21EOLACvtfcHk0lic7grDtzWMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D&md5=46ce3d839d3153d848c1ae0209263634</span></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DB%25C3%25A4ck%26aufirst%3DE.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DThorne%26aufirst%3DP.%26aulast%3DMcKenzie%26aufirst%3DM.%2BJ.%26aulast%3DBeaton%26aufirst%3DH.%26aulast%3DDavey%26aufirst%3DP.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26atitle%3DToward%2520%25CE%25B2-secretase-1%2520inhibitors%2520with%2520improved%2520isoform%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3491%26epage%3D3502%26doi%3D10.1021%2Facs.jmedchem.7b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegmund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of AM-6494: A potent and orally efficacious β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with in vivo selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2263</span>– <span class="NLM_lpage">2281</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2263-2281&author=L.+H.+Pettusauthor=M.+P.+Bourbeauauthor=J.+Bradleyauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=D.+Hickmanauthor=M.+Johnsonauthor=Q.+Liuauthor=J.+R.+Manningauthor=A.+Nanezauthor=A.+C.+Siegmundauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=J.+R.+Allenauthor=S.+Wood&title=Discovery+of+AM-6494%3A+A+potent+and+orally+efficacious+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+with+in+vivo+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b01034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16gR"><div class="casContent"><span class="casTitleNuber">16g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2</span></div><div class="casAuthors">Pettus Liping H; Bourbeau Matthew P; Bradley Jodi; Bartberger Michael D; Chen Kui; Hickman Dean; Johnson Michael; Liu Qingyian; Manning James R; Nanez Adrian; Siegmund Aaron C; Wen Paul H; Whittington Douglas A; Allen Jennifer R; Wood Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2263-2281</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is an aspartyl protease that plays a key role in the production of amyloid β (Aβ) in the brain and has been extensively pursued as a target for the treatment of Alzheimer's disease (AD).  BACE2, an aspartyl protease that is structurally related to BACE1, has been recently reported to be involved in melanosome maturation and pigmentation.  Herein, we describe the development of a series of cyclopropylthiazines as potent and orally efficacious BACE1 inhibitors.  Lead optimization led to the identification of 20, a molecule with biochemical IC50 BACE2/BACE1 ratio of 47.  Administration of 20 resulted in no skin/fur color change in a 13-day mouse hypopigmentation study and demonstrated robust and sustained reduction of CSF and brain Aβ40 levels in rat and monkey pharmacodynamic models.  On the basis of a compelling data package, 20 (AM-6494) was advanced to preclinical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmgrDHvGragzjk2McQZ6XmfW6udTcc2ebL8fm-yhqZUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D&md5=abc7ed1f6b97a705d9b43ea992712a97</span></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DManning%26aufirst%3DJ.%2BR.%26aulast%3DNanez%26aufirst%3DA.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520AM-6494%253A%2520A%2520potent%2520and%2520orally%2520efficacious%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520with%2520in%2520vivo%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2263%26epage%3D2281%26doi%3D10.1021%2Facs.jmedchem.9b01034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0ljmgNqa-sTL9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huggins, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidor, B.</span></span> <span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1444</span>, <span class="refDoi"> DOI: 10.1021/jm2010332</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design&doi=10.1021%2Fjm2010332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0liwYRKyxnJLgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444%26doi%3D10.1021%2Fjm2010332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de
Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de%0ADiegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+From+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0liwYRKyxnJLgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <i>The
cocrystal structure was obtained at Proteros according to the procedure
described in ref 20b</i>;  (accessed September 10, 2017)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The%0Acocrystal+structure+was+obtained+at+Proteros+according+to+the+procedure%0Adescribed+in+ref+20b%3B+%28accessed+September+10%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%250Acocrystal%2520structure%2520was%2520obtained%2520at%2520Proteros%2520according%2520to%2520the%2520procedure%250Adescribed%2520in%2520ref%252020b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuppuleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debulpaep, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gast, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabulovski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusznir, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miscenic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, A.</span></span> <span> </span><span class="NLM_article-title">Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1107/S0907444913006574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1107%2FS0907444913006574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=23695257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1124-1137&author=D.+W.+Bannerauthor=B.+Gsellauthor=J.+Benzauthor=J.+Bertschingerauthor=D.+Burgerauthor=S.+Brackauthor=S.+Cuppuleriauthor=M.+Debulpaepauthor=A.+Gastauthor=D.+Grabulovskiauthor=M.+Hennigauthor=H.+Hilpertauthor=W.+Huberauthor=A.+Kuglstatterauthor=E.+Kusznirauthor=T.+Laeremansauthor=H.+Matileauthor=C.+Miscenicauthor=A.+C.+Ruferauthor=D.+Schlatterauthor=J.+Steyaertauthor=M.+Stihleauthor=R.+Thomaauthor=M.+Weberauthor=A.+Ruf&title=Mapping+the+conformational+space+accessible+to+BACE2+using+surface+mutants+and+cocrystals+with+Fab+fragments%2C+Fynomers+and+Xaperones&doi=10.1107%2FS0907444913006574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones</span></div><div class="casAuthors">Banner, David W.; Gsell, Bernard; Benz, Joerg; Bertschinger, Julian; Burger, Dominique; Brack, Simon; Cuppuleri, Simon; Debulpaep, Maja; Gast, Alain; Grabulovski, Dragan; Hennig, Michael; Hilpert, Hans; Huber, Walter; Kuglstatter, Andreas; Kusznir, Eric; Laeremans, Toon; Matile, Hugues; Miscenic, Christian; Rufer, Arne C.; Schlatter, Daniel; Steyaert, Jan; Stihle, Martine; Thoma, Ralf; Weber, Martin; Ruf, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1124-1137</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The aspartic protease BACE2 is responsible for the shedding of the transmembrane protein Tmem27 from the surface of pancreatic β-cells, which leads to inactivation of the β-cell proliferating activity of Tmem27.  This role of BACE2 in the control of β-cell maintenance suggests BACE2 as a drug target for diabetes.  Inhibition of BACE2 has recently been shown to lead to improved control of glucose homeostasis and to increased insulin levels in insulin-resistant mice.  BACE2 has 52% sequence identity to the well studied Alzheimer's disease target enzyme β-secretase (BACE1).  High-resoln. BACE2 structures would contribute significantly to the investigation of this enzyme as either a drug target or anti-target.  Surface mutagenesis, BACE2-binding antibody Fab fragments, single-domain camelid antibody VHH fragments (Xaperones) and Fyn-kinase-derived SH3 domains (Fynomers) were used as crystn. helpers to obtain the first high-resoln. structures of BACE2.  Eight crystal structures in six different packing environments define an ensemble of low-energy conformations available to the enzyme.  Here, the different strategies used for raising and selecting BACE2 binders for cocrystn. are described and the crystn. success, crystal quality and the time and resources needed to obtain suitable crystals are compared.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7cIGSzKlOorVg90H21EOLACvtfcHk0liwYRKyxnJLgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2ltL0%253D&md5=902a9036109be32de055c4ad73aeacdf</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1107%2FS0907444913006574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913006574%26sid%3Dliteratum%253Aachs%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DBertschinger%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DD.%26aulast%3DBrack%26aufirst%3DS.%26aulast%3DCuppuleri%26aufirst%3DS.%26aulast%3DDebulpaep%26aufirst%3DM.%26aulast%3DGast%26aufirst%3DA.%26aulast%3DGrabulovski%26aufirst%3DD.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DKusznir%26aufirst%3DE.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMiscenic%26aufirst%3DC.%26aulast%3DRufer%26aufirst%3DA.%2BC.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26atitle%3DMapping%2520the%2520conformational%2520space%2520accessible%2520to%2520BACE2%2520using%2520surface%2520mutants%2520and%2520cocrystals%2520with%2520Fab%2520fragments%252C%2520Fynomers%2520and%2520Xaperones%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1124%26epage%3D1137%26doi%3D10.1107%2FS0907444913006574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, F.</span></span> <span> </span><span class="NLM_article-title">Self-consistent description of a metal–water interface by the Kohn–Sham density functional theory and the three-dimensional reference interaction site model</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10095</span>– <span class="NLM_lpage">10112</span>, <span class="refDoi"> DOI: 10.1063/1.478883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1063%2F1.478883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADyaK1MXivV2mu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1999&pages=10095-10112&author=A.+Kovalenkoauthor=F.+Hirata&title=Self-consistent+description+of+a+metal%E2%80%93water+interface+by+the+Kohn%E2%80%93Sham+density+functional+theory+and+the+three-dimensional+reference+interaction+site+model&doi=10.1063%2F1.478883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Self-consistent description of a metal-water interface by the Kohn-Sham density functional theory and the three-dimensional reference interaction site model</span></div><div class="casAuthors">Kovalenko, Andriy; Hirata, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10095-10112</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The authors have developed a self-consistent description of an interface between a metal and a mol. liq. by combination of the d. functional theory in the Kohn-Sham formulation (KS DFT) for the electronic structure, and the 3-dimensional generalization of the ref. interaction site model (3-dimensional RISM) for the classical site distribution profiles of liq.  The electron and classical subsystems are coupled in the mean field approxn.  The procedure takes account of many-body effects of dense fluid on the metal-liq. interactions by averaging the pseudopotentials of liq. mols. over the classical distributions of the liq.  The proposed approach is substantially less time-consuming as compared to a Car-Parrinello-type simulation since it replaces mol. dynamics with the integral equation theory of mol. liqs.  The calcn. was performed for pure H2O at normal conditions in contact with the (100) face cubic centered (fcc.) surface of a metal roughly modeled after Cu.  The results are in good agreement with the Car-Parrinello simulation for the same metal model.  The shift of the Fermi level due to the presence of H2O conforms with expt.  The electron distribution near an adsorbed H2O mol. is affected by dense H2O, and so the metal-H2O attraction follows the shapes of the metal effective electrostatic potential.  For the metal model employed, it is strongest at the hollow site adsorption positions, and H2O mols. are adsorbed mainly at the hollow and bridge site positions rather than over metal atoms.  Layering of H2O mols. near the metal surface is found.  In the 1st hydration layer, adsorbed H2O mols. are oriented in parallel to the surface or tilted with hydrogens mainly outwards the metal.  This orientation at the potential of zero charge agrees with expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_fv_k3tQTf7Vg90H21EOLACvtfcHk0liPgW4t49_YAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivV2mu7o%253D&md5=52ac54fb183b01d92fd53347ec5b2aa0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1063%2F1.478883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.478883%26sid%3Dliteratum%253Aachs%26aulast%3DKovalenko%26aufirst%3DA.%26aulast%3DHirata%26aufirst%3DF.%26atitle%3DSelf-consistent%2520description%2520of%2520a%2520metal%25E2%2580%2593water%2520interface%2520by%2520the%2520Kohn%25E2%2580%2593Sham%2520density%2520functional%2520theory%2520and%2520the%2520three-dimensional%2520reference%2520interaction%2520site%2520model%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1999%26volume%3D110%26spage%3D10095%26epage%3D10112%26doi%3D10.1063%2F1.478883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <i>Molecular
Operating Environment (MOE), 2016.01</i>; <span class="NLM_publisher-name">Chemical
Computing Group ULC</span>: 1010 Sherbooke St. West, Suite
#910, Montreal, QC, Canada, H3A 2R7, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular%0AOperating+Environment+%28MOE%29%2C+2016.01%3B+Chemical%0AComputing+Group+ULC%3A+1010+Sherbooke+St.+West%2C+Suite%0A%23910%2C+Montreal%2C+QC%2C+Canada%2C+H3A+2R7%2C+2020."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMolecular%250AOperating%2520Environment%2520%2528MOE%2529%252C%25202016.01%26pub%3DChemical%250AComputing%2520Group%2520ULC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0liPgW4t49_YAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-<i>tert</i>-Butanesulfinyl imines: versatile intermediates for the asymmetric synthesis of amines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">984</span>– <span class="NLM_lpage">995</span>, <span class="refDoi"> DOI: 10.1021/ar020066u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar020066u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=984-995&author=J.+A.+Ellmanauthor=T.+D.+Owensauthor=T.+P.+Tang&title=N-tert-Butanesulfinyl+imines%3A+versatile+intermediates+for+the+asymmetric+synthesis+of+amines&doi=10.1021%2Far020066u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Far020066u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far020066u%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DN-tert-Butanesulfinyl%2520imines%253A%2520versatile%2520intermediates%2520for%2520the%2520asymmetric%2520synthesis%2520of%2520amines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D35%26spage%3D984%26epage%3D995%26doi%3D10.1021%2Far020066u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e','cit13f'],'ref14':['cit14a','cit14b','cit14c','cit14d'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c','cit16d','cit16e','cit16f','cit16g'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Profiles of Verubecestat <b>1</b> and Dihydro-1,3-oxazine <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structures of verubecestat <b>1</b> bound to BACE1 (A) and BACE2 (B). The key water molecules are shown as a space-filling model and colored in red. The flap and 10s loops are highlighted in yellow and purple, respectively. Compound <b>1</b> and key residues are depicted as stick models. Numerical values beside water molecules represent their binding free energy, which were calculated using the solvent analysis module in MOE2016.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of compound <b>2</b> (A) (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J0P">4J0P</a>) and <b>3</b> (B) bound to BACE1. The color schemes of water, residues, and loops are the same as for <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of <b>7</b> bound to BACE1 (A) and BACE2 (B). The color schemes of water, residues, and loops are the same as for <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Propynyl Oxazines <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-propynylmagnesium bromide, THF, 0 °C, and quant; (b) (i) 2-iodoxybenzoic acid, EtOAc, and reflux and (ii) (<i>R</i>)-<i>tert</i>-butylsulfinamide, Ti(OEt)<sub>4</sub>, toluene, 80 °C, and 66% over two steps; (c) <i>n</i>-BuLi, diisopropylamine, <i>tert</i>-butyl acetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, and 80%; (d) (i) LiBH<sub>4</sub>, MeOH, THF, and rt, (ii) 4 M HCl in 1,4-dioxane, MeOH, and rt, and (iii) BzNCS, DCM, 0 °C to rt, and 86% over three steps; (e) EDC·HCl, THF, MeCN, 0 °C to rt, and 55%; (f) (i) DBU, MeOH, and 60 °C, (ii) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C, and 88% over two steps; (g) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, and 64%; and (h) RCOOH, EDC·HCl, aq HCl, MeOH, rt, and 87 and 75% for <b>3</b> and <b>4</b>, respectively.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/medium/jm0c01858_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Propynyl Oxazines <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01858/20210319/images/large/jm0c01858_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01858&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, benzyl 3,3-difluorocyclobutane-1-carboxylate, diisopropylamine, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, and 59%; (b) LiBH<sub>4</sub>, MeOH, THF, rt, and 60%; (c) (i) 4 M HCl in 1,4-dioxane, MeOH, and rt, (ii) BzNCO, DCM, 0 °C, and 80% over two steps; (d) Burgess reagent, toluene, reflux, and 50%; (e) DBU, MeOH, 60 °C, and 68%; and (f) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, and −30 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, and 80 °C, and (iii) RCOOH, EDC·HCl, aq HCl, MeOH, 0 °C, and 62 and 81% over three steps for <b>6</b> and <b>7</b>, respectively.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span> <i>World Alzheimer Report
2019</i>;  (accessed April 30, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Disease%0AInternational+World+Alzheimer+Report%0A2019%3B+%28accessed+April+30%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Alzheimer%2520Report%250A2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Alzheimer’s Association</span> <i>2020
Alzheimer’s Disease Facts and
Figures</i>;  (accessed April 30, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association+2020%0AAlzheimer%E2%80%99s+Disease+Facts+and%0AFigures%3B+%28accessed+April+30%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3D2020%250AAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%250AFigures" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chancellor, D.</span>; <span class="NLM_string-name">Dube, S.</span>; <span class="NLM_string-name">Huntley, C.</span></span> <i>Alzheimer’s disease</i>; Ref Code: DMKC4740.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chancellor%2C+D.%3B+Dube%2C+S.%3B+Huntley%2C+C.+Alzheimer%E2%80%99s+disease%3B+Ref+Code%3A+DMKC4740."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChancellor%26aufirst%3DD.%26jtitle%3DAlzheimer%25E2%2580%2599s%2520disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0lg2D5goMkt88g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lg2D5goMkt88g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lhIXIO83RvskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>; <span class="NLM_edition">3</span><sup>rd</sup> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>; <span class="NLM_string-name">Rotella, D. P.</span>; <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; vol.  <span class="NLM_volume">7</span>, pp.  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-Secretase%2520%2528BACE%2529%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761-777&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0lhIXIO83RvskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26epage%3D777%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lhIXIO83RvskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of β-site APP cleaving enzyme 1 (BACE) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0lje87VSeuOBVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1080/13543776.2021.1832463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1080%2F13543776.2021.1832463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=33006491" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=25-52&author=F.+Romboutsauthor=K.-I.+Kusakabeauthor=C.-C.+Hsiaoauthor=H.+J.+M.+Gijsen&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282011+to+2020%29&doi=10.1080%2F13543776.2021.1832463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1080%2F13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282011%2520to%25202020%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D31%26spage%3D25%26epage%3D52%26doi%3D10.1080%2F13543776.2021.1832463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)–A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29%E2%80%93A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lje87VSeuOBVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%25E2%2580%2593A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=E.+M.+Parkerauthor=J.+N.+Cummingauthor=W.+Liauthor=J.+D.+Scottauthor=K.+Coxauthor=M.+F.+Dockendorfauthor=H.+J.+Kleijnauthor=H.+Meiauthor=J.+A.+Stoneauthor=M.+Eganauthor=L.+Ereshefskyauthor=S.+Jheeauthor=B.+A.+Mattsonauthor=J.+Palczaauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span>; <span class="NLM_string-name">Scott, J. D.</span>; <span class="NLM_string-name">Strickland, C. O.</span></span> <span> </span><span class="NLM_article-title">Verubecestat</span>. In  <i>Comprehensive Medicinal Chemistry III</i>; <span class="NLM_edition">3</span><sup>rd</sup> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>; <span class="NLM_string-name">Rotella, D. P.</span>; <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; vol.  <span class="NLM_volume">8</span>, pp.  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">251</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=204-251&author=J.+N.+Cumming&author=J.+D.+Scott&author=C.+O.+Stricklandauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26atitle%3DVerubecestat%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D8%26spage%3D204%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1706441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1056%2FNEJMoa1706441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=29719179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2018&pages=1691-1703&author=M.+F.+Eganauthor=J.+Kostauthor=P.+N.+Tariotauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=B.+Vellasauthor=C.+Surauthor=Y.+Mukaiauthor=T.+Vossauthor=C.+Furtekauthor=E.+Mahoneyauthor=L.+H.+Mozleyauthor=R.+Vandenbergheauthor=Y.+Moauthor=D.+Michelson&title=Randomized+trial+of+verubecestat+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1706441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the deposition of amyloid-beta (Aβ) plaques in the brain.  Aβ is produced from the sequential cleavage of amyloid precursor protein by β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by γ-secretase.  Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer's disease.  Methods: We conducted a randomized, double-blind, placebo-controlled, 78-wk trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clin. diagnosis of mild-to-moderate Alzheimer's disease.  The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function).  Results: A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo.  The trial was terminated early for futility 50 mo after onset, which was within 5 mo before its scheduled completion, and after enrollment of the planned 1958 patients was complete.  The estd. mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group).  The estd. mean change from baseline to week 78 in the ADCS-ADL score was -8.4 in the 12-mg group, -8.2 in the 40-mg group, and -8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group).  Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, wt. loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. conclusions Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was assocd. with treatment-related adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroW5Tf-VIj2LVg90H21EOLACvtfcHk0liBdOb9K_tbKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D&md5=e6ecfbd2981616b343468ae8bed1db2d</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1706441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1706441%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMahoney%26aufirst%3DE.%26aulast%3DMozley%26aufirst%3DL.%2BH.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520trial%2520of%2520verubecestat%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D378%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1706441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span> <i>Merck & Co., Inc.</i>;  (accessed January 7, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Merck+%26+Co.%2C+Inc.%3B+%28accessed+January+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DMerck%2520%2526%2520Co.%252C%2520Inc." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimers Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=202-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span></div><div class="casAuthors">Timmers Maarten; Van Broeck Bianca; De Waepenaert Katja; Russu Alberto; Stieltjes Hans; Moechars Dieder; Mercken Marc; Kemp John; Van Nueten Luc; Tritsmans Luc; Streffer Johannes Rolf; Timmers Maarten; Engelborghs Sebastiaan; Streffer Johannes Rolf; Ramael Steven; Slemmon John; Liu Enchi; Bogert Jennifer; Shaw Leslie M; Engelborghs Sebastiaan; Sinha Vikash</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">OBJECTIVES:  Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, JNJ-54861911, were assessed after single and multiple dosing in healthy participants.  METHODS:  Two randomized, placebo-controlled, double-blind studies were performed using single and multiple ascending JNJ-54861911 doses (up to 14 days) in young and elderly healthy participants.  Regular blood samples and frequent CSF samples, up to 36 hours after last dose, were collected to assess the pharmacokinetic and pharmacodynamic (Aβ, sAPPα,β,total levels) profiles of JNJ-54861911.  RESULTS:  JNJ-54861911 was well-tolerated, adverse events were uncommon and unrelated to JNJ-54861911.  JNJ-54861911 showed dose-proportional CSF and plasma pharmacokinetic profiles.  Plasma- and CSF-Aβ and CSF-sAPPβ were reduced in a dose-dependent manner.  Aβ reductions (up to 95%) outlasted exposure to JNJ-54861911.  APOE ε4 carrier status and baseline Aβ levels did not influence Aβ/sAPPβ reductions.  CONCLUSION:  JNJ-54861911, a potent brain-penetrant BACE1 inhibitor, achieved high and stable Aβ reductions after single and multiple dosing in healthy participants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQDdblLE_E9PWfW6udTcc2eYw6Rb17Y599rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D&md5=46e0c106c2560f0b2c9aeba095fc20de</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimers%2520Dementia%26date%3D2016%26volume%3D2%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatikola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smekens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson-Hanson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matias-Guiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baquero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesseur, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">85</span>, <span class="refDoi"> DOI: 10.1186/s13195-018-0415-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1186%2Fs13195-018-0415-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFSisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=85&author=M.+Timmersauthor=J.+R.+Strefferauthor=A.+Russuauthor=Y.+Tominagaauthor=H.+Shimizuauthor=A.+Shiraishiauthor=K.+Tatikolaauthor=P.+Smekensauthor=A.+B%C3%B6rjesson-Hansonauthor=N.+Andreasenauthor=J.+Matias-Guiuauthor=M.+Baqueroauthor=M.+Boadaauthor=I.+Tesseurauthor=L.+Tritsmansauthor=L.+Van+Nuetenauthor=S.+Engelborghs&title=Pharmacodynamics+of+atabecestat+%28JNJ-54861911%29%2C+an+oral+BACE1+inhibitor+in+patients+with+early+Alzheimer%E2%80%99s+disease%3A+randomized%2C+double-blind%2C+placebo-controlled+study&doi=10.1186%2Fs13195-018-0415-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study</span></div><div class="casAuthors">Timmers, Maarten; Streffer, Johannes Rolf; Russu, Alberto; Tominaga, Yushin; Shimizu, Hiroko; Shiraishi, Ayako; Tatikola, Kanaka; Smekens, Pascale; Borjesson-Hanson, Anne; Andreasen, Niels; Matias-Guiu, Jorge; Baquero, Miquel; Boada, Merce; Tesseur, Ina; Tritsmans, Luc; Van Nueten, Luc; Engelborghs, Sebastiaan</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85/1-85/18</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: β-Secretase enzyme (BACE) inhibition has been proposed as a priority treatment mechanism for Alzheimer's disease (AD), but treatment initiation may need to be very early.  We present proof of mechanism of atabecestat (also known as JNJ-54861911), an oral BACE inhibitor for the treatment of AD, in Caucasian and Japanese populations with early AD who do not show signs of dementia.  Methods: In two similarly designed phase I studies, a sample of amyloid-pos. elderly patients comprising 45 Caucasian patients with early AD diagnosed as preclin. AD (n = 15, Clin. Dementia Rating [CDR] = 0) or with mild cognitive impairment due to AD (n = 30, CDR = 0.5) and 18 Japanese patients diagnosed as preclin. AD (CDR-J = 0) were randomized 1:1:1 to atabecestat 10 or 50 mg or placebo (n = 6-8/treatment) daily for 4 wk.  Safety, pharmacokinetics (PK), and pharmacodynamics (PD) (i.e., redn. of cerebrospinal fluid [CSF] amyloid beta 1-40 [Aβ1-40] levels [primary endpoint] and effect on other AD biomarkers) of atabecestat were evaluated.  Results: In both populations, atabecestat was well tolerated and characterized by linear PK and high central nervous system penetrance of unbound drug.  Atabecestat significantly reduced CSF Aβ1-40 levels from baseline at day 28 in both the 10-mg (67-68%) and 50-mg (87-90%) dose groups compared with placebo.  For Caucasians with early AD, the least squares mean differences (95% CI) were - 69.37 (- 72.25; - 61.50) and - 92.74 (- 100.08; - 85.39), and for Japanese with preclin. AD, they were - 62.48 (- 78.32; - 46.64) and - 80.81 (- 96.13; - 65.49), resp.  PK/PD model simulations confirmed that once-daily 10 mg and 50 mg atabecestat can attain 60-70% and 90% Aβ1-40 redns., resp.  The trend of the redn. was similar across the Aβ1-37, Aβ1-38, and Aβ1-42 fragments in both atabecestat dose groups, consistent with Aβ1-40.  CSF amyloid precursor protein fragment (sAPPβ) levels declined from baseline, regardless of patient population, whereas CSF sAPPα levels increased compared with placebo.  There were no relevant changes in either CSF total tau or phosphorylated tau 181P over a 4-wk treatment period.  Conclusions: JNJ-54861911 at 10 and 50 mg daily doses after 4 wk resulted in mean CSF Aβ1-40 redns. of 67% and up to 90% in both Caucasian and Japanese patients with early stage AD, confirming results in healthy elderly adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs-nRFnefSK7Vg90H21EOLACvtfcHk0lh9uYzSkrC51Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFSisL8%253D&md5=5368ac1a51165aa7be020c9ec1512424</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1186%2Fs13195-018-0415-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-018-0415-6%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DTominaga%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DShiraishi%26aufirst%3DA.%26aulast%3DTatikola%26aufirst%3DK.%26aulast%3DSmekens%26aufirst%3DP.%26aulast%3DB%25C3%25B6rjesson-Hanson%26aufirst%3DA.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DMatias-Guiu%26aufirst%3DJ.%26aulast%3DBaquero%26aufirst%3DM.%26aulast%3DBoada%26aufirst%3DM.%26aulast%3DTesseur%26aufirst%3DI.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DEngelborghs%26aufirst%3DS.%26atitle%3DPharmacodynamics%2520of%2520atabecestat%2520%2528JNJ-54861911%2529%252C%2520an%2520oral%2520BACE1%2520inhibitor%2520in%2520patients%2520with%2520early%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2018%26volume%3D10%26spage%3D85%26doi%3D10.1186%2Fs13195-018-0415-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, G.</span></span> <span> </span><span class="NLM_article-title">Preliminary results of a trial of atabecestat in preclinical Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1485</span>, <span class="refDoi"> DOI: 10.1056/NEJMc1813435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1056%2FNEJMc1813435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30970197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FjvFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=1483-1485&author=D.+Henleyauthor=N.+Raghavanauthor=R.+Sperlingauthor=P.+Aisenauthor=R.+Ramanauthor=G.+Romano&title=Preliminary+results+of+a+trial+of+atabecestat+in+preclinical+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMc1813435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease</span></div><div class="casAuthors">Henley David; Raghavan Nandini; Sperling Reisa; Aisen Paul; Raman Rema; Romano Gary</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1483-1485</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfD9bI0ZsheHELvajU9pjPfW6udTcc2eYw6Rb17Y599rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FjvFGqtg%253D%253D&md5=42b37561fb1b3bd8102b7ba3ba64d588</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1056%2FNEJMc1813435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMc1813435%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DD.%26aulast%3DRaghavan%26aufirst%3DN.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DAisen%26aufirst%3DP.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DRomano%26aufirst%3DG.%26atitle%3DPreliminary%2520results%2520of%2520a%2520trial%2520of%2520atabecestat%2520in%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26spage%3D1483%26epage%3D1485%26doi%3D10.1056%2FNEJMc1813435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koriyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonezawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einaru, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of atabecestat (JNJ-54861911): a thiazine-based β-amyloid precursor protein cleaving enzyme 1 inhibitor advanced to the phase 2b/3 EARLY clinical trial</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1873</span>– <span class="NLM_lpage">1888</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BB3MXjvFeguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2021&pages=1873-1888&author=Y.+Koriyamaauthor=A.+Horiauthor=H.+Itoauthor=S.+Yonezawaauthor=Y.+Babaauthor=N.+Tanimotoauthor=T.+Uenoauthor=Y.+Yamamotoauthor=T.+Yamamotoauthor=N.+Asadaauthor=K.+Morimotoauthor=E.+Einaruauthor=K.+Sakaiauthor=T.+Kanazuauthor=A.+Matsudaauthor=Y.+Yamaguchiauthor=T.+Ogumaauthor=M.+Timmersauthor=L.+Tritsmansauthor=K.-i.+Kusakabeauthor=A.+Katoauthor=G.+Sakaguchi&title=Discovery+of+atabecestat+%28JNJ-54861911%29%3A+a+thiazine-based+%CE%B2-amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+advanced+to+the+phase+2b%2F3+EARLY+clinical+trial&doi=10.1021%2Facs.jmedchem.0c01917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial</span></div><div class="casAuthors">Koriyama, Yuji; Hori, Akihiro; Ito, Hisanori; Yonezawa, Shuji; Baba, Yoshiyasu; Tanimoto, Norihiko; Ueno, Tatsuhiko; Yamamoto, Shiho; Yamamoto, Takahiko; Asada, Naoya; Morimoto, Kenji; Einaru, Shunsuke; Sakai, Katsunori; Kanazu, Takushi; Matsuda, Akihiro; Yamaguchi, Yoshitaka; Oguma, Takuya; Timmers, Maarten; Tritsmans, Luc; Kusakabe, Ken-ichi; Kato, Akira; Sakaguchi, Gaku</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1873-1888</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of amyloid β peptides (Aβ) is thought to be one of the causal factors of Alzheimer's disease (AD).  The aspartyl protease β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting protease for Aβ prodn., and therefore, BACE1 inhibition is a promising therapeutic approach for the treatment of AD.  Starting with a dihydro-1,3-thiazine-based lead, Compd. J, we discovered atabecestat 1 (JNJ-54861911) as a centrally efficacious BACE1 inhibitor that was advanced into the EARLY Phase 2b/3 clin. trial for the treatment of preclin. AD patients.  Compd. 1 demonstrated robust and dose-dependent Aβ redn. and showed sufficient safety margins in preclin. models.  The potential of reactive metabolite formation was evaluated in a covalent binding study to assess its irreversible binding to human hepatocytes.  Unfortunately, the EARLY trial was discontinued due to significant elevation of liver enzymes, and subsequent anal. of the clin. outcomes showed dose-related cognitive worsening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq20LJrxpaavLVg90H21EOLACvtfcHk0lhrNOYTIclyEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXjvFeguro%253D&md5=ad7220218f10e5f110db63153bbaa98b</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01917%26sid%3Dliteratum%253Aachs%26aulast%3DKoriyama%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DYonezawa%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DEinaru%26aufirst%3DE.%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DKanazu%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DSakaguchi%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520atabecestat%2520%2528JNJ-54861911%2529%253A%2520a%2520thiazine-based%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520advanced%2520to%2520the%2520phase%25202b%252F3%2520EARLY%2520clinical%2520trial%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2021%26volume%3D64%26spage%3D1873%26epage%3D1888%26doi%3D10.1021%2Facs.jmedchem.0c01917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <i>Alzforum</i>;  (accessed July 24, 2017)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Alzforum%3B+%28accessed+July+24%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzforum" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Kita, Y.</span>; <span class="NLM_string-name">Yamamoto, N.</span>; <span class="NLM_string-name">Khan, A.</span>; <span class="NLM_string-name">Dimopoulos, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of condensed aminodihydrothiazine derivatives as inhibitors of β-site APP-cleaving enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO2,009,091,016A1</span>, July 23, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+condensed+aminodihydrothiazine+derivatives+as+inhibitors+of+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520condensed%2520aminodihydrothiazine%2520derivatives%2520as%2520inhibitors%2520of%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüönd, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.-L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+L%C3%BC%C3%B6ndauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.-M.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.-L.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DL%25C3%25BC%25C3%25B6nd%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <i>Novartis AG</i>;  (accessed September 1, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Novartis+AG%3B+%28accessed+September+1%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DNovartis%2520AG" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santacruz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckles, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDade, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayeux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossor, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group">Dominantly inherited Alzheimer network</span> <span> </span><span class="NLM_article-title">Clinical and biomarker changes in dominantly inherited Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1202753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1056%2FNEJMoa1202753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=22784036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=795-804&author=R.+J.+Batemanauthor=C.+Xiongauthor=T.+L.+S.+Benzingerauthor=A.+M.+Faganauthor=A.+Goateauthor=N.+C.+Foxauthor=D.+S.+Marcusauthor=N.+J.+Cairnsauthor=X.+Xieauthor=T.+M.+Blazeyauthor=D.+M.+Holtzmanauthor=A.+Santacruzauthor=V.+Bucklesauthor=A.+Oliverauthor=K.+Moulderauthor=P.+S.+Aisenauthor=B.+Ghettiauthor=W.+E.+Klunkauthor=E.+McDadeauthor=R.+N.+Martinsauthor=C.+L.+Mastersauthor=R.+Mayeuxauthor=J.+M.+Ringmanauthor=M.+N.+Rossorauthor=P.+R.+Schofieldauthor=R.+A.+Sperlingauthor=S.+Sallowayauthor=J.+C.+Morrisauthor=Dominantly+inherited+Alzheimer+network&title=Clinical+and+biomarker+changes+in+dominantly+inherited+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1202753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and biomarker changes in dominantly inherited Alzheimer's disease</span></div><div class="casAuthors">Bateman, Randall J.; Xiong, Chengjie; Benzinger, Tammie L. S.; Fagan, Anne M.; Goate, Alison; Fox, Nick C.; Marcus, Daniel S.; Cairns, Nigel J.; Xie, Xianyun; Blazey, Tyler M.; Holtzman, David M.; Santacruz, Anna; Buckles, Virginia; Oliver, Angela; Moulder, Krista; Aisen, Paul S.; Ghetti, Bernardino; Klunk, William E.; McDade, Eric; Martins, Ralph N.; Masters, Colin L.; Mayeux, Richard; Ringman, John M.; Rossor, Martin N.; Schofield, Peter R.; Sperling, Reisa A.; Salloway, Stephen; Morris, John C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">795-804</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The order and magnitude of pathol. processes in Alzheimer's disease are not well understood, partly because the disease develops over many years.  Autosomal dominant Alzheimer's disease has a predictable age at onset and provides an opportunity to det. the sequence and magnitude of pathol. changes that culminate in symptomatic disease.  METHODS: In this prospective, longitudinal study, we analyzed data from 128 participants who underwent baseline clin. and cognitive assessments, brain imaging, and cerebrospinal fluid (CSF) and blood tests.  We used the participant's age at baseline assessment and the parent's age at the onset of symptoms of Alzheimer's disease to calc. the estd. years from expected symptom onset (age of the participant minus parent's age at symptom onset).  We conducted cross-sectional analyses of baseline data in relation to estd. years from expected symptom onset in order to det. the relative order and magnitude of pathophysiol. changes.  RESULTS: Concns. of amyloid-beta (Aβ)42 in the CSF appeared to decline 25 years before expected symptom onset.  Aβ deposition, as measured by positron-emission tomog. with the use of Pittsburgh compd. B, was detected 15 years before expected symptom onset.  Increased concns. of tau protein in the CSF and an increase in brain atrophy were detected 15 years before expected symptom onset.  Cerebral hypometabolism and impaired episodic memory were obsd. 10 years before expected symptom onset.  Global cognitive impairment, as measured by the Mini-Mental State Examn. and the Clin. Dementia Rating scale, was detected 5 years before expected symptom onset, and patients met diagnostic criteria for dementia at an av. of 3 years after expected symptom onset.  CONCLUSIONS: We found that autosomal dominant Alzheimer's disease was assocd. with a series of pathophysiol. changes over decades in CSF biochem. markers of Alzheimer's disease, brain amyloid deposition, and brain metab. as well as progressive cognitive impairment.  Our results require confirmation with the use of longitudinal data and may not apply to patients with sporadic Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptJNV9eDXBCLVg90H21EOLACvtfcHk0lhBCzBVB3UosA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J&md5=c4f999ea3401af9651a2770724757bed</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1202753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1202753%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DMarcus%26aufirst%3DD.%2BS.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DBlazey%26aufirst%3DT.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DSantacruz%26aufirst%3DA.%26aulast%3DBuckles%26aufirst%3DV.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DMoulder%26aufirst%3DK.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMcDade%26aufirst%3DE.%26aulast%3DMartins%26aufirst%3DR.%2BN.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DRingman%26aufirst%3DJ.%2BM.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3D%26atitle%3DClinical%2520and%2520biomarker%2520changes%2520in%2520dominantly%2520inherited%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D795%26epage%3D804%26doi%3D10.1056%2FNEJMoa1202753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzler, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilieva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span> <span> </span><span class="NLM_article-title">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">9712</span>– <span class="NLM_lpage">9717</span>, <span class="refDoi"> DOI: 10.1073/pnas.160115697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1073%2Fpnas.160115697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10931940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9712-9717&author=M.+Farzanauthor=C.+E.+Schnitzlerauthor=N.+Vasilievaauthor=D.+Leungauthor=H.+Choe&title=BACE2%2C+a+%CE%B2-secretase+homolog%2C+cleaves+at+the+%CE%B2+site+and+within+the+amyloid-%CE%B2+region+of+the+amyloid-%CE%B2+precursor+protein&doi=10.1073%2Fpnas.160115697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span></div><div class="casAuthors">Farzan, Michael; Schnitzler, Christine E.; Vasilieva, Natalya; Leung, Doris; Choe, Hyeryun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9712-9717</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prodn. of amyloid-β protein (Aβ) is initiated by a β-secretase that cleaves the Aβ precursor protein (APP) at the N terminus of Aβ (the β site).  A recently identified aspartyl protease, BACE, cleaves the β site and at residue 11 within the Aβ region of APP.  Here we show that BACE2, a BACE homolog, cleaves at the β site and more efficiently at a different site within Aβ.  The Flemish missense mutation of APP, implicated in a form of familial Alzheimer's disease, is adjacent to this latter site and markedly increases Aβ prodn. by BACE2 but not by BACE.  BACE and BACE2 respond identically to conservative β-site mutations, and alteration of a common active site Arg inhibits β-site cleavage but not cleavage within Aβ by both enzymes.  These data suggest that BACE2 contributes to Aβ prodn. in individuals bearing the Flemish mutation, and that selective inhibition of these highly similar proteases may be feasible and therapeutically advantageous.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKuCTBTrzorVg90H21EOLACvtfcHk0lhBCzBVB3UosA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D&md5=4cafdc5cf3c57bb981323281cc55cbae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.160115697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.160115697%26sid%3Dliteratum%253Aachs%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DSchnitzler%26aufirst%3DC.%2BE.%26aulast%3DVasilieva%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DChoe%26aufirst%3DH.%26atitle%3DBACE2%252C%2520a%2520%25CE%25B2-secretase%2520homolog%252C%2520cleaves%2520at%2520the%2520%25CE%25B2%2520site%2520and%2520within%2520the%2520amyloid-%25CE%25B2%2520region%2520of%2520the%2520amyloid-%25CE%25B2%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D9712%26epage%3D9717%26doi%3D10.1073%2Fpnas.160115697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyabu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel 1,3-oxazine based β-secretase (BACE1) inhibitors: Incorporation of a double bond to reduce P-gp efflux leading to robust Aβ reduction in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5122</span>– <span class="NLM_lpage">5137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5122-5137&author=K.+Fuchinoauthor=Y.+Mitsuokaauthor=M.+Masuiauthor=N.+Kuroseauthor=S.+Yoshidaauthor=K.+Komanoauthor=T.+Yamamotoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=H.+Miyajimaauthor=S.+Hiroyamaauthor=K.+Koyabuauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-i.+Kusakabe&title=Rational+design+of+novel+1%2C3-oxazine+based+%CE%B2-secretase+%28BACE1%29+inhibitors%3A+Incorporation+of+a+double+bond+to+reduce+P-gp+efflux+leading+to+robust+A%CE%B2+reduction+in+the+brain&doi=10.1021%2Facs.jmedchem.8b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></div><div class="casAuthors">Fuchino, Kouki; Mitsuoka, Yasunori; Masui, Moriyasu; Kurose, Noriyuki; Yoshida, Shuhei; Komano, Kazuo; Yamamoto, Takahiko; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Miyajima, Hirofumi; Hiroyama, Shuichi; Koyabu, Kiyotaka; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5122-5137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of Aβ peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD.  β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD.  Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration.  Starting from a 1,3-dihydrooxazine lead I identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of II that produced significant Aβ redn. with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models.  This compd. II improved the brain-to-plasma ratio relative to I by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPZsGRa22ZLVg90H21EOLACvtfcHk0lhNVTJ0QQRMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D&md5=ac366bddfe3492a0a47ce02918b5ea41</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DM.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DH.%26aulast%3DHiroyama%26aufirst%3DS.%26aulast%3DKoyabu%26aufirst%3DK.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DRational%2520design%2520of%2520novel%25201%252C3-oxazine%2520based%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%253A%2520Incorporation%2520of%2520a%2520double%2520bond%2520to%2520reduce%2520P-gp%2520efflux%2520leading%2520to%2520robust%2520A%25CE%25B2%2520reduction%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5122%26epage%3D5137%26doi%3D10.1021%2Facs.jmedchem.8b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and centrally active 6-substituted 5-fluoro-1,3-dihydro-oxazine β-secretase (BACE1) inhibitors via active conformation stabilization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5525</span>– <span class="NLM_lpage">5546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5525-5546&author=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Komanoauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Hasegawaauthor=T.+Yamamotoauthor=Y.+Sakoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.+Kusakabe&title=Discovery+of+potent+and+centrally+active+6-substituted+5-fluoro-1%2C3-dihydro-oxazine+%CE%B2-secretase+%28BACE1%29+inhibitors+via+active+conformation+stabilization&doi=10.1021%2Facs.jmedchem.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization</span></div><div class="casAuthors">Nakahara, Kenji; Fuchino, Kouki; Komano, Kazuo; Asada, Naoya; Tadano, Genta; Hasegawa, Tsuyoshi; Yamamoto, Takahiko; Sako, Yusuke; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) has an essential role in the prodn. of amyloid β peptides that accumulate in patients with Alzheimer's disease (AD).  Thus, inhibition of BACE1 is considered to be a disease-modifying approach for the treatment of AD.  The authors' hit-to-lead efforts led to a cellular potent 1,3-dihydro-oxazine I, which however inhibited hERG and showed high P-gp efflux.  The close analog of 5-fluoro-oxazine II reduced P-gp efflux; further introduction of electron withdrawing groups at the 6-position improved potency and also mitigated P-gp efflux and hERG inhibition.  Changing to a pyrazine followed by optimization of substituents on both the oxazine and the pyrazine culminated in III with robust Aβ redn. in vivo at low doses as well as reduced CYP2D6 inhibition.  On the basis of the X-ray anal. and the QM calcn. of given dihydro-oxazines, it was reasoned that the substituents at the 6-position as well as the 5-fluorine on the oxazine would stabilize a bioactive conformation to increase potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBTrC8rX3RE7Vg90H21EOLACvtfcHk0lhmGXGS2C4F6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D&md5=e622beaca28e64ea0da30c87d0828086</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSako%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520centrally%2520active%25206-substituted%25205-fluoro-1%252C3-dihydro-oxazine%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520via%2520active%2520conformation%2520stabilization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5525%26epage%3D5546%26doi%3D10.1021%2Facs.jmedchem.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of selective β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: targeting the flap to gain selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5080</span>– <span class="NLM_lpage">5095</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5080-5095&author=K.+Fujimotoauthor=E.+Matsuokaauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Yamamotoauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=H.+Itoauthor=N.+Kanegawaauthor=D.+Moecharsauthor=H.+J.+M.+Gijsenauthor=K.+Kusakabe&title=Structure-based+design+of+selective+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+targeting+the+flap+to+gain+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b00309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2</span></div><div class="casAuthors">Fujimoto, Kazuki; Matsuoka, Eriko; Asada, Naoya; Tadano, Genta; Yamamoto, Takahiko; Nakahara, Kenji; Fuchino, Kouki; Ito, Hisanori; Kanegawa, Naoki; Moechars, Diederik; Gijsen, Harrie J. M.; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5080-5095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer's disease.  BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments.  This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2.  Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design.  We targeted the flap region, where the shape and flexibility differ between these enzymes.  Anal. of the cocrystal structures of an initial lead 8 prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compds. 21 and 22.  The structures of 22 bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the 22-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity.  These findings and insights should contribute to responding to the challenges in exploring selective BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGdAN0ejWNyrVg90H21EOLACvtfcHk0lhmGXGS2C4F6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D&md5=9ceba959612bdac96dfdda689ad6f0e8</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DKusakabe%26aufirst%3DK.%26atitle%3DStructure-based%2520design%2520of%2520selective%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520targeting%2520the%2520flap%2520to%2520gain%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5080%26epage%3D5095%26doi%3D10.1021%2Facs.jmedchem.9b00309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a 6-CF<sub>3</sub>-substituted 2-amino-dihydro-1,3-thiazine β-secretase inhibitor by <i>N,N</i>-diethylsulfur trifluoride-mediated chemoselective cyclization</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">4893</span>– <span class="NLM_lpage">4897</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.8b02179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.8b02179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSrsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2019&pages=4893-4897&author=T.+Ogumaauthor=K.+Ananauthor=S.+Suzukiauthor=S.+Hisakawaauthor=A.+Takadaauthor=M.+Ogawaauthor=K.-i.+Kusakabe&title=Synthesis+of+a+6-CF3-substituted+2-amino-dihydro-1%2C3-thiazine+%CE%B2-secretase+inhibitor+by+N%2CN-diethylsulfur+trifluoride-mediated+chemoselective+cyclization&doi=10.1021%2Facs.joc.8b02179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a 6-CF3-Substituted 2-Amino-dihydro-1,3-thiazine β-Secretase Inhibitor by N,N-Diethylaminosulfur Trifluoride-Mediated Chemoselective Cyclization</span></div><div class="casAuthors">Oguma, Takuya; Anan, Kosuke; Suzuki, Shinji; Hisakawa, Shinya; Takada, Akihiro; Ogawa, Masayoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4893-4897</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a 6-CF3-substituted 2-amino-dihydro-1,3-thiazine via N,N-diethylaminosulfur trifluoride (DAST)-mediated cyclization of N-hydroxypropyl thiourea I is described.  This reaction gave 6-CF3-1,3-thiazine II with high chem. yield and chemoselectivity, suppressing the common byproduct of oxazine.  This new protocol enabled access to 6-CF3-substituted 1,3-thiazine β-secretase inhibitor III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB5R8g_SarTbVg90H21EOLACvtfcHk0lgyNFNAlqYs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSrsbbO&md5=a84b7f683474108cbbccabc9c7fa7078</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.8b02179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.8b02179%26sid%3Dliteratum%253Aachs%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DAnan%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DSynthesis%2520of%2520a%25206-CF3-substituted%25202-amino-dihydro-1%252C3-thiazine%2520%25CE%25B2-secretase%2520inhibitor%2520by%2520N%252CN-diethylsulfur%2520trifluoride-mediated%2520chemoselective%2520cyclization%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2019%26volume%3D84%26spage%3D4893%26epage%3D4897%26doi%3D10.1021%2Facs.joc.8b02179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urmaliya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bergh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verboven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Trifluoromethyl dihydrothiazine-based β-Secretase (BACE1) inhibitors with robust central β-amyloid reduction and minimal covalent binding burden</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1894</span>– <span class="NLM_lpage">1910</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1002%2Fcmdc.201900478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=31657130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFarur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1894-1910&author=K.+Ananauthor=Y.+Isoauthor=T.+Ogumaauthor=K.+Nakaharaauthor=S.+Suzukiauthor=T.+Yamamotoauthor=E.+Matsuokaauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=K.+Morimotoauthor=N.+Kanegawaauthor=Y.+Kidoauthor=T.+Kawachiauthor=T.+Fukushimaauthor=A.+Teismanauthor=V.+Urmaliyaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=N.+Austinauthor=A.+Van+Den+Berghauthor=P.+Verbovenauthor=F.+Bischoffauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=K.-i.+Kusakabe&title=Trifluoromethyl+dihydrothiazine-based+%CE%B2-Secretase+%28BACE1%29+inhibitors+with+robust+central+%CE%B2-amyloid+reduction+and+minimal+covalent+binding+burden&doi=10.1002%2Fcmdc.201900478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoromethyl Dihydrothiazine-Based β-Secretase (BACE1) Inhibitors with Robust Central β-Amyloid Reduction and Minimal Covalent Binding Burden</span></div><div class="casAuthors">Anan, Kosuke; Iso, Yasuyoshi; Oguma, Takuya; Nakahara, Kenji; Suzuki, Shinji; Yamamoto, Takahiko; Matsuoka, Eriko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Morimoto, Kenji; Kanegawa, Naoki; Kido, Yasuto; Kawachi, Tomoyuki; Fukushima, Tamio; Teisman, Ard; Urmaliya, Vijay; Dhuyvetter, Deborah; Borghys, Herman; Austin, Nigel; Van Den Bergh, An; Verboven, Peter; Bischoff, Francois; Gijsen, Harrie J. M.; Yamano, Yoshinori; Kusakabe, Kenichi</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1894-1910</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The β-site amyloid precursor protein cleaving enzyme 1 (BACE1, also known as β-secretase) is a promising target for the treatment of Alzheimer's disease.  A pKa lowering approach over the initial leads was adopted to mitigate hERG inhibition and P-gp efflux, leading to the design of 6-CF3 dihydrothiazine 8 (N-(3-((4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide).  Optimization of 8 led to the discovery of 15 (N-(3-((4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide) with an excellent balance of potency, hERG inhibition, P-gp efflux, and metabolic stability.  Oral administration of 8 elicited robust Aβ redn. in dog even at 0.16 mg/kg.  Reflecting the reduced hERG inhibitory activity, no QTc prolongation was obsd. at high doses.  The potential for reactive metabolite formation of 15 was realized in a nucleophile trapping assay using [14C]-KCN in human liver microsomes.  Utilizing covalent binding (CVB) in human hepatocytes and the max. projected human dosage, the daily CVB burden of 15 was calcd. to be at an acceptable value of below 1 mg/day.  However, hepatotoxicity was obsd. when 15 was subjected to a two-week tolerance study in dog, which prevented further evaluation of this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppg1JHQpg4S7Vg90H21EOLACvtfcHk0lgyNFNAlqYs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFarur%252FM&md5=1fbb54003cfb52eceb1ab778705314d9</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900478%26sid%3Dliteratum%253Aachs%26aulast%3DAnan%26aufirst%3DK.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DKawachi%26aufirst%3DT.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DTeisman%26aufirst%3DA.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DVan%2BDen%2BBergh%26aufirst%3DA.%26aulast%3DVerboven%26aufirst%3DP.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DTrifluoromethyl%2520dihydrothiazine-based%2520%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520robust%2520central%2520%25CE%25B2-amyloid%2520reduction%2520and%2520minimal%2520covalent%2520binding%2520burden%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1894%26epage%3D1910%26doi%3D10.1002%2Fcmdc.201900478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urmaliya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bergh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span> <span> </span><span class="NLM_article-title">Discovery of an extremely potent thiazine-based β-secretase inhibitor with reduced cardiovascular and liver toxicity at a low projected human dose</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9337</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9331-9337&author=G.+Tadanoauthor=K.+Komanoauthor=S.+Yoshidaauthor=S.+Suzukiauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Fujimotoauthor=E.+Matsuokaauthor=T.+Yamamotoauthor=N.+Asadaauthor=H.+Itoauthor=G.+Sakaguchiauthor=N.+Kanegawaauthor=Y.+Kidoauthor=S.+Andoauthor=T.+Fukushimaauthor=A.+Teismanauthor=V.+Urmaliyaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=A.+Van+Den+Berghauthor=N.+Austinauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-i.+Kusakabe&title=Discovery+of+an+extremely+potent+thiazine-based+%CE%B2-secretase+inhibitor+with+reduced+cardiovascular+and+liver+toxicity+at+a+low+projected+human+dose&doi=10.1021%2Facs.jmedchem.9b01140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13fR"><div class="casContent"><span class="casTitleNuber">13f</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose</span></div><div class="casAuthors">Tadano, Genta; Komano, Kazuo; Yoshida, Shuhei; Suzuki, Shinji; Nakahara, Kenji; Fuchino, Kouki; Fujimoto, Kazuki; Matsuoka, Eriko; Yamamoto, Takahiko; Asada, Naoya; Ito, Hisanori; Sakaguchi, Gaku; Kanegawa, Naoki; Kido, Yasuto; Ando, Shigeru; Fukushima, Tamio; Teisman, Ard; Urmaliya, Vijay; Dhuyvetter, Deborah; Borghys, Herman; Van Den Bergh, An; Austin, Nigel; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9331-9337</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer's disease.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ redn. in vivo at low concns., leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ redn. of 80% at trough level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCgZp0A9J8rbVg90H21EOLACvtfcHk0lg8A3QOWSkzrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO&md5=8f6c618bad3fc4bcf7bfb97b48972fa3</span></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DTeisman%26aufirst%3DA.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BDen%2BBergh%26aufirst%3DA.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-i.%26atitle%3DDiscovery%2520of%2520an%2520extremely%2520potent%2520thiazine-based%2520%25CE%25B2-secretase%2520inhibitor%2520with%2520reduced%2520cardiovascular%2520and%2520liver%2520toxicity%2520at%2520a%2520low%2520projected%2520human%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9331%26epage%3D9337%26doi%3D10.1021%2Facs.jmedchem.9b01140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Esterházy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döbeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+St%C3%BCtzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+D%C3%B6beliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+is+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lg8A3QOWSkzrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DSt%25C3%25BCtzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520is%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0lhyhh2vsx0wfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lhyhh2vsx0wfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rulifson, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samayoa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baribault, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltzius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Identification of human islet amyloid polypeptide as a BACE2 substrate</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0147254</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0147254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1371%2Fjournal.pone.0147254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=26840340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=I.+C.+Rulifsonauthor=P.+Caoauthor=L.+Miaoauthor=D.+Kopeckyauthor=L.+Huangauthor=R.+D.+Whiteauthor=K.+Samayoaauthor=J.+Gardnerauthor=X.+Wuauthor=K.+Chenauthor=T.+Tsurudaauthor=O.+Homannauthor=H.+Baribaultauthor=H.+Yamaneauthor=T.+Carlsonauthor=J.+Wiltziusauthor=Y.+Li&title=Identification+of+human+islet+amyloid+polypeptide+as+a+BACE2+substrate&doi=10.1371%2Fjournal.pone.0147254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human islet amyloid polypeptide as a BACE2 substrate</span></div><div class="casAuthors">Rulifson, Ingrid C.; Cao, Ping; Miao, Li; Kopecky, David; Huang, Linda; White, Ryan D.; Samayoa, Kim; Gardner, Jonitha; Wu, Xiaosu; Chen, Kui; Tsuruda, Trace; Homann, Oliver; Baribault, Helene; Yamane, Harvey; Carlson, Tim; Wiltzius, Jed; Li, Yang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0147254/1-e0147254/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Pancreatic amyloid formation by islet amyloid polypeptide (IAPP) is a hallmark pathol. feature of type 2 diabetes.  IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis.  IAPP is innocuous under homeostatic conditions but imbalances in prodn. or processing of IAPP may result in homodimer formation leading to the rapid prodn. of cytotoxic oligomers and amyloid fibrils.  The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets.  Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly assocd. with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease.  Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity.  The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degrdn.  These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-assocd. hyperamylinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxpM4hmm1pLVg90H21EOLACvtfcHk0lhyhh2vsx0wfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslOqtL4%253D&md5=ab081153a95c7462bd208bac8779bd1d</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0147254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0147254%26sid%3Dliteratum%253Aachs%26aulast%3DRulifson%26aufirst%3DI.%2BC.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DKopecky%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DSamayoa%26aufirst%3DK.%26aulast%3DGardner%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DTsuruda%26aufirst%3DT.%26aulast%3DHomann%26aufirst%3DO.%26aulast%3DBaribault%26aufirst%3DH.%26aulast%3DYamane%26aufirst%3DH.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DWiltzius%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520human%2520islet%2520amyloid%2520polypeptide%2520as%2520a%2520BACE2%2520substrate%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0147254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Voytyuk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snellinx, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">BACE2 distribution in major brain cell types and identification of novel substrates</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e201800026</span> <span class="refDoi"> DOI: 10.26508/lsa.201800026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.26508%2Flsa.201800026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=30456346" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&author=I.+Voytyukauthor=S.+A.+Muellerauthor=J.+Herberauthor=A.+Snellinxauthor=D.+Moecharsauthor=G.+van+Looauthor=S.+F.+Lichtenthalerauthor=B.+De+Strooper&title=BACE2+distribution+in+major+brain+cell+types+and+identification+of+novel+substrates&doi=10.26508%2Flsa.201800026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800026%26sid%3Dliteratum%253Aachs%26aulast%3DVoytyuk%26aufirst%3DI.%26aulast%3DMueller%26aufirst%3DS.%2BA.%26aulast%3DHerber%26aufirst%3DJ.%26aulast%3DSnellinx%26aufirst%3DA.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DBACE2%2520distribution%2520in%2520major%2520brain%2520cell%2520types%2520and%2520identification%2520of%2520novel%2520substrates%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2018%26volume%3D1%26doi%3D10.26508%2Flsa.201800026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alić, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portelius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gkanatsiou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschut, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunmeir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havlicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvartsberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmalm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hithersay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Startin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamburg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervushin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turmaine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovelet-Lecrux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krsnik, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šimić, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostović, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitrečić, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consortium, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strydom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nižetić, D.</span></span> <span> </span><span class="NLM_article-title">Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene-dose-sensitive AD-suppressor in human brain</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1038/s41380-020-0806-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1038%2Fs41380-020-0806-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1&author=I.+Ali%C4%87author=P.+A.+Gohauthor=A.+Murrayauthor=E.+Porteliusauthor=E.+Gkanatsiouauthor=G.+Goughauthor=K.+Y.+Mokauthor=D.+Koschutauthor=R.+Brunmeirauthor=Y.+J.+Yeapauthor=N.+L.+O%E2%80%99Brienauthor=J.+Groetauthor=X.+Shaoauthor=S.+Havlicekauthor=N.+R.+Dunnauthor=H.+Kvartsbergauthor=G.+Brinkmalmauthor=R.+Hithersayauthor=C.+Startinauthor=S.+Hamburgauthor=M.+Phillipsauthor=K.+Pervushinauthor=M.+Turmaineauthor=D.+Wallonauthor=A.+Rovelet-Lecruxauthor=H.+Soininenauthor=E.+Volpiauthor=J.+E.+Martinauthor=J.+N.+Fooauthor=D.+L.+Beckerauthor=A.+Rostagnoauthor=J.+Ghisoauthor=%C5%BD.+Krsnikauthor=G.+%C5%A0imi%C4%87author=I.+Kostovi%C4%87author=D.+Mitre%C4%8Di%C4%87author=L.+Consortiumauthor=P.+T.+Francisauthor=K.+Blennowauthor=A.+Strydomauthor=J.+Hardyauthor=H.+Zetterbergauthor=D.+Ni%C5%BEeti%C4%87&title=Patient-specific+Alzheimer-like+pathology+in+trisomy+21+cerebral+organoids+reveals+BACE2+as+a+gene-dose-sensitive+AD-suppressor+in+human+brain&doi=10.1038%2Fs41380-020-0806-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1038%2Fs41380-020-0806-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41380-020-0806-5%26sid%3Dliteratum%253Aachs%26aulast%3DAli%25C4%2587%26aufirst%3DI.%26aulast%3DGoh%26aufirst%3DP.%2BA.%26aulast%3DMurray%26aufirst%3DA.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DGkanatsiou%26aufirst%3DE.%26aulast%3DGough%26aufirst%3DG.%26aulast%3DMok%26aufirst%3DK.%2BY.%26aulast%3DKoschut%26aufirst%3DD.%26aulast%3DBrunmeir%26aufirst%3DR.%26aulast%3DYeap%26aufirst%3DY.%2BJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DN.%2BL.%26aulast%3DGroet%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DHavlicek%26aufirst%3DS.%26aulast%3DDunn%26aufirst%3DN.%2BR.%26aulast%3DKvartsberg%26aufirst%3DH.%26aulast%3DBrinkmalm%26aufirst%3DG.%26aulast%3DHithersay%26aufirst%3DR.%26aulast%3DStartin%26aufirst%3DC.%26aulast%3DHamburg%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPervushin%26aufirst%3DK.%26aulast%3DTurmaine%26aufirst%3DM.%26aulast%3DWallon%26aufirst%3DD.%26aulast%3DRovelet-Lecrux%26aufirst%3DA.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DVolpi%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DJ.%2BE.%26aulast%3DFoo%26aufirst%3DJ.%2BN.%26aulast%3DBecker%26aufirst%3DD.%2BL.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DKrsnik%26aufirst%3D%25C5%25BD.%26aulast%3D%25C5%25A0imi%25C4%2587%26aufirst%3DG.%26aulast%3DKostovi%25C4%2587%26aufirst%3DI.%26aulast%3DMitre%25C4%258Di%25C4%2587%26aufirst%3DD.%26aulast%3DConsortium%26aufirst%3DL.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DStrydom%26aufirst%3DA.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DNi%25C5%25BEeti%25C4%2587%26aufirst%3DD.%26atitle%3DPatient-specific%2520Alzheimer-like%2520pathology%2520in%2520trisomy%252021%2520cerebral%2520organoids%2520reveals%2520BACE2%2520as%2520a%2520gene-dose-sensitive%2520AD-suppressor%2520in%2520human%2520brain%26jtitle%3DMol.%2520Psychiatry%26date%3D2020%26spage%3D1%26doi%3D10.1038%2Fs41380-020-0806-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1016%2Fj.bmc.2009.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=20045648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=630-639&author=M.+S.+Malamasauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=P.+Zhouauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=M.+Pangalosauthor=P.+Reinhartauthor=A.+J.+Robichaud&title=Di-substituted+pyridinyl+aminohydantoins+as+potent+and+highly+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1016%2Fj.bmc.2009.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Barnes, Keith; Johnson, Matthew; Hui, Yu; Zhou, Ping; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Pangalos, Menelas; Reinhart, Peter; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">630-639</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of highly selective small mol. di-substituted pyridinyl aminohydantoins as β-secretase inhibitors is reported.  The more potent and selective analogs demonstrate low nanomolar potency for the BACE1 enzyme as measured in a FRET assay, and exhibit comparable activity in a cell-based (ELISA) assay.  In addn., these pyridine-aminohydantoins are highly selectivity (>500×) against the other structurally related aspartyl proteases BACE2, cathepsin D, pepsin and renin.  Our design strategy followed a traditional SAR approach and was supported by mol. modeling studies based on the previously reported aminohydantoin I.  We have taken advantage of the amino acid difference between the BACE1 and BACE2 at the S2' pocket (BACE1 Pro70 changed to BACE2 Lys86) to build ligands with >500-fold selectivity against BACE2.  The addn. of large substituents on the targeted ligand at the vicinity of this aberration has generated a steric conflict between the ligand and these two proteins, thus impacting the ligand's affinity and selectivity.  These ligands have also shown an exceptional selectivity against cathepsin D (>5000-fold) as well as the other aspartyl proteases mentioned.  One of the more potent compds. (S)-II displayed an IC50 value for BACE1 of 10 nM, and exhibited cellular activity with an EC50 value of 130 nM in the ELISA assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPjXCZYzfhLVg90H21EOLACvtfcHk0ljZslyHJEvrqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D&md5=7b509e226d91b162059777507e7f8463</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDi-substituted%2520pyridinyl%2520aminohydantoins%2520as%2520potent%2520and%2520highly%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D630%26epage%3D639%26doi%3D10.1016%2Fj.bmc.2009.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">O’Neill, B. T.</span>; <span class="NLM_string-name">Barreiro, G.</span>; <span class="NLM_string-name">Lachapelle, E. A.</span>; <span class="NLM_string-name">Rogers, B. N.</span></span> <span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>h</i>)-yl-1,3-thiazol-4-yl) Amides as Inhibitors of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO2,015,155,626A1</span>, Oct 15, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=E.+M.+Beck&author=C.+R.+Butler&author=L.+Zhang&author=B.+T.+O%E2%80%99Neill&author=G.+Barreiro&author=E.+A.+Lachapelle&author=B.+N.+Rogers&title=Preparation+of+N-%282-Amino-6-methyl-4%2C4a%2C5%2C6-tetrahydropyrano%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-8a%288h%29-yl-1%2C3-thiazol-4-yl%29+Amides+as+Inhibitors+of+Beta-site+Amyloid+Precursor+Protein+Cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520N-%25282-Amino-6-methyl-4%252C4a%252C5%252C6-tetrahydropyrano%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-8a%25288h%2529-yl-1%252C3-thiazol-4-yl%2529%2520Amides%2520as%2520Inhibitors%2520of%2520Beta-site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Hembre, E. J.</span>; <span class="NLM_string-name">Lopez, J. E.</span>; <span class="NLM_string-name">Winneroski, L. L.,  Jr.</span>; <span class="NLM_string-name">Woods, T. A.</span>; <span class="NLM_string-name">Mcmahon, J. A.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Amino-5-(1,1-difluoroalkyl)-4,4<i>a</i>,5,7-tetrahydrofuro[3,4-<i>d</i>][1,3]thiazin-7<i>a</i>-yl-4-fluorophenyl-5-(1,2,4-triazol-1-yl)pyrazine-2-carboxamides as Selective BACE1 Inhibitors</span>. <span class="NLM_patent">US20,160,244,465A1</span>, Aug 25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+J.+Richards&author=E.+J.+Hembre&author=J.+E.+Lopez&author=L.+L.+Winneroski&author=T.+A.+Woods&author=J.+A.+Mcmahon&title=Preparation+of+2-Amino-5-%281%2C1-difluoroalkyl%29-4%2C4a%2C5%2C7-tetrahydrofuro%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-7a-yl-4-fluorophenyl-5-%281%2C2%2C4-triazol-1-yl%29pyrazine-2-carboxamides+as+Selective+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DS.%2BJ.%26atitle%3DPreparation%2520of%25202-Amino-5-%25281%252C1-difluoroalkyl%2529-4%252C4a%252C5%252C7-tetrahydrofuro%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-7a-yl-4-fluorophenyl-5-%25281%252C2%252C4-triazol-1-yl%2529pyrazine-2-carboxamides%2520as%2520Selective%2520BACE1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span>; <span class="NLM_string-name">Amegadzie, A.</span>; <span class="NLM_string-name">Bourbeau, M. P.</span>; <span class="NLM_string-name">Brown, J. A.</span>; <span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Frohn, M. J.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Pettus, L. H.</span>; <span class="NLM_string-name">Qian, W.</span>; <span class="NLM_string-name">Reeves, C. M.</span>; <span class="NLM_string-name">Siegmund, A. C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Vinyl Fluoride Cyclopropyl Fused Thiazin-2-amine Compounds as Beta-secretase Inhibitors and Methods of Use</span>. <span class="NLM_patent">WO2,017,024,180A1</span>, Feb 9, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+R.+Allen&author=A.+Amegadzie&author=M.+P.+Bourbeau&author=J.+A.+Brown&author=N.+Chen&author=M.+J.+Frohn&author=L.+Liu&author=Q.+Liu&author=L.+H.+Pettus&author=W.+Qian&author=C.+M.+Reeves&author=A.+C.+Siegmund&title=Preparation+of+Vinyl+Fluoride+Cyclopropyl+Fused+Thiazin-2-amine+Compounds+as+Beta-secretase+Inhibitors+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DPreparation%2520of%2520Vinyl%2520Fluoride%2520Cyclopropyl%2520Fused%2520Thiazin-2-amine%2520Compounds%2520as%2520Beta-secretase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Chapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of clinical candidate PF-06751979: A potent, brain penetrant, β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor lacking hypopigmentation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4476</span>– <span class="NLM_lpage">4504</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00246</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00246" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4476-4504&author=B.+T.+O%E2%80%99Neillauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=C.+E.+Nolanauthor=C.+Gonzalesauthor=L.+Zhangauthor=S.+D.+Doranauthor=K.+Laphamauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=G.+Barreiroauthor=X.+Houauthor=L.+A.+Martinez-Alsinaauthor=B.+N.+Rogersauthor=A.+Villalobosauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=E.+A.+La+Chapelleauthor=C.+Changauthor=L.+F.+Lanyonauthor=C.+M.+Steppanauthor=A.+Robshawauthor=K.+Halesauthor=G.+G.+Boucherauthor=K.+Pandherauthor=C.+Houleauthor=C.+W.+Ambroiseauthor=D.+Karanianauthor=D.+Riddellauthor=K.+R.+Balesauthor=M.+A.+Brodney&title=Design+and+synthesis+of+clinical+candidate+PF-06751979%3A+A+potent%2C+brain+penetrant%2C+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+lacking+hypopigmentation&doi=10.1021%2Facs.jmedchem.8b00246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16eR"><div class="casContent"><span class="casTitleNuber">16e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation</span></div><div class="casAuthors">O'Neill, Brian T.; Beck, Elizabeth M.; Butler, Christopher R.; Nolan, Charles E.; Gonzales, Cathleen; Zhang, Lei; Doran, Shawn D.; Lapham, Kimberly; Buzon, Leanne M.; Dutra, Jason K.; Barreiro, Gabriela; Hou, Xinjun; Martinez-Alsina, Luis A.; Rogers, Bruce N.; Villalobos, Anabella; Murray, John C.; Ogilvie, Kevin; La Chapelle, Erik A.; Chang, Cheng; Lanyon, Lorraine F.; Steppan, Claire M.; Robshaw, Ashley; Hales, Katherine; Boucher, Germaine G.; Pandher, Karamjeet; Houle, Christopher; Ambroise, Claude W.; Karanian, David; Riddell, David; Bales, Kelly R.; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4476-4504</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2.  The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphol. resulting in a depigmentation phenotype.  Herein, the authors describe the identification of clin. candidate PF-06751979 (I), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2.  Chronic dosing of I for up to 9 mo in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1F61vo0jBbVg90H21EOLACvtfcHk0ljwPQcorwcuHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D&md5=3d8cae0bb20298e66f6da1c26cf8d5bc</span></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DLapham%26aufirst%3DK.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DLa%2BChapelle%26aufirst%3DE.%2BA.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DLanyon%26aufirst%3DL.%2BF.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DHales%26aufirst%3DK.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DPandher%26aufirst%3DK.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DAmbroise%26aufirst%3DC.%2BW.%26aulast%3DKaranian%26aufirst%3DD.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520clinical%2520candidate%2520PF-06751979%253A%2520A%2520potent%252C%2520brain%2520penetrant%252C%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520lacking%2520hypopigmentation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4476%26epage%3D4504%26doi%3D10.1021%2Facs.jmedchem.8b00246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bäck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span> <span> </span><span class="NLM_article-title">Toward β-secretase-1 inhibitors with improved isoform selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3491</span>– <span class="NLM_lpage">3502</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3491-3502&author=P.+Johanssonauthor=K.+Kasperssonauthor=I.+K.+Gurrellauthor=E.+B%C3%A4ckauthor=S.+Eketj%C3%A4llauthor=C.+W.+Scottauthor=G.+Cebersauthor=P.+Thorneauthor=M.+J.+McKenzieauthor=H.+Beatonauthor=P.+Daveyauthor=K.+Kolmodinauthor=J.+Holenzauthor=M.+E.+Dugganauthor=S.+B.+Haeberleinauthor=R.+W.+B%C3%BCrli&title=Toward+%CE%B2-secretase-1+inhibitors+with+improved+isoform+selectivity&doi=10.1021%2Facs.jmedchem.7b01716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16fR"><div class="casContent"><span class="casTitleNuber">16f</span><div class="casTitle"><span class="NLM_cas:atitle">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span></div><div class="casAuthors">Johansson, Patrik; Kaspersson, Karin; Gurrell, Ian K.; Baeck, Elisabeth; Eketjaell, Susanna; Scott, Clay W.; Cebers, Gvido; Thorne, Philip; McKenzie, Michael J.; Beaton, Haydn; Davey, Paul; Kolmodin, Karin; Holenz, Joerg; Duggan, Mark E.; Budd Haeberlein, Samantha; Burli, Roland W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3491-3502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ prodn., and has been indicated to play a key role in the pathogenesis of Alzheimer's disease.  The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein.  To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors.  Cocrystal structures of 47 compds. were analyzed and clustered according to their selectivity profiles.  Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket.  Several new mols. were designed and tested to make use of this observation.  The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead mol. 28, which exhibited ∼50-fold selectivity.  Compared to a nonselective BACE1/2 inhibitor, 28 showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functional selectivity of this inhibitor class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCCtmcFz6HrVg90H21EOLACvtfcHk0lg_TJygzWVG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D&md5=46ce3d839d3153d848c1ae0209263634</span></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DB%25C3%25A4ck%26aufirst%3DE.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DThorne%26aufirst%3DP.%26aulast%3DMcKenzie%26aufirst%3DM.%2BJ.%26aulast%3DBeaton%26aufirst%3DH.%26aulast%3DDavey%26aufirst%3DP.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26atitle%3DToward%2520%25CE%25B2-secretase-1%2520inhibitors%2520with%2520improved%2520isoform%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3491%26epage%3D3502%26doi%3D10.1021%2Facs.jmedchem.7b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegmund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of AM-6494: A potent and orally efficacious β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with in vivo selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2263</span>– <span class="NLM_lpage">2281</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2263-2281&author=L.+H.+Pettusauthor=M.+P.+Bourbeauauthor=J.+Bradleyauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=D.+Hickmanauthor=M.+Johnsonauthor=Q.+Liuauthor=J.+R.+Manningauthor=A.+Nanezauthor=A.+C.+Siegmundauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=J.+R.+Allenauthor=S.+Wood&title=Discovery+of+AM-6494%3A+A+potent+and+orally+efficacious+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+with+in+vivo+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b01034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16gR"><div class="casContent"><span class="casTitleNuber">16g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2</span></div><div class="casAuthors">Pettus Liping H; Bourbeau Matthew P; Bradley Jodi; Bartberger Michael D; Chen Kui; Hickman Dean; Johnson Michael; Liu Qingyian; Manning James R; Nanez Adrian; Siegmund Aaron C; Wen Paul H; Whittington Douglas A; Allen Jennifer R; Wood Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2263-2281</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is an aspartyl protease that plays a key role in the production of amyloid β (Aβ) in the brain and has been extensively pursued as a target for the treatment of Alzheimer's disease (AD).  BACE2, an aspartyl protease that is structurally related to BACE1, has been recently reported to be involved in melanosome maturation and pigmentation.  Herein, we describe the development of a series of cyclopropylthiazines as potent and orally efficacious BACE1 inhibitors.  Lead optimization led to the identification of 20, a molecule with biochemical IC50 BACE2/BACE1 ratio of 47.  Administration of 20 resulted in no skin/fur color change in a 13-day mouse hypopigmentation study and demonstrated robust and sustained reduction of CSF and brain Aβ40 levels in rat and monkey pharmacodynamic models.  On the basis of a compelling data package, 20 (AM-6494) was advanced to preclinical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmgrDHvGragzjk2McQZ6XmfW6udTcc2eYHkNnsZzCQNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D&md5=abc7ed1f6b97a705d9b43ea992712a97</span></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DManning%26aufirst%3DJ.%2BR.%26aulast%3DNanez%26aufirst%3DA.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520AM-6494%253A%2520A%2520potent%2520and%2520orally%2520efficacious%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520with%2520in%2520vivo%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2263%26epage%3D2281%26doi%3D10.1021%2Facs.jmedchem.9b01034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0liJMM3gZliTjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huggins, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidor, B.</span></span> <span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1444</span>, <span class="refDoi"> DOI: 10.1021/jm2010332</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design&doi=10.1021%2Fjm2010332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0liJMM3gZliTjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444%26doi%3D10.1021%2Fjm2010332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de
Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de%0ADiegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+From+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lgQnyJ-LPIPjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <i>The
cocrystal structure was obtained at Proteros according to the procedure
described in ref 20b</i>;  (accessed September 10, 2017)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The%0Acocrystal+structure+was+obtained+at+Proteros+according+to+the+procedure%0Adescribed+in+ref+20b%3B+%28accessed+September+10%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%250Acocrystal%2520structure%2520was%2520obtained%2520at%2520Proteros%2520according%2520to%2520the%2520procedure%250Adescribed%2520in%2520ref%252020b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuppuleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debulpaep, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gast, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabulovski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusznir, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miscenic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, A.</span></span> <span> </span><span class="NLM_article-title">Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1107/S0907444913006574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1107%2FS0907444913006574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=23695257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1124-1137&author=D.+W.+Bannerauthor=B.+Gsellauthor=J.+Benzauthor=J.+Bertschingerauthor=D.+Burgerauthor=S.+Brackauthor=S.+Cuppuleriauthor=M.+Debulpaepauthor=A.+Gastauthor=D.+Grabulovskiauthor=M.+Hennigauthor=H.+Hilpertauthor=W.+Huberauthor=A.+Kuglstatterauthor=E.+Kusznirauthor=T.+Laeremansauthor=H.+Matileauthor=C.+Miscenicauthor=A.+C.+Ruferauthor=D.+Schlatterauthor=J.+Steyaertauthor=M.+Stihleauthor=R.+Thomaauthor=M.+Weberauthor=A.+Ruf&title=Mapping+the+conformational+space+accessible+to+BACE2+using+surface+mutants+and+cocrystals+with+Fab+fragments%2C+Fynomers+and+Xaperones&doi=10.1107%2FS0907444913006574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones</span></div><div class="casAuthors">Banner, David W.; Gsell, Bernard; Benz, Joerg; Bertschinger, Julian; Burger, Dominique; Brack, Simon; Cuppuleri, Simon; Debulpaep, Maja; Gast, Alain; Grabulovski, Dragan; Hennig, Michael; Hilpert, Hans; Huber, Walter; Kuglstatter, Andreas; Kusznir, Eric; Laeremans, Toon; Matile, Hugues; Miscenic, Christian; Rufer, Arne C.; Schlatter, Daniel; Steyaert, Jan; Stihle, Martine; Thoma, Ralf; Weber, Martin; Ruf, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1124-1137</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The aspartic protease BACE2 is responsible for the shedding of the transmembrane protein Tmem27 from the surface of pancreatic β-cells, which leads to inactivation of the β-cell proliferating activity of Tmem27.  This role of BACE2 in the control of β-cell maintenance suggests BACE2 as a drug target for diabetes.  Inhibition of BACE2 has recently been shown to lead to improved control of glucose homeostasis and to increased insulin levels in insulin-resistant mice.  BACE2 has 52% sequence identity to the well studied Alzheimer's disease target enzyme β-secretase (BACE1).  High-resoln. BACE2 structures would contribute significantly to the investigation of this enzyme as either a drug target or anti-target.  Surface mutagenesis, BACE2-binding antibody Fab fragments, single-domain camelid antibody VHH fragments (Xaperones) and Fyn-kinase-derived SH3 domains (Fynomers) were used as crystn. helpers to obtain the first high-resoln. structures of BACE2.  Eight crystal structures in six different packing environments define an ensemble of low-energy conformations available to the enzyme.  Here, the different strategies used for raising and selecting BACE2 binders for cocrystn. are described and the crystn. success, crystal quality and the time and resources needed to obtain suitable crystals are compared.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7cIGSzKlOorVg90H21EOLACvtfcHk0lgQnyJ-LPIPjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2ltL0%253D&md5=902a9036109be32de055c4ad73aeacdf</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1107%2FS0907444913006574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913006574%26sid%3Dliteratum%253Aachs%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DBertschinger%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DD.%26aulast%3DBrack%26aufirst%3DS.%26aulast%3DCuppuleri%26aufirst%3DS.%26aulast%3DDebulpaep%26aufirst%3DM.%26aulast%3DGast%26aufirst%3DA.%26aulast%3DGrabulovski%26aufirst%3DD.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DKusznir%26aufirst%3DE.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMiscenic%26aufirst%3DC.%26aulast%3DRufer%26aufirst%3DA.%2BC.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26atitle%3DMapping%2520the%2520conformational%2520space%2520accessible%2520to%2520BACE2%2520using%2520surface%2520mutants%2520and%2520cocrystals%2520with%2520Fab%2520fragments%252C%2520Fynomers%2520and%2520Xaperones%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1124%26epage%3D1137%26doi%3D10.1107%2FS0907444913006574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, F.</span></span> <span> </span><span class="NLM_article-title">Self-consistent description of a metal–water interface by the Kohn–Sham density functional theory and the three-dimensional reference interaction site model</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10095</span>– <span class="NLM_lpage">10112</span>, <span class="refDoi"> DOI: 10.1063/1.478883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=10.1063%2F1.478883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADyaK1MXivV2mu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1999&pages=10095-10112&author=A.+Kovalenkoauthor=F.+Hirata&title=Self-consistent+description+of+a+metal%E2%80%93water+interface+by+the+Kohn%E2%80%93Sham+density+functional+theory+and+the+three-dimensional+reference+interaction+site+model&doi=10.1063%2F1.478883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Self-consistent description of a metal-water interface by the Kohn-Sham density functional theory and the three-dimensional reference interaction site model</span></div><div class="casAuthors">Kovalenko, Andriy; Hirata, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10095-10112</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The authors have developed a self-consistent description of an interface between a metal and a mol. liq. by combination of the d. functional theory in the Kohn-Sham formulation (KS DFT) for the electronic structure, and the 3-dimensional generalization of the ref. interaction site model (3-dimensional RISM) for the classical site distribution profiles of liq.  The electron and classical subsystems are coupled in the mean field approxn.  The procedure takes account of many-body effects of dense fluid on the metal-liq. interactions by averaging the pseudopotentials of liq. mols. over the classical distributions of the liq.  The proposed approach is substantially less time-consuming as compared to a Car-Parrinello-type simulation since it replaces mol. dynamics with the integral equation theory of mol. liqs.  The calcn. was performed for pure H2O at normal conditions in contact with the (100) face cubic centered (fcc.) surface of a metal roughly modeled after Cu.  The results are in good agreement with the Car-Parrinello simulation for the same metal model.  The shift of the Fermi level due to the presence of H2O conforms with expt.  The electron distribution near an adsorbed H2O mol. is affected by dense H2O, and so the metal-H2O attraction follows the shapes of the metal effective electrostatic potential.  For the metal model employed, it is strongest at the hollow site adsorption positions, and H2O mols. are adsorbed mainly at the hollow and bridge site positions rather than over metal atoms.  Layering of H2O mols. near the metal surface is found.  In the 1st hydration layer, adsorbed H2O mols. are oriented in parallel to the surface or tilted with hydrogens mainly outwards the metal.  This orientation at the potential of zero charge agrees with expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_fv_k3tQTf7Vg90H21EOLACvtfcHk0lhKvWRVvo3Ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivV2mu7o%253D&md5=52ac54fb183b01d92fd53347ec5b2aa0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1063%2F1.478883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.478883%26sid%3Dliteratum%253Aachs%26aulast%3DKovalenko%26aufirst%3DA.%26aulast%3DHirata%26aufirst%3DF.%26atitle%3DSelf-consistent%2520description%2520of%2520a%2520metal%25E2%2580%2593water%2520interface%2520by%2520the%2520Kohn%25E2%2580%2593Sham%2520density%2520functional%2520theory%2520and%2520the%2520three-dimensional%2520reference%2520interaction%2520site%2520model%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1999%26volume%3D110%26spage%3D10095%26epage%3D10112%26doi%3D10.1063%2F1.478883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <i>Molecular
Operating Environment (MOE), 2016.01</i>; <span class="NLM_publisher-name">Chemical
Computing Group ULC</span>: 1010 Sherbooke St. West, Suite
#910, Montreal, QC, Canada, H3A 2R7, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular%0AOperating+Environment+%28MOE%29%2C+2016.01%3B+Chemical%0AComputing+Group+ULC%3A+1010+Sherbooke+St.+West%2C+Suite%0A%23910%2C+Montreal%2C+QC%2C+Canada%2C+H3A+2R7%2C+2020."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMolecular%250AOperating%2520Environment%2520%2528MOE%2529%252C%25202016.01%26pub%3DChemical%250AComputing%2520Group%2520ULC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lhKvWRVvo3Ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-<i>tert</i>-Butanesulfinyl imines: versatile intermediates for the asymmetric synthesis of amines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">984</span>– <span class="NLM_lpage">995</span>, <span class="refDoi"> DOI: 10.1021/ar020066u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar020066u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=984-995&author=J.+A.+Ellmanauthor=T.+D.+Owensauthor=T.+P.+Tang&title=N-tert-Butanesulfinyl+imines%3A+versatile+intermediates+for+the+asymmetric+synthesis+of+amines&doi=10.1021%2Far020066u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Far020066u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far020066u%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DN-tert-Butanesulfinyl%2520imines%253A%2520versatile%2520intermediates%2520for%2520the%2520asymmetric%2520synthesis%2520of%2520amines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D35%26spage%3D984%26epage%3D995%26doi%3D10.1021%2Far020066u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J0P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J0P','PDB','4J0P'); return false;">PDB: 4J0P</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01858">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18510"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01858?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01858</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings, BACE1 IC<sub>50</sub>, BACE2 IC<sub>50</sub>, and cellular Aβ42 IC<sub>50</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental procedures and characterization data for compound <b>5</b>; HPLC spectra for final compounds; Figure S1, conformational analysis of 5-substituted oxazines; Figure S2, superposition of the flap in the <b>7</b>-bound BACE2 and apo-BACE2; Figure S3, NOESY analysis for compound <b>26</b>; Chart S1, biochemical profiles of compounds <b>7</b> and <b>8a</b>–<b>8c</b>; experimental procedures for BACE2 biochemical and BACE1 and BACE2 binding assays; and crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_001.csv">jm0c01858_si_001.csv (0.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01858/suppl_file/jm0c01858_si_007.pdf">jm0c01858_si_007.pdf (937.15 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><b>1</b> bound to BACE1: 7D2V; <b>1</b> bound to BACE2: 7D5B; <b>3</b> bound to BACE1: 7D2X; <b>7</b> bound to BACE1: 7D5A; and <b>7</b> bound to BACE2: 7D5U.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01858&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01858%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01858" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992aeb0f381943","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
